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 The swine industry is ever evolving as it strives to produce healthy, wholesome 
pork for consumers. As such, the industry is constantly looking for ways to improve 
production and reduce costs. This includes using novel feed ingredients to reduce cost 
and improve animal health, genetic selection for increased performance, and vaccines to 
attenuate or prevent illness. Research plays a significant role in assessing the 
effectiveness of these strategies. Overall, the objective of this thesis was to assess how 
genetic selection, vaccines, and feed additives may impact growth performance, health, 
nutrient digestibility, and the microbiome. 
 In Chapter 2, pigs were either infected with or vaccinated for PCV2. Fecal 
samples taken from these pigs were used to assess changes in the microbiome. Overall, 
the microbiome did not differ at the phylum level, although some organisms were shown 
to be positively and negatively associated with growth and IgG production. 
 In Chapter 3, experiments were performed to assess the impact of genetic 
selection for PCV2 resistance on nursery and long-term performance of pigs. Pigs 
resistant to PCV2 infection had reduced viremia and IgG production. Despite no overall 
 
 
effect on growth performance, the resistant genotypes were found to have lower 
production costs, especially when infected with PCV2. 
 In Chapter 4, pigs were supplemented with tryptophan to improve post-weaning 
response Tryptophan improved feed efficiency in experiment 1 and reduced production 
costs. Tryptophan did not provide the same benefit in experiment 2. Supplementation of 
tryptophan numerically increased Lactobacillus abundance in experiment 1, but not in 
experiment 2. 
 In Chapter 5, a series of cell culture experiments were performed to assess the 
effects of rhamnolipids on IPEC-J2 cells and jejunal explants. Rhamnolipid 
concentrations exceeding 0.01% were found to be cytotoxic. Lower concentrations were 
found to be less cytotoxic, but reduced transepithelial resistance in a dose dependent 
fashion. Secretion of interleukin-8, a marker of inflammation, was observed to be similar 
to control and LPS samples. Jejunum explants treated with 0.5% rhamnolipid had an IL-8 
response higher than controls.  
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CHAPTER 1: LITERATURE REVIEW 
 
 
 
Introduction 
 
 With an ever-growing world population, the need for healthy and nutritious foods 
to feed this population continues to be an issue in 21st century. Producers continue to 
work towards improving efficiency and sustainability while maintaining a profitable 
enterprise. The current global population is estimated to be 7.6 billion people and 
growing at a rate of 1.09% per annum (Worldometers, 2018). Despite the great carrying 
capacity of the planet, effects of population growth (i.e., urban sprawl) has led to a loss of 
31 million acres of agricultural land since 1981 (Sorensen et al., 2018). In addition, the 
effect of climate change on increasing severity of weather systems can potentially 
damage production of crops and animals and devastate infrastructure of affected areas. 
Thus, it is important for farmers and producers to continue pushing the efficiency of 
production to maximize land carrying capacity of agricultural products. 
 
Swine Production 
 
Pork production is the top meat commodity produced across the world, with beef 
and broiler (poultry) production being the other two. Global production of beef, broiler 
meat, and pork, and is expected to reach 63.0, 92.5, and 113.5 million tons, respectively, 
in 2018 (USDA-FAS, 2018). In regard to pork, according to USDA-FAS, production has 
been led by China, the European Union (EU), and the United States with 54.7, 23.3, and 
12.2 million metric tons expected in 2018, respectively. Of the 8.3 million tons of pork 
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exported, the EU and US are expected to account for 35 and 32% of global exports, 
respectively, while China accounts for 20% of global imports. Hog production in the US 
is estimated to generate over $20 billion in gross income (NPPC, 2018). At present, 
December-February 2018, the U.S. pig inventory totals 72.9 million head. This includes a 
breeding inventory of 6.2 million head with an average litter rate of 10.58 piglets and a 
market hog inventory of 66.7 million head (USDA-NASS, 2018).  
Swine production encompasses multiple parts. Breeding companies maintain 
nucleus herds for creating genetic lines to maximize desirable maternal traits (e.g., 
number of piglets born). Progeny from these groups are used to maintain nucleus herds 
while also being shipped to other sites to be used for multiplication. Gilts from these 
herds are than developed and bred using boar semen from terminal lines. These lines are 
selected for rapid growth and meat quality characteristics to produce market animals for 
slaughter. Thus, the focus on reproduction and propagation of favorable genetics (e.g., 
maternal traits, disease resistance, muscling) is important. The market side of swine 
production focuses on the growth and finishing of the terminal line pigs that will be sold 
to slaughter and ultimately generate profit for commercial swine producers. 
Swine health is important in all facets of the industry. Stress and illness can 
increase producer’s costs due to added treatments, decreased feed efficiency and added 
days on feed, or pig mortality. Over the years, strides have been made to decrease stress 
and improve herd health. Improvement in animal welfare training, monitoring, and 
regulation coupled with well-designed facilities, including sow housing and slaughter 
plants, has led to better animal handling practices, improved meat quality, and improved 
public perception of the swine industry (Grandin, 2017).  Although it should be noted that 
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the latter continues to be challenge for the livestock industry as a whole. At the same 
time, herd health has improved as a result of using genetics, vaccines, and improved 
biosecurity. Additionally, improvement in the nutritional value of diets has facilitated the 
near maximal growth rates of pigs. Inclusion of feed additives in the diet has also aimed 
to improve performance and prevent health challenges. Despite these efforts, disease can 
still occur across all levels of production. In these cases, antibiotics may be given to help 
fight bacterial illness or prevent secondary infections that can occur.  
 
Stress 
 
Stress can be prominent factor in the health status of an animal. Causes of stress 
can be attributed to a number of sources including environment, social, handling, and 
transport to name a few (Campbell et al., 2013). A newly weaned piglet will typically 
experience several stressors in the 24-hour period post weaning. These include removal 
from the dam, handling, transport, thermal conditions in transit to nursery barn, and 
social hierarchy establishment in their new pens. Piglets need time to adjust to the new 
conditions and including finding feed troughs and waterers for consumption. Failure to 
adapt may result in pigs falling behind their cohorts leading to smaller body size, illness, 
or death. Stress can have a broad impact on host physiology regarding energy usage, 
hormone secretion, and tissue function. Intestinal function can be hampered by stress 
through decreases in gut barrier function, such as increased intestinal permeability, 
allowing bacteria and toxins to translocate across the barrier into other host tissue and 
blood (Moeser et al., 2017). Ultimately, this can lead to illness forcing an immune 
response, which will repartition nutrients and tissue proteins towards this response.  
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Disease 
 
A large number of infectious diseases exist that can affect pigs. These diseases 
may originate from bacteria (Streptococcus suis), viruses (Porcine Epidemic Diarrhea 
Virus, PEDV; Porcine Respiratory and Reproductive Syndrome Virus, PRRSV), or other 
microbial origins. Disease may ultimately cost the industry millions of dollars in lost 
productivity (Schulz and Tonsor, 2015; Nathues et al., 2017). The severity of disease 
depends largely on the type of the disease, the severity of the strain, and the age of pigs 
when infected. Additionally ambient temperature may play a role as well with viruses 
generally being more prevalent in cooler months than hot ones (Pujols and Segalés, 
2014). For example, PEDV, which caused diarrhea in pigs, was more likely to cause high 
mortality in prewean pigs, whereas older pigs display some illness but little to no 
mortality (Stevenson et al., 2013). On the other hand, PRRSV can negatively affect the 
feed efficiency, nutrient digestibility of grower pigs (Schweer et al., 2017a), but can 
reduce farrowing rate in sows (Rossow, 1998). Severity of disease is determined by the 
virulence of the strain as some strains may result in clinical signs and mortality whereas 
less virulent strains may only be subclinical, and animals appear to “walk through” the 
challenge (Brockmeier et al., 2017). Furthermore, diseases like PRRSV can alter the 
immune response, such as suppressing the interferon response (Patel et al., 2010), which 
is important in the antiviral response, subsequently leaving the animal open to secondary 
challenges. 
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Porcine Circovirus  
 
Porcine circovirus (PCV) is a single stranded DNA virus of the family 
Circoviridae and is classified as type 1 or type 2, although a type 3 has recently been 
identified (Palinski et al., 2017). As reviewed by Segalés (2012), porcine circovirus type 
2 (PCV2) is considered to be ubiquitous across the world, although the occurrence of 
clinical disease is lower, especially with PCV2 vaccines on the market. As a result, some 
herds may have subclinical PCV2 infections that reduce growth of animals without 
presenting clinical signs (Jacobsen et al., 2009). Porcine circovirus diseases may be 
labeled differently depending on the main clinical signs shown (Opriessnig et al., 2007). 
The most prominent, PCV2 systemic disease (PCV2-SD), has also been known as post 
weaning multisystemic wasting syndrome (PMWS), has been characterized by reduced 
weight gain or weight loss resulting in lowered performance in pigs (Rosell et al., 1999). 
It may be further coupled with respiratory and gastrointestinal clinical signs and 
lymphocyte depletion (Rosell et al., 1999). Additionally, respiratory or gastrointestinal 
tract issues may be also classified as PCV2 lung disease or PCV2 enteric disease 
respectively (Segalés, 2012). Like PCV2-SD, these types will also have a high titer of 
PCV2 and immune responses in the local tissues without microscopic lesions in the 
lymphoid tissues typically found in PCV2-SD (Segalés, 2012). Furthermore, PCV2 may 
also cause reproductive disease resulting in abortions or mummifications of the fetuses or 
alter return to estrus (Madson et al., 2009). In some cases, PCV2 in combination with 
other pathogens can cause porcine respiratory disease complex (PRDC), which often 
serves as a clinical sign of PCV2-SD (Hansen et al., 2010). In a review by Chae (2016), 
the summarized data showed that PCV2 viremia and lesions can be enhanced by an 
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earlier PRRSV infection or vaccination while the reverse, PCV2 infection or vaccination, 
has no effect on PRRSV. Similarly, Mycoplasma hyopneumoniae infections or 
vaccination can also increase PCV2 severity and lesions, but PCV2 infection or 
vaccination has no effect on M. hyopneumoniae illness. These responses are primarily 
due to PRRSV and M. hyopneumoniae infections stimulating proliferation of immune 
cells, a primary target of PCV2. Thus, in commercial herds where PCV2, PRRSV, and M. 
hyopneumoniae are prevalent, vaccination for PCV2 is a priority.  
 Clinical incidence of PCV2-related disease has largely been mitigated due to the 
development and use of PCV2 vaccines. Four vaccines are currently on the market for 
use in the United States and other areas in the world: Ingelvac CircoFLEX (Boehringer-
Ingelheim), Circumvent PCV (Merck), Fostera (Zoetis), and Circovac (Merial). A recent 
meta-analysis by da Silva et al. (2014) found that all four vaccines are associated with 
increased growth in pigs from wean to finish. However, the estimated grow improvement 
varies with each vaccine.  
 
Antimicrobials 
 
Antimicrobials are a broad group of compounds that can have an effect on the 
microbes inhabiting the bodies of animals. Antibiotics are the classic and most commonly 
used antimicrobials due to their ability to kill or inhibit microbial growth (Gaskins et al., 
2002). There are numerous classes of antibiotics such as penicillins, tetracyclines, and 
quinolones to name a few, but it is their mode of action, which is important. The majority 
of antibiotics are capable of disrupting one of three categories of microbial growth: 
nucleic acid synthesis, protein synthesis, or cell wall synthesis. Due to the commonality 
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of these processes, some antibiotics are considered broad spectrum for their ability to 
inhibit or kill a diverse group of organisms.  
 Antibiotics have been beneficial to the livestock industry as they were useful in 
controlling illness in herds and thus reducing morbidity and mortality at both low and 
high levels of disease incidence (Cromwell, 2002). An additional benefit was realized as 
antibiotics could help suppress subclinical illness when fed independently of specific 
disease resulting in increased growth performance (Cromwell, 2002). This led to 
continued use of antibiotics for growth promotion purposes. Usage of antibiotics has been 
beneficial for swine reproduction as it generally improved sow farrowing rate, piglets 
born alive, and improved piglet survivability to weaning (Cromwell, 2002). Overall, 
usage of antibiotics has been useful for herd health and saving the producer $2.99, 0.69, 
0.30 per pig in the grow-finish, breeding and lactation periods respectively (Cromwell, 
2002). Despite all the benefits, one consequence of prolonged usage of antibiotics, 
regardless of human or animal use, has been the development of antibiotic resistance 
strains of disease, such as drug resistant E. coli and Salmonella, and methicillin-resistant 
Staphylococcus aureus (MRSA), some of the more common resistant pathogenic bacteria 
found in humans (Marshall and Levy, 2011). Due to the increase in incidence of resistant 
bacteria, there has been concern about poorly regulated use of antibiotics in the livestock 
industry and limiting the use of “medically important” antibiotics needed for human 
health. This is especially important with last resort antibiotics such as vancomycin, 
because currently, there is a risk of vancomycin resistant S. aureus (McGuinness et al., 
2017).  
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 The Animal Drug Availability Act of 1996 (ADAA) was designed to increase the 
number of newly approved animal drugs with support from the FDA and animal industry 
groups (FDA, 1996). The ADAA allowed for the creation of a new drug category called 
“Veterinary Feed Directive (VFD) Drugs”, which deals with the approval and use of new 
animal drugs in animal feed. However, a licensed veterinarian can only administer a VFD 
drug through prescription. Overall, the goal of the VFD is reduce off label use of drugs, 
to facilitate judicious use of medically important antimicrobials, and to allow better 
tracking of drug use. The VFD no longer allows the use of VFD drugs for growth 
promotion purposes. Usage of medicated feeds had been common practice to help ease 
the weaning transition in pigs both for disease and growth promotion purposes 
(Cromwell, 2002). This has further added pressure to find new or improve other 
antimicrobials to fill the gap left by the loss of antibiotics (Dębski, 2016). 
 
Antibiotic Alternatives 
 
Antibiotic alternatives are antimicrobials that are being used in lieu of antibiotics. 
Many alternatives have been researched and used prior to the VFD going into full effect. 
A list of common antibiotic alternatives can be found in Table 1.1. Alternatives vary in 
terms of direct or indirect action. Lysozyme, minerals, and essential oils typically have 
more direct action against bacteria (Cromwell, 2002; Oliver and Wells, 2015; Omonijo et 
al., 2018). Indirect action relies on the growth of beneficial bacteria that can out compete 
pathogenic bacteria either by supplying them directly (probiotics/DFMs) or feeding them 
via prebiotics, oligosaccharides, or fiber. Additionally, metabolites produced by the gut 
bacteria may stimulate antimicrobial peptide secretions from the host Paneth cells 
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(Ouellette, 2010). Pigs are believed to not have Paneth cells (Trautman and Fiebiger, 
1952), although some histological (Myer, 1982) and transcription factor (Gonzalez et al., 
2013) evidence of hallmark Paneth expression has been published. 
Although numerous antibiotic alternatives are on the market and have been 
researched, the efficacy of these products has been highly variable in terms of response. 
This could be due to genetics, conditions, and dosage rate. A meta-analysis by Schweer et 
al. (2017b) looked at the impact of antibiotic alternatives on pig ADG relative to controls 
(Figure 1.1). Over a total of 2034 trials, antibiotic alternatives exhibited a positive impact 
on average daily gain, average daily feed intake, and feed efficiency occurred at a rate of 
28.6, 14.3, and 17.3%, respectively. The majority of trials saw no change in growth and 
very few studies observed negative results (< 3.4%), although this could be a limited by 
the analysis method or presence of published studies. 
 
  
 20 
Table 1.1. List of antibiotic alternatives and descriptions1 
Probiotics/Direct Fed Microbials (DFM) Bacterial organisms (Lactobacillus, Bacillus) 
considered beneficial by competing against 
other bacteria or through secondary 
metabolite production (Allen et al., 2013) 
Prebiotics/oligosaccharides Carbohydrates (fructo-, galacto-, mannan-
oligosaccharides, inulin) or other compounds 
used by beneficial gut microbes for growth or 
secondary metabolites (Allen et al., 2013) 
Organic Acids SCFAs decrease environmental pH, can 
reduce spoilage in feed, reduce pathogen 
survivability (Allen et al., 2013) 
Botanicals Essential oils derived from plants with 
antimicrobial, anti-inflammatory, anti-oxidant 
properties (Omonijo et al., 2018) 
Yeast Fed as live or various cell and/or extract 
preparations to promote prebiotic or probiotic 
benefits 
Starch/Fiber Resistant starch or fiber from foods that can 
be fermented into SCFAs and serve as 
prebiotics 
Minerals Zinc/Copper Fed at pharmacological doses that elicit 
antimicrobial effects (Cromwell, 2002) 
Lysozyme Naturally occurring enzyme that breaks down 
peptidoglycan layer of bacterial cell wall 
(Oliver and Wells, 2015) 
1All items comprehensively reviewed by Liu et al. (2018) 
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Figure 1.1. Percentage of outcomes for average daily gain when using antibiotic 
alternatives. No response (blue), negative response (green), positive response (grey), and 
no response reported (yellow) for outcomes. Adapted from Schweer et al., (2017b).  
 
Rhamnolipids 
 
 Rhamnolipids are glycolipids that are anionic amphiphilic molecules containing 
hydrophilic mono- or di-rhamnose heads and lipophilic beta-hydroxyalkanoic acid tails 
with a typical length of eight to twelve carbons (Figure 1.2). This structure allows 
rhamnolipids to function as biosurfactants capable of reducing surface tension of liquids, 
thus making them good emulsifiers. Rhamnolipids are produced by numerous species of 
bacteria, but bacteria of the genus Pseudomonas tend to be prolific producers of 
rhamnolipids and P. aeruginosa is the predominate organism used due to its consistent 
and high production of rhamnolipid in fermentation settings (Chong and Li, 2017). 
Rhamnolipids serve a broad number of functions for their host organisms by enhancing 
motility, biofilm formation, and facilitate nutrient uptake of low solubility substrates 
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(Abdel-Mawgoud et al., 2010). Additionally, rhamnolipids appear to have antimicrobial 
effects against some Gram positive and negative bacteria, filamentous and 
phytopathogenic fungi, and limited activity against other microbial types (Abdel-
Mawgoud et al., 2010). Furthermore, these molecules play a role in virulence of P. 
aeruginosa by inducing histamine release from mast cells, suppressing phagocytic action 
of macrophages, or increasing permeability by opening up the tight junctions between 
epithelial cells, to name a few (Abdel-Mawgoud et al., 2010). Pseudomonas aeruginosa 
is a common, problematic colonizer of cystic fibrosis patients as it exacerbates the 
patient’s condition due to virulence factors (Abdel-Mawgoud et al., 2010). Rhamnolipids 
may also play a role in flagellin-mediated immune stimulation by inducing flagellin 
removal from the cell membrane (Gerstel et al., 2009). Rhamnolipids from a small 
number of species may have endotoxin like activity, but lacks the potency typically seen 
with lipopolysaccharide (Andrä et al., 2006) and comes at the expense of antimicrobial 
activity (Benincasa et al., 2004). 
 
 
Figure 1.2. Structure of a di-rhamnolipid with rhamnose and lipid motieties on the left 
and right respectively.  
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 A considerable amount of the literature regarding rhamnolipids is dedicated 
towards P. aeruginosa pathology and industrial applications (Chong and Li, 2017). The 
amphipathic nature of rhamnolipids makes them useful as emulsifiers and they have been 
used for bioremediation of sites contamination with petroleum, heavy metals or 
pesticides. Rhamnolipids have been considered for use as biopesticides on crops to 
reduce phytopathogens or in food processing to reduce growth of food-borne pathogens 
or biofilm production (Chong and Li, 2017). Additionally, these antimicrobial properties 
are beneficial for reducing medical device biofilms and inhibiting growth of cancer. As 
rhamnolipids increase epithelial cell permeability, they have been considered for 
excipient use in the pharmaceutical industry (Jiang et al., 2013; Jiang et al., 2014). 
 The ability of rhamnolipids to function as an emulsifier and antimicrobial makes 
it an interesting compound for an animal. The emulsification action may be beneficial to 
animals, especially those with reduced absorption capacity due to illness for increase 
nutrient uptake in the intestine. The antimicrobial nature could be useful for reducing 
pathogenic bacteria in the gut and for stimulating mucin production to enhance barrier 
function. Unfortunately to date, no research has been published on rhamnolipid use in 
animal models for its effects on growth performance and gut health. We aim to address 
some of this with research in Chapter 5 and in future research studies. 
 
Tryptophan 
 
Tryptophan (Trp) is an essential amino acid. Like other amino acids, tryptophan is 
necessary for incorporation into body tissue via protein synthesis. Tryptophan can play a 
role with cellular signaling and function by differentially regulating tight junction 
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proteins in intestinal cells (Wang et al., 2015; Tossou et al., 2016) and promoting 
activation of mTOR for protein synthesis, cell growth and decreased protein degradation 
(Wang et al., 2015). Tryptophan also serves as a precursor molecule for secondary 
substrates in the body (e.g., serotonin, kynurenine, and indole derivatives). Serotonin is a 
tryptophan metabolite that functions as a neurotransmitter in neurological tissues. 
Kynurenine serves as precursor to niacin, needed to synthesize NAD and NADP for 
cellular metabolism. Kynurenine also can interact with the aryl hydrocarbon receptor 
(AhR) (Opitz et al., 2011). Indole derivatives (e.g., indole-3-aldehyde, indole-3 acetic 
acid, and indole-3-acetylaldehyde) like kynurenine, are capable of interacting with AhR 
(Chung and Gadupudi, 2011). The AhR serves as a transcription factor for numerous 
genes encoding drug-metabolizing enzymes including cytochrome P450 (Beischlag et al., 
2008). In the gut, AhR ligands activate IL-22 production by group 3 innate lymphoid 
cells (ILC3), which play a role in microbiota tolerance (Lee et al., 2012), that stimulates 
tissue protection, survival, and differentiation in epithelial cells (Eyerich et al., 2017). 
Phosphorylation of STAT3 through IL-22 activity is necessary for inducing antimicrobial 
factors offering protection against enteric viral challenges in vitro in IPEC-J2 cells (Xue 
et al., 2017). 
Tryptophan is considered one of the first four limiting amino acids in the diets of 
pigs, the others being lysine, threonine, and methionine. To ensure adequate 
concentrations of tryptophan in the diet, tryptophan may be supplemented in crystalline 
form to meet dietary needs. The essential amino acids are fed relative to lysine (Lys) 
content in the diet on standardized ileal digestibility (SID) basis. In the swine NRC 
(2012), the recommended SID Trp:Lys ratio was 0.163 or 16.3%. The requirement was 
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estimated to be higher than 19.5% by Guzik et al. (2005) and a meta-analysis by 
Simongiovanni et al. (2012) found increasing the requirement from 17% to 22% 
improved ADG by 8%. Goncalves et al. (2015) estimated the SID Trp:Lys requirement at 
20.4% and 23.9% for G:F and ADG, respectively, in 6 to 11 kg BW pigs, and 16.6% and 
21.2% for G:F and ADG, respectively, in 11 to 20 kg BW pigs. Different types of 
stressors can adversely affect animal health. Health challenges certainly alter pig 
homeostasis due to activation of the immune system and repartitioning nutrients (Le 
Floc'h et al., 2009) away from tissue deposition to production of acute phase proteins, 
immune cell proliferation, and antibody production (Reeds et al., 1994). Tryptophan has 
been shown to be the first limiting amino acid during an acute phase response indicating 
an increase need for and possibly incorporation of tryptophan into acute phase proteins 
(Preston et al., 1998). When tryptophan is limited in the diet, stimulation of the immune 
system reduces N retention and protein deposition efficiency of tryptophan, suggesting a 
7% increase in requirement (de Ridder et al., 2012). An increase in dietary tryptophan 
was shown to improve feed efficiency in pigs infected with enterotoxigenic Escherichia 
coli (ETEC) (Capozzalo et al., 2012; Capozzalo et al., 2015). Pigs susceptible to 
intestinal adhesion by ETEC saw a decrease in microbial richness, which was attenuated 
with supplemental tryptophan (Messori et al., 2013). Supplementing both threonine and 
tryptophan mitigated lung damage from a PRRS modified live vaccine and improved the 
immune response in pigs (Xu et al., 2014). Supplementation of threonine, tryptophan, and 
methionine not only improved growth performance in poor sanitary conditions, but also 
decreased incidences of damaging behaviors (e.g., tail and ear biting) (van der Meer et 
al., 2016; 2017). A mouse study by Zelante et al. (2013) found supplemental tryptophan 
 26 
to be beneficial in reducing Candida infections in the stomach, however, this was 
mediated by indole-derivative activation of AhR via Lactobacillus metabolism of 
tryptophan. Altogether, tryptophan plays an important role in host tissue deposition and 
immune function, but understanding where the optimal SID Trp:Lys ratio is will be 
important for cost effective pig production. 
 
Gut Microbiome  
 
The microbiome is the collection of microbes that colonize the surfaces (e.g., 
skin, gastrointestinal, urogenital) of the body. The composition of the microbiome differs 
from site to site as the environment and access to nutrients change (The Human 
Microbiome Project et al., 2012) (Figure 1.3). This section will focus on the 
gastrointestinal or gut microbiome, specifically the pig, where possible. The population 
of bacterial cells in and on the human body is nearly the same number as human cells 
(Sender et al., 2016) with a substantial amount of these being found in the cecum and 
colon across animal species (Whitman et al., 1998). The commensal microbiota within 
the gastrointestinal tract play an important role in the health and homeostasis of animals 
(Nicholson et al., 2012). The microbiome in the gut trains the immune system to tolerate 
commensal organisms, aids in the defense of pathogens, utilizes nutrients that our bodies 
cannot directly breakdown (e.g., fiber), and provides volatile fatty acids (VFAs) to serve 
as an energy source (Nicholson et al., 2012; Arnolds and Lozupone, 2016). The 
microbiome contains a highly diverse population that may vary from individual to 
individual, but provides functional redundancy through similar gene profiles (The Human 
Microbiome Project et al., 2012). Individuals may have niche microbes and functions that 
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allow for special and unique microbial arrangements that can be masked due to broad 
classifications of microbes and genes (Lozupone et al., 2012). Our understanding of the 
composition and role that the microbiome plays has increased in the last few decades 
with advances in genome sequencing and the “-omics” (e.g., metabolomics, proteomics, 
and transcriptomics). With this knowledge has come the understanding that the 
relationship between the host and microbiome is a complex one as composition may not 
only affect nutrient breakdown and gut health, but neuroendocrine signaling from the gut 
to the brain of the host (Lyte, 2013). 
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The microbiome encompasses nine phyla: Firmicutes, Actinobacteria, 
Bacteroidetes, Proteobacteria, Fusobacteria, Tenericutes, Spirochaetes, Cyanobacteria, 
and Verrucomicrobia. Firmicutes and Bacteroidetes are typically the most abundant (> 
85%) phyla in pigs (Holman et al., 2017), although Proteobacteria and Actinobacteria 
may be more abundant depending on breed, diet, and location. Microbial phyla and 
genera may differ in composition throughout the gastrointestinal tract (Holman et al., 
2017), but expression of metabolic pathways between gastrointestinal locations and 
species is largely consistent (The Human Microbiome Project et al., 2012; Mao et al., 
2015). 
For most animal species, the microbiome is established with parturition as the 
progeny receive their first inoculum via exposure to the mother’s vaginal microbiome. In 
the case of progeny born via Cesarean section, first exposure is likely to come from the 
skin microbiome (Dominguez-Bello et al., 2010). As a result, the initial gut microbiome 
will be a reflection of mother’s, just dependent on site of birth. Interestingly, this 
difference may have long-term impact on the progeny’s health and risk for disease 
(Johnson and Versalovic, 2012) although diet, antibiotic exposure, and illness may also 
play an important role. Subsequently, lactation will serve as another point of exposure for 
inoculation and provide substrate for growth of the animal and influence the evolution of 
the piglet’s microbiome. Pannaraj et al. (2017) found that children predominantly 
breastfed through 30 days post birth received a greater proportion of their microbiome 
from the breast milk and skin. Likewise, exposure to the environment and other animals 
may also play an influential role in the development of the microbiome. Age plays a 
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partial role in the changes that may occur, but more so than that, diet will be the largest 
driver of microbial change and diversity (Frese et al., 2015). For mammalian livestock, 
this is the transition from mother’s milk to solid feed and forage that will provoke the 
largest and most sustained changes. For the microbiome, bacteria will see a shift from 
milk proteins and sugars towards plant proteins, sugars, and fiber. Bacteria members such 
as Prevotella typically increase post weaning (Pajarillo et al., 2014) due to their ability to 
degrade xylans (Lamendalla et al., 2011). As the animal grows, fiber concentration in the 
diet typically increases as adult pigs have greater capacity for degrading fiber (Varel, 
1987) although increasing the fiber content of the diet may increase cellulolytic bacteria 
numbers also (Varel and Pond, 1985). Variety in the diet can play a large role in shaping 
the microbiome as a more diverse diet can result in a more diverse microbiome and one 
that may handle perturbations more readily (Heiman and Greenway, 2016). Ultimately, a 
diverse microbiome may result in better health outcomes with large capacity for 
functional redundancy, but also specificity (Le Chatelier et al., 2013). Functional 
specificity enables organisms to utilize uncommon nutrients for their metabolism or 
facilitate part of missing pathway (Lozupone et al., 2012). Oxalobacter formigenes is a 
bacteria known for using oxalate as its sole energy source (Allison et al., 1986), however, 
loss of this organism through antibiotic usage can result in an increased risk for oxalate 
based kidney stones (Kelly et al., 2011). Thus, loss of functional gene specificity may not 
have a large impact but may result in long-term consequences. 
The gut microbiome plays an important role in host nutrition by enhancing energy 
capture in the diet and up-regulating lipogenesis in the host leading to greater adipose 
deposition and decreased feed intake relative to germ-free mice (Bäckhed et al., 2004). It 
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was further demonstrated that the gut microbiome influences signaling for energy 
partitioning (Backhed et al., 2007). To a point, the host serum metabolite profile can be 
considered a reflection of the microbial metabolism occurring in the gut (Velagapudi et 
al., 2010). 
The relationship between the immune system and the gut microbiota is as 
important as it is complex, due to the interaction between the two. In the absence of 
microbes, the immune system is woefully under developed with reductions in the size of 
lymphatic tissues, cell number (e.g., T cells), and expression of cell surface markers 
important for immune function (Round and Mazmanian, 2009). Microbial tolerance 
appears to be initially driven by a blunted immune response in neonates to suppress 
inflammatory signals in lieu of regulatory signals allowing for development of the 
immune system and lymphoid tissues (Belkaid and Hand, 2014). Exposure to microbial 
antigens leads to the induction of immune cells, but importantly, the induction of T 
regulatory cells is necessary for regulating the inflammatory response (Weiner et al., 
2011). Regulation of T helper 1 and 17 cells via T regulatory cells or anergy and deletion 
play a significant role in microbial tolerance and attenuation of the immune response 
(Weiner et al., 2011). Besides training the immune system, the commensal organisms 
themselves serve as barrier to pathogens directly by providing competition by 
overwhelming pathogens with numbers, using up available substrate, and modifying the 
environment (e.g. pH, inhibitory compounds) (Kamada et al., 2013). The microbiome can 
also compete indirectly by stimulating barrier function properties (e.g. mucins, 
antimicrobial peptides, RegIIIγ) via the immune system and T helper 17 cells (Kamada et 
al., 2013). When gut dysbiosis occurs, due to health challenges or use of antibiotics, this 
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can decrease competition and enable pathogens to grow unchecked and overwhelm the 
gut causing illness. For example, Clostridium difficile is an opportunistic pathogen that is 
normally held to small numbers, but will flourish in environments where antibiotics or 
illness have compromised the commensal population (Dicks et al., 2018). 
 
Alteration by Diet 
 
 Diet is the biggest driver of change in the microbiome throughout the life of an 
animal (Bauer et al., 2007). Piglets initially consume the dam’s milk for nutrition, but 
prior to and after weaning, introduction to solid feed will occur. The nursery diets are 
typically high in crude protein and easily digestible. As the pig grows and moves on to 
grower and finish diets, crude protein (CP) will be reduced in the diet and fiber will 
typically be increased. The microbiome will see its largest adjustment with the transition 
to solid feed and will remain fairly constant for its adult life (Frese et al., 2015), barring 
an significant health challenges, antibiotics use, or physiologic changes (e.g., pregnancy). 
The following sections will go into more detail in regard to protein, lipid, and 
carbohydrate effects on the microbiome and growth. It should be noted that while the 
focus is to use papers focused on using the pig as the model of choice, a lack of literature 
requires using other species for reference. 
Protein 
 Proteins, or more specifically, amino acids, are necessary for tissue deposition and 
bodily function. Sow’s milk is estimated to contain an average of 5.16% CP (NRC, 
2012). Amino acid requirements in the NRC (2012) suggest that piglets start at 22.69% 
CP. Although the amino acid requirements increase with size, crude protein density 
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decreases as AA requirements are met with an increase in feed consumption. By the late 
finishing phase, CP drops to 10.41%. 
 To ease weaning stress and get piglets started, prestarter and early nursery diets 
contain a diversity of protein sources that are easily digestible to facilitate growth and 
maturation of the gut to promote downstream nutrient absorption and growth. Although 
diets can contain higher CP levels than those suggested in the NRC 2012, too much CP 
can be concern for causing post-weaning diarrhea (Prohászka and Baron, 1980). 
Decreasing CP in nursery diets reduced growth performance, but also resulted in lower 
plasma urea and ammonia in the digesta with no effect on the microbiome (Nyachoti et 
al., 2006; Lynch et al., 2009). Wellock et al. (2007) observed that higher CP in the diet 
increased the fluidity and coliform counts of the feces while reducing Lactobacillus 
counts. Similarly, the increase in CP also increased ADG and G:F without any effect on 
ADFI. Opapeju et al. (2009) showed similar growth performance results, but after 
challenging with ETEC, found that higher CP did not have a better growth response 
compared to lower CP, but maintained a higher bacterial diversity in the colon and had a 
higher percentage of pigs shedding the ETEC at d 3 and 7 post challenge. Decreasing 
dietary CP resulted in a reduction in biogenic amine concentration in the colon while a 
decrease from 16 to 13% CP led to increased expression of occludin, a tight junction 
protein (Fan et al., 2017). Interestingly, a further reduction to 10% CP reduced expression 
of occludin, biomarkers for intestinal stem cells, and ileal morphology. Work by Peng et 
al. (2017) showed that CP reduction did not result in a linear decrease in biogenic amines 
in digesta from ileum, cecum, or colon, but linear decreases in ammonia, and cecal and 
colonic SCFA occurred. Changes in intestinal SCFA production were not affected by 
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reduction in CP shown by Bikker et al. (2006), which may have resulted from using 
younger aged pigs. Furthermore, while there was no difference in Lactobacillus counts 
between CP levels, Bifidobacterium decreased linearly with CP content (Peng et al., 
2017). A nursery pig study showed that Lactobacillus spp. increased as CP content 
increased in ileal digesta regardless of protein source (Rist et al., 2014). It is worth noting 
that changes in Lactobacillus counts appear to vary with CP content and fluctuation may 
be due to differences in diet, genetics, or even the starting microbiome.  
 Comparing the effects of dietary protein sources on the microbiota has been 
minimally studied. Work by Cao et al. (2016a), found that pigs fed SBM and fishmeal 
had discriminately different microbial profiles compared with cottonseed meal (CSM) or 
SBM-CSM combination. Likewise, fishmeal, SBM, and SBM-CSM had greater bacterial 
diversity compared with feeding solely CSM. Interestingly, where the majority of diets 
showed the Firmicutes phyla to be the predominate one, Proteobacteria was the 
dominate phyla in the fishmeal-based diet. It was further shown that CSM-based diets 
had increased abundance of Lactobacillus spp. and may be beneficial for intestinal health. 
On the other hand, fishmeal had increased abundance of Escherichia and Shigella species 
demonstrating that fishmeal may promote an environment with increased susceptibility to 
post-weaning diarrhea.  
Lipid 
Due to their energy density, dietary lipids have mostly been a concern as an 
energy source and less emphasis on lipid composition. Studies assessing the effect of 
dietary fat level are skewed towards high fat Western diet-obesity models. Additionally, 
these models use higher fat inclusions than typically seen in commercial diets. 
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Furthermore, many of these models also incorporate the use of fiber, prebiotics, or other 
anti-obeseogenic compounds for determination of weight loss or decreased fat deposition 
(Yan et al., 2013; Heinritz et al., 2016). Other literature has covered lipid composition, 
identifying the effects of saturated (SFA), monounsaturated (MUFA), and 
polyunsaturated fatty acids (PUFA) on the growth and physiology of pigs.  
Usage of DDGS at high levels has been of concern in grow-finish production as 
the higher unsaturated fats derived from DDGS have been known to cause soft bellies 
during meat processing, specifically bacon slicing (Whitney et al., 2006; Leick et al., 
2010; Cromwell et al., 2011). However, Xu et al. (2010) reported that belly firmness can 
be increased by withdrawing DDGS from the diet a few weeks prior to slaughter. Feeding 
conjugated linoleic acid was reported to help improve belly firmness in pigs fed DDGS 
(White et al., 2009).  
Due to their potential anti-inflammatory effects, omega-3 fatty acids have also 
been considered in nutrition studies. Gestation and lactation diets supplemented with 
PUFA enhanced glucose uptake in intestinal tissue and glycogen storage in weanling pigs 
(Gabler et al., 2007). Diets with PUFA supplementation appear to decrease intestinal 
endotoxin transport, endotoxemia, and TLR-4 activation when compared with SFA 
supplementation (Liu et al., 2012; Mani et al., 2013). Inclusion of omega-3 PUFA 
appeared to decrease Bacteroides species in the cecum of pigs without any effect of diet 
or microbiome on fat accumulation (Andersen et al., 2011). Supplementation of a high fat 
diet with PUFA decreased abundance of Streptococcus, Clostridium, and pathogenic 
Enterobacteriaceae while also increasing bacterial diversity in premature infants 
(Younge et al., 2017). A mice model found that omega-6 PUFA induced inflammation 
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prone organisms, Clostridia sp. and Enterobacteriaceae, whereas omega-3 PUFA 
suppressed inflammatory organisms while promoting Lactobacillus and Bifidobacteria 
(Ghosh et al., 2013). Altogether, omega-3 PUFA supplementation may be useful for gut 
health and modulating the microbiome to favor beneficial commensal organisms over 
pathogenic bacteria. In human studies, supplementation of omega-3 PUFA generally did 
not cause a change at the phylum level, although some changes did occur at the genus 
level, but there was no consistency in which bacteria were up or down regulated due to 
the variation in study type (Costantini et al., 2017). However, the authors note that 
supplementation of omega-3 may still be beneficial in promoting eubiosis of the gut. 
 
Carbohydrates 
Carbohydrates range from simple mono- and disaccharides to the prebiotic 
oligosaccharides and polysaccharides, which include starch and nonstarch 
polysaccharides, the latter being commonly referred to as dietary fiber. This section will 
primarily focus on nonstarch polysaccharides. While fiber does serve a role as bulking 
agent in diets, it does provide benefits to the gut and gut microbiota. In young pigs, 
higher fiber content promoted Lactobacillus abundance in the small intestine and VFA 
formation in the hindgut (Bikker et al., 2006). Diets devoid of fiber or just containing 
prebiotic carbohydrates were found to dramatically shift the microbiome of mice by 
promoting mucus degrading bacteria compared to those on fiber rich diets (Desai et al., 
2016). This resulted in a decreased mucus thickness of the colon while increasing 
susceptibility to Citrobacter rodentium, an enteric pathogen in mice, leading to increased 
shedding, weight loss, and death.  
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 A recent report has suggested that insoluble fiber content from a 30% DDGS diet 
not only shifts the microbiome by reducing the Firmicutes:Bacteroidetes ratio and 
Lactobacillus abundance, but this reduction along with alterations in the metabolome 
may leave pigs susceptible to colitis (Burrough et al., 2015). When using fiber derived 
from different grain products in nursery diets, Chen et al. (2013) found that wheat bran 
fiber increased villus height and villus:crypt depth ratio in the ileum and ileum and colon 
Goblet cell number compared with maize and soybean fiber. Soybean fiber resulted in 
higher colon VFA concentrations relative to maize fiber, but similar VFA concentrations 
were noted in wheat bran and pea fiber diets. Abundance of Lactobacillus and 
Bifidobacterium appeared to increase due to pea, maize, and wheat bran fiber inclusion, 
but decreased in control and soybean fiber diets. Wheat bran fiber diets reduced E. coli 
counts in ileal and colonic digesta, whereas soybean fiber had increased numbers of these 
bacteria. Wheat bran fiber also increased transcription of tight junction proteins zonula 
occludens 1 and occludin, and TLR2, which could translate to improved barrier function. 
A follow up study by Chen et al. (2014) with grow-finish pigs found that wheat bran 
improved ileal villus:height ratio and sucrose production when compared with soybean 
fiber also. Soybean fiber inclusion promoted acetate production in both the ileum and 
cecum when compared to the control diet although no difference was noted in total VFA 
production. Wheat bran inclusion resulted in increased cecal butyrate compared to all 
treatments, suggesting potential for improving cell tissue health similar to data reported 
by Molist et al. (2009). Interestingly, alfalfa and pure cellulose were shown to increase 
gene expression for genes related to butyrate production in the lumen of the cecum, but 
not the mucosa when compared against wheat bran (Mu et al., 2017). Alfalfa increased 
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total VFAs in the proximal colon compared with wheat bran, but was not different in the 
cecum or distal colon. 
Similar to their previous data (Chen et al., 2013), Chen et al. (2014) found that 
pea fiber and wheat bran increased ileal Bifidobacterium, numerically, and Lactobacillus 
while decreasing E. coli concentrations with the opposite occurring in soybean fiber. 
Similar trends were noted in the colonic digesta. Pea fiber increased jejunal GLUT2 gene 
expression compared with the control and soybean fiber diets. Pea fiber and wheat bran 
both increased ileal glucagon and GLUT2 gene expression over maize and soybean 
fibers, while only wheat bran improved SGLT1 expression.   
Molist et al. (2009) found that insoluble fiber from wheat bran had less unbound 
water in the colonic digesta compared with control or sugar beet pulp diets suggesting 
higher water binding capacity, allowing for increased substrate for large intestine 
microflora.  Milled wheat bran was shown to increase fecal score and E. coli 
concentration while decreasing total VFA and acetic acid production compared with 
coarse wheat bran after being challenged with E. coli (Molist et al., 2011). The coarse 
wheat bran had similar fecal scores to the antibiotic control, reduction in E. coli, and an 
increase in VFA production. 
 Cao et al. (2016b) reported Lantang pigs fed a low fiber diet had increased 
methane production compared with pigs fed a high fiber diet. This methane production 
was positively correlated with higher density of methanogenic bacteria although the 
mode of action of rice hulls in the high fiber diet on decreasing methane production was 
unclear. Likewise, inclusion of pea fiber increased the diversity of methanogenic bacteria 
 39 
in weanling and finisher pigs (Luo et al., 2017), but it was not reported if this altered 
methane production. 
 
Antibiotics and Alternatives 
 Antibiotics and alternatives have been highly researched for their effects on swine 
growth performance and modulation of the microbiome. Antibiotics have been shown to 
modulate the gut microbiome (Holman and Chénier, 2015), although this modulation is 
highly variable due to breed of pigs used, location, and antibiotics used. Which 
antibiotics are used can play a role as many classes (e.g., tylosin, lincomycin, and 
penicillin) target gram positive bacteria (Gaskins et al., 2002). Other antibiotic classes are 
broad spectrum (e.g., carbadox, tetracycline, and sulfonamides) targeting both gram 
negative and positive and are commonly used throughout the swine industry. Antibiotic 
alternatives, besides lysozyme, are less likely to target specific microbes but more likely 
drive a response due to promoting commensal bacteria to outcompete pathogenic 
organisms (Verstegen and Williams, 2002). 
Reviewing the current literature for all antibiotic and antibiotic alternative studies 
would be a daunting task. Rather, it would be more worthwhile to mention that the 
complexity of the microbiome increases as we add more variables to it. Overall, 
antibiotic- or antibiotic alterative-mediated changes to the microbiome may not be 
apparent at the phylum level or for alpha diversity, but more noticeable at the family or 
genus level and with beta diversity (Soler et al., 2018). Studies reviewed by Holman and 
Chénier (2015) have shown that diversity may decrease, increase, or stay the same with 
antibiotic treatment. However, the authors did see that feed additive supplementation 
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increased abundance of Bacillus and Lactobacillus species compared to control or 
antibiotic supplemented animals.  
 Antibiotics benefit growth promotion through prevention and tempering of 
infection while suppressing bacteria, commensal or pathogenic, that may divert nutrients 
away from the host for their own use (Brüssow, 2015). The usage of probiotics or 
commensal stimulating prebiotic compounds may benefit the host by stabilizing the gut 
microbiome (Brüssow, 2017). The plethora of antibiotic alternative studies reviewed by 
(Schweer et al., 2017b) may corroborate this as few have positive impact on growth 
performance and those that do may not see major alterations in taxa, save for a few 
species. It is also noted that besides the differences in diets, breeds, locations and 
experimental designs, the large differences in methodology used to characterize the 
microbial communities can be inconsistent or lacking in depth (Allen et al., 2013). 
 
Conclusions 
 The swine industry is a vast one working to continue producing wholesome and 
healthy pork that is affordable for consumers. This can be challenging as feed prices, 
production costs, government regulations, and consumer perceptions drive the evolution 
of the industry. Antibiotics have been useful for improving the efficiency of the industry 
and even with the VFD, will still be critical for treating disease so that herds can remain 
healthy and productive. Continued research into the microbiome and antibiotic 
alternatives will be critical for understanding host health, the functions and improving 
swine performance. 
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ABSTRACT: This study assessed the effect of porcine circovirus 2 (PCV2) vaccination 
compared to inoculation on the intestinal microbiome of piglets. Ninety-six weaned 
barrows (age 27 to 40 d; 7.1 kg BW) were either vaccinated (VAC) for or inoculated 
(PCV) with PCV2 on d 0. Fecal samples were collected at d 0, 14, and 28 
(n=6/treatment). Microbial community structure was analyzed using Ion Torrent 
technology by sequencing the 16S rRNA gene. No differences (P > 0.10) were detected at 
the genus level between d 0 samples. Prevotella spp. decreased from d 14 to 28 in VAC 
pigs (P < 0.05) and was reduced compared with PCV at d 28 (P < 0.10). A core set of 383 
operational taxonomic units (OTU), present in >80% of samples, were analyzed using a 
multivariate analysis by linear models. A total of 58 OTUs were correlated with at least 
one phenotypic trait or fixed effect i.e., BW, day, PCV-status, (P <0.05, q < 0.05). Of 
these, 15 OTUs were determined to be of the genus Prevotella. Abundance of P. 
stercorea (r = 0.21) and Solitalea koreenis (r = 0.41) were shown to be associated with 
serum IgG concentration, while Intestinimonas butyriciproducens (r = -0.07) and 
Oscillbacter valericigenes (r = -0.09) were inversely associated with serum IgM 
concentration. Presence of P. stercorea (r = -0.11) was negatively associated with VAC 
pigs by d 28; whereas, Ruminiclostridium thermosuccinogenes (r = 0.11) presence 
increased. These data suggest that Prevotella spp. flourish during a PCV challenge, 
irrespective of PCV-status (vaccinated or inoculated), but decrease sooner in VAC pigs 
than PCV pigs. However, an age-dependent shift in the microbiome may also play a role. 
 
Keywords: microbiome, pig, Porcine Circovirus 2, vaccination 
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INTRODUCTION 
 Porcine Circovirus 2 (PCV2) is one of the top diseases causing economic loss to 
the pork industry.  Pigs affected by PCV2 infection often have increased susceptibility to 
co-infections (Gillespie et al., 2009; Takada-Iwao et al., 2011; Opriessing and Halbur, 
2012), which is a necessary factor to form PCV2 associated diseases (PCVAD; e.g., post-
weaning multi-systemic wasting syndrome).  The prevention and treatment of PCVAD 
result in significant financial loss in terms of the vaccination, management intervention, 
and reduced performance associated with PCVAD (Alacron et al., 2013).  It has been 
estimated that the cost associated with PCVAD can range from 3 to 20 dollars/pig 
culminating in a total loss of up to 2 billion dollars for the U.S pork industry (Gillespie et 
al., 2009).  
 In recent years, research into the microbiome has dramatically increased. The 
microbiome plays a large role in intestinal health, digestion of undigested feed particles, 
and immune modulation, to name a few (Kosiewicz et al., 2011). As such, dysbiosis of 
the microbiome can enable pathogens to flourish causing intestinal disturbances such as 
diarrhea, inflammation, and activation of the immune system (Kosiewicz et al., 2011). 
The goal of this study was to assess if pigs vaccinated against PCV2 display an altered 
microbiome compared with those inoculated with PCV2.  
 
MATERIALS AND METHODS 
 The experimental protocol was reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of Nebraska, Lincoln. 
Animals and Experimental Design 
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 Initially, a total of 160 weaned crossbred barrows (Large White × Landrace) were 
screened for PCV2-specific IgG and IgM by ELISA (Ingenasa, Madrid, Spain) from 
blood samples obtained at 14 d of age at the Agricultural Research and Development 
Center Swine Unit (Mead, NE). Individuals (n = 32) with a sample-to-positive ratio lower 
than 0.3 for passive IgG (all pigs were IgM negative) were included in the current 
experiment. At 16 to 17 d of age, one half (n = 16) of the pigs were vaccinated for 
PCVAD with a single dose of Ingelvac CircoFLEX vaccine (Boehringer Ingelheim 
GmbH, Ingelheim am Rhein, Germany).  At weaning, all pigs were fed a standard corn-
soybean meal diet (without antibiotics) until approximately 30 d of age at which time all 
pigs were transferred to the University of Nebraska-Lincoln animal science complex 
(Lincoln, NE) where the experimental infection was conducted.  Upon arrival at the 
University of Nebraska-Lincoln animal science complex, pigs (n = 32; average 33.5 d of 
age; 7.1 kg average BW) were sorted by initial BW and PCV status (vaccinated for PCV2 
[VAC] or inoculated with PCV2 [PCV]) and randomly assigned to 8 pens (4 pigs/pen; 4 
pens/treatment) 2 d prior to the beginning of the experiment. Pens were fed a simple 
corn-soybean meal diet with no added antibiotics that met or exceeded NRC 
requirements. During the 28-d experiment, pigs were housed in a common room in 24 
identical pens with a combination of slatted and solid surface flooring.  The pens 
provided approximately 0.65 m2 of floor space per pig.  All pigs were allowed ad libitum 
access to feed and water. 
Experimental PCV2 Inoculation  
The PCV2b isolate used in the experimental infection was recovered from a pig 
that had symptoms characteristic of PCV2 infection and is the same isolate used in 
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previous experiments. On d 0 (average 33.5 d of age) all naïve pigs (n = 16) were 
intranasally (2 mL) and intramuscularly (1 mL) infected with a titer of 104 median tissue 
culture infective dose/mL. Pigs were observed daily for clinical signs of infection and 
facial thermometers were used to monitor daily body temperature (data not shown) for 7 
d post-inoculation. Serum samples were collected via jugular venipuncture on d 0, 7, 14, 
21, and 28 to assess serum IgG and IgM using method described above. 
Growth Performance 
Pig BW and feed disappearance measurements were obtained at the beginning of 
the experiment and weekly thereafter (d 0, 7, 14, 21, and 28).  Pig BW and feed 
disappearance data were used to calculate ADG, ADFI, and G:F. 
Fecal Sample Collection and Extraction 
 Fecal samples were obtained from the pigs on d 0, 14, and 28, using clean and 
disinfected plastic loops interested into the rectum for sampling. For each treatment and 
time point, samples were collected from the same pigs (n = 6). Samples were placed in 
autoclaved 2 mL tubes and stored at -20˚C for later use.  
Fecal samples were extracted for genomic DNA following the procedure 
described by Martínez et al. (2009). The DNA pellet was resuspended in Tris-HCl buffer 
(10 mM pH 8.0). Concentration and purity of DNA was measure using a Nanodrop 
spectrophotometer (Nanodrop Technologies Inc., Wilmington, DE). Extracted DNA 
samples were checked for quality using a 1% agarose gel. Samples were stored at -20˚C 
until later use.  
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PCR Amplification and Sequencing of 16S rRNA  
Samples were processed following a protocol previously reported by Tran et al. 
(2018). Samples were amplified using the V3 region of the 16SrRNA gene using 341F 
and 518R barcoded primers (Whiteley et al., 2012). A 25 uL PCR mixture was used and 
contained 0.25 uL of Terra PCR Direct polymerase (Clontech Laboratories, 
Moutainview, CA), 12.5 uL of 2X PCR Direct reaction buffer, 0.5 uL of 341 forward 
primers (25 umol), 1 uL of 518 reverse primers (10 umol) 0.25 uL of BSA, and 2 uL of 
DNA (20-50 ng). Conditions for amplification were as follows: 98˚C for 3 m; 30 cycles 
of 98˚C for 30 s, 53˚C for 30 s and 68˚C for 40 s; and a single final extension step at 68˚C 
for 4 m. Amplified DNA was run on a 2% agarose gel and band intensity was determined 
using GeneTools 1D (Syngene, Frederick, MD) gel analysis. Afterwards, amplicons were 
pooled to equal concentrations and purified using the MinElute PCR Purification Kit 
(Qiagen, Valencia, CA). Fragments of DNA containing the V3 region in the pooled 
sample were selected using an E-gel SizeSelect 2% agarose (Invitrogen, Life 
Technologies, South San Francisco, CA). Quality and concentration were assessed using 
a Bioanalyzer 2100 (Agilent Technologies, Santa Clara, CA).  Samples were diluted to 15 
pM for templating to Ion Sphere particles and subsequent emulsion PCR using the Ion 
OneTouch 2 instrument (life Technologies, South San Francisco, CA). Templated-Ion 
Sphere particles were sequenced on a 316-chip kit with the Ion Torrent Personnel 
Genome Machine (Life Technologies, Carlsbad, CA) according to manufacturer’s 
instructions.  
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Quality Control of Sequences and Analysis 
Initial processing of obtained sequences was done as described by Tran et al. 
(2018). An operational taxonomic unit (OTU) table was constructed using Quantitative 
Insights Into Microbial Ecology (QIIME, 1.8.0) (Caporaso et al., 2012) and reverse 
complemented with Mothur (1.34.1) (Schloss et al., 2009). Sequences were clustered into 
OTU of >97% similarity using the UPARSE pipeline in USEARCH (Edgar, 2010, 2013). 
Taxonomic information was added using the 12_10 Greengenes database release in 
QIIME. Cyanobacteria were filtered out of the OTU table prior to further analysis. 
Sequences were aligned using The Ribosomal Database Project (RDP) Aligner tool (Cole 
et al., 2014). A distance matrix and phylogenetic tree were created in Mothur using the 
alignment file from RDP and the dist.seqs() and clearcut commands. Total number of 
sequences varied between samples, as such, samples were subsampled to the lowest 
sequences (2,137) using QIIME. Singletons were removed from the OTU table. Using 
QIIME, core sequences were identified as those belonging to 83% of the treatment 
samples. Total, singleton, and core sequence sets were rarefied for Chao1, Shannon, and 
Simpson indices of alpha diversity. Beta diversity and jackknifed beta diversity were 
performed to generate weighted and unweighted Unifrac plots. Additionally, all three 
sequence sets had taxa summary plots generated. The core OTU table was averaged by 
treatment x time point to generate new plots for readability.   
Statistical Analysis 
 Analysis was performed using Multivariate Association with Linear Models 
(Huttenhower, 2014) previously described by Morgan et al. (2015) by finding 
associations between metadata and microbial community abundance utilizing the 
 62 
distribution of OTUs in samples. Metadata used included day, treatment (PCV and 
VAC), BW, IgG, IgM, and day × treatment interaction. Associations were considered 
significant with a P- and q-value ≤ 0.05 (minimum false discovery rate). Significantly 
associated OTU were then submitted to National Center for Biotechnology Basic Local 
Alignment Search Tool (BLAST) for bacterial identification. 
 
RESULTS AND DISCUSSION 
 To determine the microbial profile in our PCV or VAC pigs, fecal samples were 
sequenced and analyzed (Fig. 1). Within d-0 samples, there were no differences between 
PCV- or VAC-treated pigs, indicating that vaccination for PCV2 resulted in little to no 
change in the microbiome relative to unvaccinated contemporaries. The microbiome 
profile in our study is similar to those reported by Pajarillo et al. (2014) and Frese et al. 
(2015) for weaned pigs. Overall, the majority of shifts in the microbiome occurred in the 
Bacteroidales, Clostridiales, and Lactobacillales orders. The proportion of 
Lactobacillaceae and Bacteroidales decreased, whereas Clostridiales increased over the 
experimental period. The decrease in Lactobacillaceae abundance is may be the result of 
weaning and the absence of sow’s milk or milk-derived products in the diet fed. 
Prevotellaceae increased from approximately 31% in abundance from d-0 PCV and VAC 
pigs to 45% in d-14 VAC pigs but decreased to 24% in PCV pigs. However, by d 28, 
Prevotellaceae abundance had decreased substantially to 14% in VAC pigs and increased 
to 42% in PCV pigs. In a human study conducted by Qin et al. (2015), Prevotella has 
been previously shown by (Lamendalla et al., 2011) to be a major contributor to the 
microbiome in post weaned swine due to ability to degrade plant fibers seen in the diet. 
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Unclassified Bacteroidales and Ruminococcaceae were increased in d-14 PCV and d-28 
VAC samples but were decreased in d-14 VAC and d-28 PCV samples.  
 Using MaAsLin (Huttenhower, 2014), both positive and negative associations 
were identified between sequenced OTU and metadata (Table 1). Oscillibacter 
valericigenes (-0.094) and Intestimonas butyriciproducens (-0.073) were associated with 
blood IgM whereas Prevotella stercorea (0.214) and Solitalea koreensis (0.407) were 
associated with blood IgG. Interestingly, Prevotella were prominently featured in 
associations with metadata; however, only those with a coefficient greater than 0.05, 
positive or negative are shown here. These data show that Prevotella salivae and 
Prevotella scopos, associate positively and negatively with increased and decreased 
Prevotella abundance as would be expected, but P. stercorea showed a negative 
association when Prevotella abundance was increased, suggesting that individual species 
may modulate differently than other members of the genus. 
These data suggest Prevotella spp. may flourish during a PCV challenge, 
irrespective of PCV status (vaccinated or inoculated), but decrease sooner in VAC pigs 
than PCV pigs. However, an age-dependent shift may also play a role. Additional time 
points during the 28-d period and beyond may be required to elucidate the fluctuations 
occurring within the microbiome over the course of a PCV2 challenge. Further data is 
needed to determine if PCV2 or other viral challenges select for specific microbial 
species or phenotypes and their impact on short- and long-term animal health. 
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Figure 2.1. Proportion of microbial sequences relative to total averaged across treatment. 
Other categories are individual sequences totaling < 1% of total population combined 
together. Microbial groups are labeled with order and family names. PCV = inoculated 
with porcine circovirus 2; VAC = vaccinated for porcine circovirus 2. 
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ABSTRACT: A prior experiment identified a PCV2-susceptibility marker QTL (C, 
resistant; T, susceptible) in pigs infected with PCV2. Thus, an experiment was conducted 
to test the effect of this QTL marker in a nursery setting and through grow-finish. For 
Exp. 1, a total of 156 crossbred barrows were genotyped and screened for PCV2 specific 
immunoglobulin G (IgG) and M (IgM). Pigs with a sample-to-positive ratio (S/P) lower 
than 1.26 for passive IgG, and 1.0 for passive IgM were used for the study. Piglets were 
either vaccinated for PCV2 prior to experiment starting (VAC) or inoculated with PCV2 
(PCV) at the beginning of the experiment. Pigs (n =111; 7.1 kg) were sorted by initial 
body weight (BW) and PCV status and randomly assigned to 24 pens (4-5 pigs/pen) with 
the following treatments: CC-PCV, CT-PCV, TT-PCV, CT-VAC, and TT-VAC. At 34 d 
of age, PCV pigs were inoculated with PCV2. Growth performance, viremia, IgG, and 
IgM were monitored over six weeks. For Exp. 2, 8 pigs from each treatment in Exp. 1 
(31.5±1.26 kg BW) were selected and housed 2 pigs per pen and fed a four-phase grow-
finish diet. Growth performance, digestibility, and carcass traits were assessed. For Exp. 
1, no differences in growth performance were detected. Viremia was reduced in CC-PCV 
compared with CT-PCV and TT-PCV from d 7 to 21 and d 7 to 28 respectively (P < 
0.05). Titers of IgG were also reduced in CC-PCV pigs compared to both CT-PCV and 
TT-PCV pigs at d 28 (P < 0.05). Total tract digestibility for gross energy and dry matter 
at 14 dpi was increased (P < 0.05) in PCV pigs compared to VAC pigs. For Exp. 2, 
average daily feed intake was similar for both treatment groups with the exception that 
feed intake was greater (P < 0.01) for PCV pigs during the finisher 1 (wk 6 to 10) phase 
compared to VAC pigs. For feed efficiency, VAC pigs had greater (P < 0.05) efficiency 
compared to PCV pigs during the last three grow-finish phases. No differences were 
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observed in dry matter or gross energy digestibility with the exception that VAC pigs had 
greater (P < 0.05) dry matter and gross energy apparent total tract digestibility compared 
to PCV pigs at the end of the Finisher 1 (wk 10) phase.  No differences were observed for 
carcass traits. Despite no differences in growth performance, analysis of production costs 
observed that the presence of the C allele reduced production costs from nursery to finish, 
regardless of PCV-status. Together these data show that selecting for PCV resistance is 
beneficial during a clinical infection and for long-term production costs. 
Keywords: digestibility, health, pig, porcine circovirus type 2 
 
INTRODUCTION 
 Porcine circovirus type 2 (PCV2) is a single stranded DNA virus that is known for 
causing severe lymphoid depletion leading to coinfection with secondary diseases known 
by many names: post weaning multisystemic wasting syndrome (PMWS), PCV2-
associated diseases (PCVAD), or PCV2 systemic disease (PCV2-SD) (Segalés, 2012). 
Infection with PCVAD causes weight loss and lethargy and may cause diarrhea and 
respiratory symptoms in growing pigs (Gillespie et al., 2009; Segalés, 2012). 
Additionally, lymphocyte depletion and inflammation of lymphoid tissues along with 
high expression of PCV2 in these cites may also be seen histologically (Segalés, 2012). 
Infections may cause low to moderate morbidity and mortality, but morbidity losses have 
been estimated from $3 to 20 per pig or a total of $2 billion annually (Gillespie et al., 
2009). Although PCV2 is considered ubiquitous across the world, occurrence of clinical 
disease has largely been reduced due to the use of vaccines (da Silva et al., 2014). 
However, despite the use of vaccines, they do not completely prevent or eliminate the 
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spread of disease, but allow for reduction in viremia, clinical symptoms, and viral 
shedding (Beach and Meng, 2012).  
 Pigs vaccinated for PCV2 show an improvement in growth performance 
compared against non-vaccinated animals (Jacela et al., 2011; Shelton et al., 2012; Potter 
et al., 2014). Increasing the standardized ileal digestibility ratio of lysine to metabolizable 
energy improved feed efficiency regardless of PCV2 vaccination status (Shelton et al., 
2012). Surprisingly, there is no published research on PCV2 affecting nutrient 
digestibility. However, as diarrhea has been reported as possible clinical sign (Segalés, 
2012) and the gut functions as the largest lymphatic organ (Burkey et al., 2009), it is 
likely that a PCV2 response in the gut-associated lymphatic tissue may cause some 
intestinal dysbiosis resulting in diarrhea.  
 Previously, the genetics of crossbred pigs were analyzed for variation in PCVAD 
susceptibility (Engle et al., 2014a). Two QTLs were shown to be associated with viral 
load. The first QTL, identified on Sus scrofa chromosome (SCC) 7 as swine leukocyte 
antigen II was shown to account for 2.8% of the variation (Engle et al., 2014b) while the 
second QTL, found on SCC 12 (UNLPCV2.2009), accounted for 11.5% of the variation. 
Presence of a T or C allele on the SNP within the SSC 12 QTL was correlated with 
greater or reduced susceptibility, respectively. However, this data did not elucidate any 
other response criteria besides viremia and ADG. We hypothesized that pigs with the 
favorable C allele will display an attenuated immune response and reduced reduction in 
growth performance compared to presence of the T allele. Thus, a study was conducted to 
determine the phenotypic difference between the SNP alleles for growth performance and 
digestibility in the nursery and grow-finish phases of production. 
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MATERIALS AND METHODS 
The experimental protocol was reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of Nebraska, Lincoln. 
Animals and Experimental Design.  
Experiment 1. Initially, a total of 156 crossbred barrows (Large White x Landrace) were 
screened for PCV2 specific immunoglobulin (Ig) G and M by ELISA (Ingenasa, Madrid, 
Spain) from blood samples obtained at 14 d (± 4 d) of age at the UNL ENREC Swine 
Unit (Mead, NE). Pigs were also genotyped for SSC12 SNP alleles. Pigs (n = 111) with a 
sample-to-positive ratio (S/P) lower than 1.26 for passive IgG, and 1.0 for passive IgM 
were used for the study. At d 17 of age, 40 piglets were vaccinated for PCVAD with a 
single dose of Ingelvac CircoFLEX vaccine (Boehringer Ingelheim). The remaining 71 
pigs were not vaccinated for PCVAD. 
At weaning, all pigs were fed a standard corn-soybean meal diet (without antibiotics) 
until approximately 30 d of age at which time all pigs were transferred to the UNL 
Animal Science Complex (Lincoln, NE) where the experimental infection was conducted. 
Upon arrival at the UNL Animal Science Complex, pigs (n =111; 7.1 kg BW; 34.3 d of 
age) were sorted by initial BW and PCV status (vaccinated or inoculated) and genotype 
(CC, CT, and TT) for the following treatments (pigs per treatment): CC-PCV (11), CT-
PCV (32), TT-PCV (28), CT-VAC (20), and TT-VAC (20) (Table S3.1). Pigs were 
assigned to 24 pens (4-5 pigs/pen) such that VAC and PCV may interact through nose-to-
nose contact.  
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During the 42-d experiment, pigs were housed in a common room in 24 identical pens 
with a combination of slatted and solid surface flooring.  The pens provided 
approximately 0.65 m2 of floor space per pig.  All pigs were allowed ad libitum access to 
feed and water. Pigs were fed a corn-soybean meal diet (Table 1) that met or exceeded 
NRC (2012) requirements with no antibiotic inclusion. Titanium dioxide was added into 
the experimental diet at 0.5% for use in assessing nutrient digestibility. 
Experiment 2 and 3. The pigs from experiment 1 were selected using a statistical analysis 
to determine growth residuals between actual and predicted final BW using initial and 
final BW, day of infection, litter, pen, and maternal IgG from experiment 1.  
For experiment 2, eight pigs from each of the previous five treatments (average BW, 
31.5±1.26 kg), with a low net residual BW were selected, and were housed two pigs/pen 
by treatment for a total of 40 pigs (Table S3.2). For experiment 3, eight pigs from each of 
the previous treatments, excluding the CC-PCV group, were selected from experiment 1 
pigs (Table S3.2).  The pigs selected for experiment 3 included an equal number of pigs 
with high (positive) BW residuals (average BW, 33.6±3.22 kg) and with low (negative) 
residuals (average BW, 27.6±4.48), greater or lesser final BW compared with predicted 
BW, respectively. Therefore, experiment 3 was a 2x2x2 factorial arrangement for 
genotype (CT or TT), PCV status (PCV or VAC), and residual (high or low). These 32 
pigs were individually housed in a different room within the UNL Animal Science 
Complex.  
For experiment 2 and 3, animals had ad libitum access to water and feed. Pigs were 
sequentially fed the grower 1 diet for 2 weeks, and grower 2, finisher 1 and finisher 2 
diets for 4 weeks (Table 2). Diets were corn-soybean meal based and designed to meet or 
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exceed NRC (2012) requirements. In the last week of each phase, diets with 0.5% 
titanium dioxide were used for digestibility analysis. 
Experimental PCV2 Inoculation. The PCV2b isolate used in the experimental infection 
was recovered from a pig that had symptoms characteristic of PCV2 infection and is the 
same isolate used in previous experiments (McKnite et al., 2014).  On d 0 (34.3 d of age) 
all naïve pigs (n = 71) were infected intranasally (2 mL) and intramuscularly (1 mL) with 
a titer of 104 TCID50/mL. Additionally, pen design allowed for nose-to-nose contact to 
occur between VAC and PCV pigs. Quantification of PCV2 viral titer was done 
according to the protocol previously reported by McKnite et al. (2014). 
Growth Performance. Pig BW and feed disappearance were measured at the beginning of 
experiment 1 and weekly thereafter for the 6 wk trial. For experiments 2 and 3, pig BW 
and feed disappearance were measured every 2 weeks. Pig BW and feed disappearance 
were used to calculate ADG, ADFI, and G:F. 
Blood Collection. Blood samples were obtained from each pig (5 to 9 mL) via jugular 
venipuncture in serum separator tubes at d 0, 7, 14, 21, 28, 35, and 42 of experiment 1 
and at the end of each diet phase in experiments 2 and 3. Tubes containing blood samples 
were immediately placed on ice and allowed to clot overnight before harvesting serum by 
centrifugation (1,500 × g for 20 min at 4°C).  Serum samples were aliquoted and stored at 
-80oC for subsequent analyses. 
Genotyping. Genomic DNA was extracted from docked tails using the DNeasy tissue kit 
(Qiagen, CA). Quantification of DNA was performed using a NanoDrop 
Spectrophotometer (Thermo Scientific) and quality was assessed using agarose gel 
electrophoresis. All experimental animals were genotyped using second generation of the 
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porcine SNP60K BeadArray (Illumina), which included 61,565 SNPs respectively. 
Mapping of common SNPs to a porcine reference assembly and genome-wide association 
analyses was done according McKnite et al. (2014). 
Digestibility Analysis. Proximate analysis was carried out on feed and pooled fecal 
samples as previously described (Patience et al., 2009; Jacobs et al., 2011). On d 14, 28, 
42, fecal samples were collected from each pen for experiment 1. For experiments 2 and 
3, fecal samples were collected by pen and individually, respectively, at the end of each 
diet phase. All samples were frozen at -20˚C for later analysis. Samples were later dried 
in a 100˚C forced-air oven for 3 d and then ground afterwards. Samples were analyzed 
for DM and gross energy using bomb calorimetry (Parr, Moline, IL). Total tract 
digestibility coefficients were calculated using indigestible marker methodology (Kerr et 
al., 2010). 
Carcass Traits. At the end of the finisher 2 phase, animals from Exp. 2 and Exp. 3 were 
analyzed for loin-eye area (LEA) and backfat at the 10th rib using ultrasound probing. 
Animals were then sent to a commercial slaughter facility where hot carcass weight 
(HCW) was provided. To calculate lean content, the procedure 6 equation from Burson 
(2006) was used: Lb. lean = 5.7769 + (0.401 x HCW, lbs) – (18.838 x 10th rib fat depth, 
in.) + (4.357 x 10th rib LEA, sq. in.) + (1.006 x sex of pig) (barrow = 1, gilt = 2). Lean 
was further converted from lbs to kg. Lean percentage was calculated as lean, percent = 
lean, kg / HCW, kg * 100. 
Economic Analysis. For experiment 1, feed cost per kg of BW gain was calculated. Pen 
feed disappearance was multiplied by the feed cost of $0.31 per kg to determine pen feed 
cost. This was then divided by the net BW gain per pen to determine feed cost per kg of 
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BW gain. For experiments 2 and 3, slope and intercepts were determined for individual 
pigs based on weekly BW and days. Using a linear model, these values were then used to 
predict the number of days on feed each pig needed to reach a market weight of 128 kg 
or, if all pigs were marketed on the same day, their respective BW at day 167. Feed 
intake was calculated based on days on feed in each respective phase and at an average 
cost of $0.33 per kg. Barn cost was $0.10 per pig day. Carcass value was determined 
either at 128 kg for same weight marketing, or at calculated weight for market on the 
same day. Weights were converted to pounds and a dressing percentage of 75.6 was used, 
and finally multiplied by $54.95 per cwt based on the National Base Average price 
reported 12 December 2015. Barn and feed costs were subtracted from the carcass value 
to determine net profit. 
Statistics. Data were analyzed with the MIXED procedure of SAS using LSMEANS with 
the Tukey-Kramer adjustment. In Exp. 1, pen was used as the experimental unit for 
growth performance and digestibility while BW at wk 0 served as a covariate. For 
viremia, IgM, and IgG, pig was used as the experimental unit with covariates of age at 
infection and d0 IgG, and pen and litter as random effects. In Exp. 2, pen was used as the 
experimental unit for all data. Both Exp. 1 and Exp. 2 were analyzed for the primary 
effects of PCV-status, genotype, and the interaction of both. The CC-PCV group was 
excluded from these effects although contrast statements and pairwise comparisons were 
made to discern the effect of genotype in the PCV group. In Exp. 3, pig was used as the 
experimental unit for all data and BW wk 0 as a covariate. The primary of effects of 
genotype, PCV-status, residual, and the corresponding interactions were used for Exp. 3. 
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RESULTS 
Experiment 1. To determine the infectious status of the pigs, PCV2 viremia was 
measured in the serum. As expected, PCV pigs expressed higher PCV2 viremia than 
VAC counterparts from 7 to 42 days post infection (dpi) (Figure 1). No difference was 
observed between genotypes in the VAC group, whereas differences were observed in the 
PCV group. As expected, PCV pigs carrying at least one C allele had numerically 
decreased viremia compared to the TT genotype. The CC genotype showed reduced 
viremia compared from 7 to 28 dpi compared with TT genotype (P < 0.05) and 14 to 21 
dpi with the CT genotype. Immunoglobulin response was measured next for PCV2 
specific IgM and IgG. No difference was observed for genotype in either the PCV or 
VAC group. Similar to viremia, IgG was no different in the VAC group whereas the PCV 
group had a genotypic response. Post 14 dpi, IgG was numerically lower for PCV pigs 
presenting at least one C allele. The CC pigs had the lowest IgG levels of the PCV group, 
although only significantly different at 28 dpi (P < 0.05). Despite the differences in 
viremia and IgG titer, growth performance was not impacted by genotype, PCV status, or 
the interaction of genotype and PCV status (Table 3.3). Likewise, total tract digestibility 
for GE or DM was mostly unaffected by treatments, although the PCV group had 
increased (P < 0.025) digestibility during wk 2 compared with the VAC group (Figure 
3.3). In terms of feed cost per kg of gain (Figure 3.4), genotype had no effect on cost for 
VAC pigs. Cost was largely decreased for CC-PCV pigs compared to the TT-PCV group 
($2.27 v. 2.61); however, contrary to our expectations, the CT-PCV group had a highest 
cost ($2.81) out of the three genotypes. 
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Experiment 2. Pigs representing all 5 genotype-PCV status groups were fed through the 
grow-finish period (Table 3.4). Body weight and ADG showed no differences or trends 
through the period. Overall, ADFI was numerically higher for the TT-PCV group 
compared to other treatments. Specifically, TT-PCV had greater ADFI than CC-PCV 
(Grower 1) and CT-PCV (Finisher 1) (P < 0.05).  Genotype had no effect on G:F, but the 
VAC pigs were more efficient than the PCV pigs from Grower 2 to Finisher 2 (P <0.10). 
Genotype was observed to effect nutrient digestibility during Grower 1 through Finisher 
1, in favor of the C allele genotypes (P < 0.05). Vaccinated pigs appeared to have 
numerically higher digestibility, but only Finisher 1 was significant. Despite the previous 
differences in ADFI and ATTD, there were no differences in backfat, loin eye area or 
lean percentage for any of the treatments (Table 3.5). With respect to cost of production  
(Table 3.6), regardless of pigs slaughtered at same weight or age, the PCV2 infection 
increased cost compared with VAC pigs. Interestingly, genotype had a beneficial 
response by decreasing feed usage and by proxy cost and profit. Similar to Exp. 1, we 
saw favorable genotypes increase profit with the exception of the CT-PCV group, which 
had the highest feed cost and lowest profit of all treatment groups (P < 0.05). 
Experiment 3. Pigs from the TT and CT genotypes with either PCV-status were split into 
high and low residuals and were fed individually through the grow-finish period (Table 
3.7). Similar to the previous experiments, no difference in BW was observed. The low 
residual group had increased ADG during the finisher 1 phase compared to the high 
residual pigs (P < 0.05), while the PCV pigs had increased BW during the finisher 2 
phase over the VAC group (P < 0.10). The VAC group was observed to have increased 
ADFI during grower 1 (P < 0.05), whereas the low residual was increased during the 
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finishing phase (P < 0.05). The low residual group also benefitted from improved feed 
efficiency during the grower 2 and finisher 1 phases (P < 0.05). No differences were 
observed for DM or GE ATTD during the experiment (Table 3.8). Lean weight and 
percentage (P < 0.05) were both increased, while backfat decreased (P < 0.07) in the CT 
pigs compared with TT pigs. Production costs were numerically lower in the CT-PCV 
group compared with the TT-PCV group by $3.00, but this difference was not present in 
the VAC pigs (Table 3.9). Unsurprisingly, pigs from the low residual group saw 
increased production costs either due to combination of increased feed intake and lower 
carcass yield compared to the high residual group (P < 0.01). 
 
DISCUSSION 
 The objective of the experiments described was to assess the effects of genotypic 
selection at the SSC12 QTL (ALGA0122080) on nursery and long-term growth 
performance after a PCV2 infection or vaccination. This QTL, previously identified by 
Engle et al. (2014a), was one of two QTL found to be associated with viral load. Pigs 
with high viral loads showed a decrease in ADG during a four-week experimental PCV2b 
infection. At week 4, ADG in high viral load pigs remained 33% lower compared to low 
viral load pigs. However, this data was reflective of both QTLs reported, whereas our 
study only looked at SSC12 and encompassed the highest and lowest 10% of pig viral 
load. In the current experiment, pigs infected with PCV2 showed a phenotypic response 
for viremia, IgG, and IgM as expected among the different genotypes represented. In 
addition, VAC pigs began show an increase in PCV2 specific IgG and IgM after d 35 
indicating the potential for PCV2 infection, however, this was not further investigated. 
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Data previously reported by McKnite et al. (2014) observed a reduction in viral load as 
the total number of favorable alleles, across multiple SNP sites, increased. However, we 
did not see an increase in ADG for pigs carrying the favorable C allele throughout our 
study. This differs from previous work (McKnite et al., 2014) as pigs carrying at least one 
favorable allele were observed to have a 30% increase in ADG; however, this occurred 
over three different SNP sites. Additionally, our pigs were not genotyped for the 
previously reported SNPs ALGA0050315 (SSC9) and MARC0001766 (SSC12) (McKnite 
et al., 2014) or swine leukocyte antigen II (SSC7) (Engle et al., 2014b). Thus, the lack of 
variation between treatments could be a result of the presence, or lack therefore, of these 
favorable alleles. Long-term growth performance over Exp. 2 and 3 showed no difference 
between genotypes, however, ATTD increased with favorable allele presence in infected 
pigs. Over the course of the three experiments, genotype had no impact on the growth 
performance or digestibility of pigs vaccinated for PCV2, implying that genotypic effects 
may be largely a result of experimental PCV2 infection as opposed to PCV vaccination. 
Interestingly, despite the lack of differences in growth performance, analysis of the data 
for production costs appears to indicate that presence of the favorable alleles may reduce 
production costs by $4-10 per head. These savings appear to be largely driven by 
decrease in ADFI, which, when also considering viremia and IgG production, would 
indicate a decreased immune response, and thus a reduction in energy and amino acids 
needed to fuel that response (Pastorelli et al., 2011). 
 This study did not explore the use of a co-infection model, but as PCVAD is 
known to include additional pathogens with PCV2 (Segalés, 2012), utilizing a co-
infection model will be needed. Chae (2016) summarized that PCV2 viremia can be 
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enhanced by prior PRRS or Mycoplasma hyopneumoniae vaccination or infection and 
that PVC2 vaccination should be a priority in herds. Vaccination for PCV2 was shown to 
improve pig performance in commercial settings (Jacela et al., 2011; Shelton et al., 2012; 
Potter et al., 2014). Although there are a number of effective PCV2 vaccines on the 
market (da Silva et al., 2014) that may preclude the need for this work, the 
UNLPCV2.2009 SNP may be beneficial to pigs experiencing PCVAD conditions.  
Overall, these data show that pigs containing favorable alleles at the 
UNLPCV2.2009 SNP have decreased viremia, and through immunoglobulin 
concentration or titers, a decreased immune response, allowing them to handle a PCV2 
challenge more effectively. While this does not necessarily improve growth performance 
during the challenge or subsequent growth and finish phases, it may have an impact on 
reducing production cost for producers. 
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Table 3.1. Diet formulation and chemical 
composition for experiment 1 (%, as-fed basis).1 
Ingredients, % Diet 
Corn 58.99 
SBM, 47.7% CP 33.40 
Dicalcium phosphate, 18.5% 1.73 
Limestone 0.35 
Salt 0.30 
Vitamin premix2 0.25 
Trace mineral premix3 0.15 
Corn oil 3.85 
Lysine-HCl 0.30 
DL-Methionine 0.11 
L-Threonine 0.07 
Titanium dioxide 0.50 
Calculated composition, %  
SID Lys 1.22 
SID Thr 0.72 
SID Trp 0.23 
SID Met 0.39 
CP 21.16 
ME, kcal/kg 3.56 
Ca 0.86 
Available P 0.43 
1Formulated using NRC (2012) 
2Vitamin premix supplied per kg of diet: 
vitamin A (as retinyl acetate), 5500 IU; vitamin 
D (as cholecalciferol), 550 IU; vitamin E (as 
tocopheryl acetate), 30 IU; vitamin K (as 
menadione dimethylpyrimidinol bisulfate), 4.4 
mg; riboflavin, 11.0 mg; d-pantothenic acid, 
22.05 mg; niacin, 33.0 mg; vitamin B12 (as 
cyanocobalamin), 33.0 mg 
3Trace mineral premix containing: copper (as 
CuSO4H2O), 10 mg/kg; iodine (as Ca(IO3) · 
H2O), 0.25 mg/kg; iron (as FeSO4 · 2H2O), 
125 mg/kg; manganese (MnO), 15 mg/kg; 
selenium (Na2SeO3), 0.3 mg/kg; zinc (ZnSO4 · 
H2O), 125 mg/kg 
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Table 3.2. Diet formulation and predicted composition for experiments 2 and 31. 
  Grower 1 Grower 2 Finisher 1 Finisher 2 
Ingredients, %         
Corn2 59.92 65.14 68.36 74.55 
Soybean meal, 46.5% CP 33.00 28.00 25.00 19.00 
Dicalcium phosphate, 18.5% P 1.00 0.90 0.70 0.55 
Limestone 0.85 0.75 0.73 0.70 
Salt 0.30 0.30 0.30 0.30 
Vitamin premix3 0.25 0.25 0.25 0.25 
Trace mineral premix4 0.15 0.15 0.15 0.15 
Corn Oil 4.00 4.00 4.00 4.00 
Lysine·HCl 0.30 0.30 0.30 0.30 
DL-Methionine 0.08 0.06 0.05 0.04 
L-Threonine 0.15 0.15 0.15 0.14 
L-Trp 0.00 0.00 0.01 0.02 
Calculated composition, %         
CP 17.63 15.89 14.86 12.78 
ME, kcal/kg 3474 3485 3496 3508 
Ca 0.67 0.60 0.53 0.47 
STTD P 0.32 0.29 0.25 0.22 
SID Lys 1.22 1.09 1.02 0.87 
SID Met 0.36 0.32 0.30 0.26 
SID Thr 0.80 0.73 0.69 0.60 
SID Trp 0.23 0.20 0.19 0.17 
1Formulated using NRC (2012) 
2Titanium dioxide added at 0.5% in diet, in place of corn 
3Vitamin premix supplied per kg of diet: vitamin A (as retinyl acetate), 5500 IU; 
vitamin D (as cholecalciferol), 550 IU; vitamin E (as tocopheryl acetate), 30 IU; 
vitamin K (as menadione dimethylpyrimidinol bisulfate), 4.4 mg; riboflavin, 11.0 
mg; d-pantothenic acid, 22.05 mg; niacin, 33.0 mg; vitamin B12 (as 
cyanocobalamin), 33.0 mg 
4Trace mineral premix containing: copper (as CuSO4H2O), 10 mg/kg; iodine (as 
Ca(IO3) · H2O), 0.25 mg/kg; iron (as FeSO4 · 2H2O), 125 mg/kg; manganese (MnO), 
15 mg/kg; selenium (Na2SeO3), 0.3 mg/kg; zinc (ZnSO4 · H2O), 125 mg/kg 
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Table 3.3. Growth performance1 data from Exp. 1 for pigs selected for genotype (CC, CT, 
and TT)2 vaccinated for or inoculated with porcine circovirus type 2 (PCV2)  
Item Inoculated Vaccinated SE P-value 
CC CT TT CT TT 
BW, kg               
d 03 7.1 7.1 7.1 7.1 7.1     
d 7 8.5 8.7 8.9 8.8 8.8 0.21 0.65 
d 14 11.7 11.6 12.0 11.8 11.7 0.39 0.87 
d 21 15.6 15.4 15.7 16.0 15.4 0.62 0.89 
d28 20.0 19.2 19.6 20.2 19.7 0.82 0.79 
d 35 25.5 24.5 24.9 25.8 25.4 1.11 0.78 
d 42 31.8 30.5 30.8 32.0 31.5 1.40 0.83 
d 0-7               
ADFI, kg/d 0.48 0.51 0.52 0.55 0.53 0.067 0.67 
ADG, kg/d 0.22 0.23 0.22 0.24 0.22 0.030 0.70 
G:F 0.47 0.44 0.46 0.48 0.43 0.084 0.99 
d 7-14               
ADFI, kg/d 0.80 0.73 0.68 0.72 0.73 0.047 0.82 
ADG, kg/d 0.48 0.43 0.44 0.45 0.40 0.035 0.78 
G:F 0.60 0.59 0.64 0.62 0.56 0.043 0.48 
d 14-21               
ADFI, kg/d 0.83 0.85 0.87 0.91 0.89 0.073 0.91 
ADG, kg/d 0.58 0.54 0.51 0.60 0.51 0.047 0.75 
G:F 0.70 0.64 0.59 0.67 0.59 0.074 0.93 
d 21-28               
ADFI, kg/d 1.15 1.11 1.06 1.07 1.10 0.093 0.97 
ADG, kg/d 0.69 0.56 0.53 0.64 0.58 0.053 0.51 
G:F 0.61 0.51 0.51 0.61 0.54 0.082 0.78 
d 28-35               
ADFI, kg/d 1.54 1.25 1.43 1.30 1.48 0.151 0.30 
ADG, kg/d 0.84 0.76 0.72 0.81 0.79 0.063 0.79 
G:F 0.55 0.63 0.53 0.64 0.54 0.098 0.78 
d 35-42               
ADFI, kg/d 1.58 1.60 1.56 1.58 1.64 0.097 0.86 
ADG, kg/d 0.93 0.87 0.83 0.89 0.85 0.058 0.96 
G:F 0.59 0.55 0.54 0.57 0.52 0.060 0.93 
1BW = body weight; ADFI = average daily feed intake; ADG = average daily gain; G:F = 
gain to feed ratio 
2CC = resistant to PCV2, CT = heterozygous, TT = susceptible to PCV2 
3Group average body weight of 7.1 kg was used for statistical estimates 
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Table 3.4. Growth performance1 data from 14-week grow-finish period (Experiment 2) of 
pigs selected for genotype (CC, CT, and TT) and vaccinated for or inoculated with 
porcine circovirus type 2 (PCV2) 
Treatment 
 Genotype 
Inoculated Vaccinated SEM P-value CC CT TT CT TT 
BW, kg               
wk 0 40.0 40.1 37.5 35.2 39.5 2.04 0.414 
wk 1 to 2 53.0 54.0 51.3 48.1 52.9 2.39 0.473 
wk 2 to 6 77.5 77.0 76.0 73.9 76.7 2.05 0.755 
wk 6 to 10 106.9 108.6 105.5 104.5 106.9 2.60 0.826 
wk 10 to 14 131.4 135.6 133.9 132.5 130.6 3.78 0.886 
ADFI, kg/d               
wk 1 to 2** 2.16a 2.63ab 2.79b 2.46ab 2.46ab 0.122 0.029 
wk 2 to 6 2.93 3.04 3.35 3.12 3.08 0.133 0.295 
wk 6 to 10†† 3.39ab 3.23a 4.08b 3.49ab 3.71ab 0.182 0.041 
wk 10 to 14# 3.28 3.57 4.50 3.76 3.61 0.277 0.069 
ADG, kg/d               
wk 1 to 2 0.93 0.99 0.98 0.93 0.96 0.04 0.689 
wk 2 to 6 1.16 1.16 1.16 1.21 1.13 0.039 0.774 
wk 6 to 10 1.03 1.05 1.04 1.08 1.03 0.075 0.987 
wk 10 to 14 0.81 0.94 1.02 0.97 0.85 0.063 0.161 
G:F               
wk 1 to 2 0.38 0.4 0.42 0.39 0.41 0.039 0.967 
wk 2 to 6† 0.4 0.39 0.35 0.39 0.37 0.013 0.127 
wk 6 to 10† 0.3 0.33 0.25 0.31 0.28 0.018 0.066 
wk 10 to 14† 0.25 0.27 0.23 0.26 0.24 0.014 0.259 
1BW = body weight; ADFI = average daily feed intake; ADG = average daily gain; G:F = 
gain to feed ratio 
a,bSuperscripts represent differences between treatments, P < 0.05 
*Genotype, P < 0.10; **Genotype, P < 0.05 
†PCV status, P < 0.10; ††PCV status, P < 0.05 
#Genotype x PCV, P < 0.10; ##Genotype x PCV, P < 0.05 
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Table 3.5. Carcass trait and digestibility coefficients during 14-week grow-finish 
(Experiment 2) period of pigs selected for genotype (CC, CT, and TT) and vaccinated for 
or inoculated with porcine circovirus type (PCV2) 
Treatment  
Genotype 
Inoculated Vaccinated SEM P-value CC CT TT CT TT 
Backfat, cm 2.36 2.29 2.38 2.66 2.41 0.163 0.499 
LEA1, cm2 54.4 53.9 55.6 55.7 52.4 1.83 0.644 
Lean, kg 54.8 55.5 54.0 54.5 54.0 1.24 0.890 
Lean, % 51.5 51.2 51.9 50.4 50.4 0.81 0.592 
DM ATTD1, %               
wk 2** 80.6 78.9 77.0 80.4 82.0 1.18 0.084 
wk 6** 84.5b 82.8ab 81.3a 83.0ab 82.8ab 0.61 0.035 
wk 10**††## 85.1b 84.4b 80.8a 83.9ab 83.7ab 0.73 0.023 
wk 14# 83.8 84.8 81.7 83.9 84.1 0.84 0.165 
GE ATTD1, %               
wk 2** 80.4 78.3 76.5 80.3 82.0 1.27 0.065 
wk 6** 84.9b 82.8ab 81.5a 83.4ab 83.0ab 0.69 0.053 
wk 10*††# 85.2b 84.4ab 80.6a 83.9ab 83.7ab 0.84 0.037 
wk 14# 83.3 84.7 81.1 83.3 83.9 0.91 0.123 
1LEA = loin eye area; ATTD = apparent total tract digestibility; DM = dry matter; GE = 
gross energy 
a,bSuperscripts represent differences between treatments, P < 0.05 
*Genotype, P < 0.10; **Genotype, P < 0.05 
†PCV status, P < 0.10; ††PCV status, P < 0.05 
#Genotype x PCV, P < 0.10; ##Genotype x PCV, P < 0.05 
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Figure 3.1. Weekly serum viremia of pigs vaccinated for or inoculated with porcine 
circovirus type 2 (PCV2) and genotyped during experiment 1. 
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A) 
  
B) 
  
 
Figure 3.2. Serum titers of porcine circovirus type 2 (PCV2)-specific IgM (A) and IgG 
(B) in pigs vaccinated for or inoculated with PCV2 and genotyped during experiment 1.
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Figure 3.3. Apparent total tract digestibility coefficients for gross energy (GE) and dry 
matter (DM) at wk 2, 4, and 6 of Experiment 1. PCV = inoculated with porcine circovirus 
2 (PCV2); VAC = vaccinated with PCV2. Bars represent least square means ± SEM.
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Figure 3.4. Feed cost per kg of body weight gain during experiment 1. PCV = inoculated 
with porcine circovirus 2 (PCV2); VAC = vaccinated with PCV2. Bars represent least 
square means ± SEM   
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ABSTRACT:  Weaning is a particularly important transition for the young pig due to a 
variety of factors. This is emphasized with current trends to restrict the use of antibiotics 
in feed. In an effort to improve weaning transition, two experiments were conducted to 
examine the effects of additional tryptophan (Trp) in nursery diets on weaned pig growth 
performance, digestibility, and Lactobacillus populations. In Exp. 1, 72 weanling pigs 
were split across two replications and randomly allocated across six pens, with a total of 
six pens per treatment. A two-phase nursery diet was utilized with a control diet (0.22 
SID Trp:Lys) or control plus L-Trp (0.025%, Phase 1; 0.02%, Phase 2; 0.24 SID 
Trp:Lys).  In Exp. 2, 72 weanling pigs were randomly allocated across 18 pens and 
assigned to one of three diets: control and Trp diets (as in Exp. 1), or Trp+ (0.05%, Phase 
1; 0.04%, Phase 2; 0.26 SID Trp:Lys). Diets in Exp. 2 contained titanium dioxide as a 
marker of digestibility. In both experiments, phase 1 and 2 diets were fed for 2 and 3 wk, 
respectively. Growth performance was recorded weekly, and fecal samples were 
collected at the end of each dietary phase for microbiome analysis. Statistical analysis 
was performed utilizing Proc Mixed (SAS 9.2) with pen as the experimental unit and wk 
0 BW as a covariate. In Exp. 1, no difference was observed in BW, ADG, or ADFI. Gain 
to feed ratio, however, was increased 9% in pigs on the Trp diet across both phases (P < 
0.01). In Exp. 2, no differences in BW, ADG, ADFI, or G:F were observed. Phase 2 DM 
and GE digestibility was increased (P < 0.01) in Trp pigs, as compared with to control 
pigs (P < 0.01). Lactobacillus populations increased with Trp supplementation in Exp. 1 
(P > 0.10), but not Exp. 2. Together, increased Trp supplementation may improve nursery 
pig performance.  
 
Key words: Lactobacillus, pig, tryptophan 
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INTRODUCTION 
 
 Implementation of the Veterinary Feed Directive has resulted in the removal of 
antibiotics being used for growth promotion purposes in animal agriculture from the 
market. As a result, there is increased emphasis on using antibiotic alternatives to 
improve the weaning transition and promote growth. Despite the large number of 
antibiotic alternatives on the market, a recent literature review by Schweer et al. (2017) 
found that 66.5% of alternatives exhibit no impact on ADG compared to the 28.6% that 
have a positive response. Thus, there is a need to continue developing strategies for 
improving piglet performance.  
 Tryptophan is an essential amino acid that can be limiting in the swine diet. 
Because of its role in immune function, limiting tryptophan reduces N retention and 
protein deposition efficiency of tryptophan under immune stimulation (de Ridder et al., 
2012). Supplementing tryptophan in the diet has been shown to be beneficial to animals 
under health challenge by supporting immune function and improving feed efficiency 
(Capozzalo et al., 2012; Messori et al., 2013; Xu et al., 2014; Capozzalo et al., 2015). 
Tryptophan is used for proteins synthesis and tissue deposition, but also serves as a 
precursor to serotonin, niacin, and indole derivatives. While tryptophan is important for 
host tissue growth and function, microbes in the gut can also utilize nutrients prior to 
their absorption by the host. 
Lactobacillus species are prominent members of the microbiome in suckling and 
weanling piglets when lactose is consumed. However, Lactobacillus decreases in 
abundance, proportionally speaking, as the piglet ages and the diet changes (Frese et al., 
2015). The Lactobacillus species are capable of metabolizing tryptophan under 
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carbohydrate starvation conditions (Gummalla and Broadbent, 1999), but may metabolize 
tryptophan into indole derivatives under normal gut nutrient conditions (Zelante et al., 
2013). Tryptophan supplementation in conventional mice resulted in an increase in 
Lactobacillus reuteri in the stomach and L. reuteri mediated conversion of indole-3-
aldehyde from tryptophan causing increased IL-22 production via the aryl hydrocarbon 
receptor (AhR) (Zelante et al., 2013). Interleukin-22 stimulates antimicrobial factors from 
Paneth cells in the intestinal crypts (Eyerich et al., 2017). It has been reported that Paneth 
cells are absent in pigs (Trautman and Fiebiger, 1952), however,  it was shown that 
epithelial cells can respond to IL-22 stimulus resulting in production of antiviral factors 
and beta defensin 2 (Xue et al., 2017). Altogether, metabolism of tryptophan by 
Lactobacillus can stimulate the AhR-IL-22 pathway potentially benefitting host gut 
health. 
 Although tryptophan has been supplemented in pig diets and under disease 
challenges previously (Capozzalo et al., 2012; Messori et al., 2013; Xu et al., 2014; 
Capozzalo et al., 2015; Goncalves et al., 2015), it has not been shown if supplementing 
tryptophan benefits pigs through an increase in intestinal Lactobacillus populations or 
animal health through the AhR-IL-22 pathway. 
  
 
MATERIALS AND METHODS 
 
The experimental protocol was reviewed and approved by the Institutional 
Animal Care and Use Committee of the University of Nebraska, Lincoln.   
 
Animals and Experimental Design 
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A total of 144 ((Landrace x Nebraska White) x Duroc) were used across two 
experiments. Piglets were weaned at the ENREC Swine Unit (Mead, NE) of the 
University of Nebraska. Pigs were transported to the Animal Science Complex for 
studies.  
For experiment 1, 72 pigs across two replicates (36 pigs per replicate) were 
housed in six pens and assigned to one of two treatments (six pigs per pen; three pens per 
treatment): a control diet (Con) or the control with supplemental tryptophan (Trp). For 
experiment 2, 72 pigs were housed in 18 pens and assigned to one of three treatments 
(four pigs per pen; six pens per treatment): a control diet, control with supplemental Trp, 
and a control with two times the supplemental Trp. In all experiments, pigs were on trial 
for five weeks with body weight (BW) and feed disappearance monitored weekly to 
calculate average daily gain (ADG), average daily feed intake (ADFI), and gain to feed 
ratio (G:F). 
 
Diets. Pigs were fed a two-phase nursery diet and fed the nursery 1 diet for two weeks 
and nursery 2 for three weeks (Table 4.1). Tryptophan was supplemented at 0.025 and 
0.020% for phase 1 and 2, respectively, to ensure the standardized ileal digestibility 
(SID) Trp : Lys remained the same during the trial. In Exp. 2, Trp was supplemented at 
0.05 and 0.04% for the Trp+ diet. Diets contained no antibiotics or antibiotic alternatives 
and were formulated to meet or exceed NRC (2012) requirements. Titanium dioxide was 
fed at 0.5% in Exp. 2 to facilitate digestibility measurements. 
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Sample Collection. During Exp. 1, blood samples were obtained on wk 1 and 5 from two 
pigs per pen (5-9 mL each) via jugular venipuncture in serum tubes. Tubes were allowed 
to clot before harvesting serum by centrifugation (1,500 x g for 10 min at 4˚C). Serum 
samples were aliquoted and stored at -80˚C for subsequent analyses. On wk 0, 2, and 5, 
fecal samples were collected directly from the rectum and frozen at -80˚C for microbial 
analysis. At wk 1, two pigs per pen were euthanized using a lethal dose of sodium 
pentobarbital. Fresh ileum and cecum tissue were collected and frozen at -80˚C for later 
analysis. 
   
Cytokine Analysis. Serum and tissue homogenates were used to measure interleukin-8 
and -22 respectively. Interleukin-8 was measured using porcine specific ELISA kit (R & 
D Systems, Minneapolis, MN) following manufacturers instructions with inter- and intra-
assay CV of 8.4 and 7.9%. Interleukin-22 was measured using a porcine specific ELISA 
kit (RayBiotech, Norcross, GA) following manufacturers instructions with inter- and 
intra-assay CV of 3.3 and 6.45%. 
 
Digestibility Analysis. Proximate analysis was carried out on feed and pooled fecal 
samples as previously described (Patience et al., 2009; Jacobs et al., 2011). At the end of 
each phase fecal samples were collected from each pen for Exp. 2. All samples were 
frozen at -20˚C for later analysis. Samples were later dried in a 100˚C forced-air oven for 
3 d and then ground afterwards. Samples were analyzed for dry matter (DM) and gross 
energy (GE) using bomb calorimetry (Parr, Moline, IL). Total tract digestibility 
coefficients were calculated using indigestible marker methodology (Kerr et al., 2010). 
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Microbial Extraction and Sequencing. Fecal samples were extracted using the Mag Bind 
Soil DNA kit (Omega Bio-tek, Carlsbad, CA) following instructions with the following 
modifications. Samples (0.25 g) were loaded in to 2-mL Safe-Lock tubes (Eppendorf) 
with 0.5 g of 0.1 mm zirconia beads (Biospec Products, Bartlesville, OK) and 700 uL of 
SLX-Mlus buffer. Samples were lysed using a Tissuelyser (Qiagen, Valencia, CA) for 10 
m at frequency 20. Samples tubes were incubated at 90˚C for 7 m.  
Prior to the KingFisher step, the nucleic acids were precipitated in the following 
steps. 70 uL of 10 mM sodium acetate was added to each tube, mixed, and placed on ice 
for 5 m. Tubes were centrifuged at 16,000 x g for 15 m at 4˚C. Supernatant was added to 
a new tube and 400 uL of ice-cold isopropanol was added and the tube vortexed. Tubes 
were incubated on ice for 30 m and centrifuged at 16,000 x g for 15 m at 4˚C. 
Supernatant was discarded and the nucleic acid pellet was washed with 500 uL ice cold 
70% ethanol and vortexed. Tubes were centrifuged at room temperature for 2 m at 13,000 
x g. The wash was decanted, and the pellet allowed to dry for 3 m. The pellet was then 
dissolved in 450 uL of Tris (10 mM pH 8) and transferred to a deep well plate. Following 
the Omega kit again, DNA was purified using a MagMax Express 96 (Applied 
Biosystems, Foster City, CA) and stored at -20˚C. 
Amplicons for the V4 region of the 16S rRNA gene were prepared as described 
by Kozich et al. (2013). Amplification for each sample via PCR was done in 25 uL 
reactions of the following: 12.5 uL Terra buffer, 0.5 uL Terra Polymerase (CloneTech 
Laboratories, Mountainview, CA), 1 uL of indexed fusion primers, 9 uL of PCR water, 
and 2 uL of DNA. Conditions for amplification were as follows: 98˚C for 3 m; 25 cycles 
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of 98˚C for 30 s, 55˚C for 30 s and 68˚C for 45 s; and a single final extension step at 68˚C 
for 4 m. Purity of amplified samples was determined by running samples on a 1.5% 
agarose gel. Libraries were normalized using the PCR Purification and Normalization kit 
(Charm Biotech, San Diego, CA) and the library subsequently pooled. Pooled libraries 
were purified using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel, 
Bethlehem, PA). To concentrate libraries, a DNA precipitation was performed as follows: 
0.1X volume of Sodium acetate (3M, pH 5.2), 2.5X volume of 100% isopropanol, and 1 
uL of carrier RNA (Qiagen, Valencia, CA) were added to each library and mixed. 
Libraries were stored at -80˚C overnight and centrifuged at 14,000 x g for 30 m at 4˚C. 
Supernatant was removed and pellets washed with 50 uL of ice cold 70% ethanol. 
Libraries were centrifuged at 14,000 x g for 15 m at 4˚C. Supernatant was discarded, 
tubes were allowed to dry for 3 m, and 6-10 uL of elution buffer (Qiagen, Valencia, CA) 
added to dissolve the pellet. 
Libraries were checked for quality using a High Sensitivity DNA Chip on an 
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA) and quantified using 
a High Sensitivity dsDNA kit (Denovix, Wilmington, DE). All libraries were pooled, and 
re-quantified to confirm concentrations. Pooled libraries were run on an Illumina MiSeq 
platform (Illumina, San Diego, CA) using the V2 500 cycles kit according to 
manufacturer’s instructions.  
Microbiome Sequence Processing 
Protocol for processing of sequences can be found in Appendix B. In short, 
generated fastq files were processed in RStudio using the dada2 pipeline 
(https://benjjneb.github.io/dada2/tutorial.html). The quality profile for sequenced reads 
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fell below a quality score of 30 around read 250. When filtering and truncating the reads, 
a threshold of a 240 was used for the forward and reverse reads and max of 2 expected 
errors per read. Samples were dereplicated into unique amplicon sequence variants 
(ASV).  The ASV is alternate method allowing for unique sequences to be resolved down 
to single nucleotide differences as opposed to using operational taxonomic units which 
clusters sequences with less than 3% dissimilarity threshold (Callahan et al., 2017). 
Chimeras were removed with and represented less than 1% of total sequence variant 
abundance. Taxonomy was assigned using the Silva reference database (v132) 
(https://mothur.org/wiki/Silva_reference_files). A phylogenetic tree was created using 
Mothur and the Silva v132 seed database. The phylogenetic tree, biom file and mapping 
file were then merged using phyloseq (https://joey711.github.io/phyloseq/index.html). 
The data was rarefied to an even depth using the minimum number of sequence reads in 
the dataset. Bray-Curtis, Unifrac, and Weighted Unifrac distance matrices were generated 
from the dataset to be used in a PERMANOVA analysis. Additionally, samples were 
processed through Quantitative Insights Into Microbial Ecology (QIIME) to generate taxa 
plots as shown in Appendix A.   
 Separately, using the ASV counts, relative abundance of each Lactobacillus ASV 
in every sample was calculated. Total Lactobacillus relative abundance was then 
calculated. 
 
Economic Data. Pen feed disappearance by week was multiplied by cost per kg of feed, 
with respect to treatment and phase, to determine feed usage cost. The feed usage cost 
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was divided by weekly net BW gain to calculate the feed cost per kg of BW gain. The 
difference in cost between Trp or Trp+ and the control were calculated.  
 
Statistics. All experiments were analyzed using the Proc MIXED procedure of SAS 9.2 
(SAS Inst. Inc., Cary, NC) and all results were expressed as least square means ± SEM. 
Pen was the experimental unit and the model included fixed effect of treatment; with 
random effects of initial BW. If initial BW was found to be significant, it was added as a 
covariate to the model. Relative abundance of Lactobacillus ASV was analyzed with pig 
as the experimental unit. Additionally, data from experiment 1 was analyzed with 
replication as a covariate, where necessary. Statistical significance of differences was 
determined by Tukey’s range test for pair wise comparisons. Differences were deemed 
significant at P ≤ 0.05 and tendencies at P ≤ 0.10.  
 
RESULTS 
  
 Pigs were supplemented with and without extra Trp in the diet for five weeks and 
replication being significant (P < 0.05). Individually, improvements for G:F in the Trp 
group were observed in replication 1 (P < 0.10) and replication 2 (P < 0.05). No 
difference was found in BW, ADFI, or ADG during the trial period (Table 4.2). Despite 
this, pigs supplemented with Trp were 9.3% more feed efficient through both phases and 
over the total experimental period (P < 0.05) (Figure 4.1A). Throughout, the trial the Trp 
pigs had a $0.20-0.28 lower feed cost/kg gain (P > 0.05) (Table 4.4). Similar to the 
previous experiments, Exp. 2 resulted in no differences in BW, ADFI, and ADG. The 
control pigs had numerically lower G:F compared with to both Trp treatments and the 
Trp+ pigs had reduced G:F compared to the Trp group although no statistical difference 
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was found (P > 0.10) (Figure 4.1B). The Trp treatments saw a $0.18-0.25 feed cost per 
kg gain difference with the control pigs in phase 1, but this benefit was lost in phase 2 as 
cost increased to $0.05-0.07 over the control (P > 0.10). Surprisingly, the Trp group 
showed a 1.5% decrease in ATTD during phase 1, but a 1.5% increase in ATTD during 
phase 2 compared with the control and Trp+ groups. (P < 0.05) (Figure 4.2). No 
differences were found for IL-8 in the serum or IL-22 in intestinal samples (Figure 4.3). 
Sequencing of 156 samples yielded 2.55 million sequences with a mean of 16347 
sequences per sample. Overall, no differences were seen between treatments while age of 
pig had an effect (P < 0.05). Supplementing tryptophan numerically increased the relative 
abundance of the Lactobacillales order and Lactobacillus, across 30 Lactobacillus ASV 
identified in experiment 1 (P > 0.10), although this pattern was not seen in experiment 2 
(Figure 4.4; Figure 4.5). 
 
DISCUSSION 
 
 The goal of this experiment was to assess the benefit of supplemental Trp on 
nursery pig performance and changes in Lactobacillus populations. The SID Trp: Lys 
requirement for nursery pigs was estimated at 16.3% in the NRC (2012).  The 
requirement was estimated to be higher than 19.5% by Guzik et al. (2005) and a meta-
analysis by Simongiovanni et al. (2012) found increasing the requirement from 17% to 
22% improved ADG by 8%. Goncalves et al. (2015) estimated the SID Trp:Lys 
requirement at 20.4% and 23.9% for G:F and ADG, respectively, in 6 to 11 kg BW pigs, 
and 16.6% and 21.2% for G:F and ADG, respectively, in 11 to 20 kg BW pigs. Nursery 
diets used for the Nebraska swine herd are currently formulated at 22% SID Trp:Lys. As 
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we wanted to ensure that supplemented Trp was in excess of requirement, usage of 22% 
was deemed appropriate for this study.  
 Supplementing pigs with Trp improved feed efficiency, although this was more 
pronounced in the first two experiments and not the third. The titration study by 
Goncalves et al. (2015), had similar SID Trp:Lys levels at the top end of curve, but 
whereas 24% level had a decrease in G:F, our study showed an increase. Considering the 
potential differences between location, genetics, and diet, these could account for the 
differences in performance seen. However, similar to the prior study, we did find that the 
26% level (Trp+) in our third experiment did have reduced performance compared to the 
24% (Trp) thus indicating that there was point where extra Trp was not as beneficial. We 
were surprised to find that Exp. 2 did not show the same results for G:F compared with 
Exp. 1. Week 1 growth performance and observed diarrhea appeared to indicate 
subclinical illness was present, but despite the inclusion of Trp and numerical increases in 
performance overall, no significant differences were seen in the performance. This is 
surprising as numerous studies (Capozzalo et al., 2012; Messori et al., 2013; Xu et al., 
2014; Capozzalo et al., 2015) have shown supplementing Trp to be beneficial to pigs in 
poor sanitation conditions or exposed to a health challenge. This may have also impacted 
ATTD as the control and Trp+ pigs had increased digestibility at the end one phase 1 
when the pigs were likely recovering. Phase 2 ATTD was increased in the Trp, however 
this gain was not reflected in ADG or G:F and no measurements were taken to assess 
backfat or loin eye area.   
 We also wanted to assess if tryptophan had an effect on Lactobacillus 
populations. Overall, we saw a numerical increase in Lactobacillus abundance in Exp. 1, 
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but not Exp. 2. Few studies with tryptophan have looked into Lactobacillus populations. 
Zelante et al. (2013) showed that proportions of individual Lactobacillus species changed 
in the murine stomach and feces but didn’t quantify Lactobacillus abundance relative to 
other Firmicutes. Liang et al. (2018), showed a decrease in Lactobacillus abundance as 
Trp concentrations increased, however, Trp concentrations were 10-fold higher than our 
study and exceed other published literature values. The lack of differences in 
Lactobacillus abundance may explain why we didn’t see any difference in IL-8 or IL-22, 
although our model was also a low stress model compared to prior work (Zelante et al., 
2013; Capozzalo et al., 2012; Capozzalo et al., 2015).   
 Production cost is extremely important to producers. Supplementation of Trp did 
increase in G:F, but simply measuring this using feed intake did not account for ADG 
improvement in replication 2. As such, we compared feed consumption cost against the 
tissue deposited during the trial. Even though the Trp diet was more expensive due to 
increased Trp content, the $3.11 per pig savings in efficiency offset the cost in 
experiment 1. Experiment 3 saw a reduced benefit in the phase 1 compared to the prior 
experiment, but still positive. However, much like the growth performance from phase 2, 
supplementation of Trp provided no benefit. However, performing a follow-up study and 
assessing backfat and loin eye area would be prudent for elucidating additional economic 
factors.  
 Overall, increasing Trp in the diet appears to have positive effects on growth 
performance via feed efficiency, can potentially improve nutrient digestibility, and 
decreased cost of production. As feed cost is the most variable and generally costly 
component of production, reducing these costs can be beneficial to the producer’s bottom 
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line. However, more work is needed to determine additional benefits of Trp 
supplementation across swine production as it evolves. 
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Table 4.1. Experimental diet composition for Exp. 1 and 21 
  Phase 1 Phase 2 
Item Control Trp Trp+ Control Trp Trp+ 
Ingredient, %       
Corn 43.63 43.60 43.57 60.21 60.18 60.16 
SBM 32.00 32.00 32.00 33.75 33.75 33.75 
Whey 15.00 15.00 15.00 0.00 0.00 0.00 
Fishmeal 4.00 4.00 4.00 0.00 0.00 0.00 
Corn oil 3.00 3.00 3.00 3.00 3.00 3.00 
Dicalcium 1.00 1.00 1.00 1.65 1.65 1.65 
Limestone 0.35 0.35 0.35 0.63 0.63 0.63 
Sodium Chloride 0.30 0.30 0.30 0.30 0.30 0.30 
Vitamin Mineral Premix2,3 0.40 0.40 0.40 0.40 0.40 0.40 
DL-Met 0.03 0.03 0.03 0.03 0.03 0.03 
Zn Oxide 0.30 0.30 0.30 0.00 0.00 0.00 
L-Trp 0.00 0.025 0.05 0.00 0.02 0.04 
L-Lys 0.00 0.00 0.00 0.04 0.04 0.04 
Calculated analysis             
Net energy, kcal/kg 2561 2561 2562 2542 2542 2543 
SID AA, %             
Lys 1.21 1.21 1.21 1.03 1.03 1.03 
Met 0.37 0.37 0.37 0.32 0.32 0.32 
Thr 0.78 0.78 0.78 0.66 0.66 0.66 
Trp 0.26 0.29 0.31 0.23 0.25 0.27 
Trp:Lys 0.215 0.240 0.256 0.223 0.243 0.262 
1For experiment 2, 0.5% Titanium dioxide was added in place of corn 
2Vitamin premix supplied per kg of diet: vitamin A (as retinyl acetate), 5500 IU; vitamin 
D (as cholecalciferol), 550 IU; vitamin E (as tocopheryl acetate), 30 IU; vitamin K (as 
menadione dimethylpyrimidinol bisulfate), 4.4 mg; riboflavin, 11.0 mg; d-pantothenic 
acid, 22.05 mg; niacin, 33.0 mg; vitamin B12 (as cyanocobalamin), 33.0 mg 
3Trace mineral premix containing: copper (as CuSO4H2O), 10 mg/kg; iodine (as Ca(IO3) 
· H2O), 0.25 mg/kg; iron (as FeSO4 · 2H2O), 125 mg/kg; manganese (MnO), 15 mg/kg; 
selenium (Na2SeO3), 0.3 mg/kg; zinc (ZnSO4 · H2O), 125 mg/kg 
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Table 4.2. Growth performance1 of pigs supplemented with or without tryptophan 
(Trp) for 5 wk (Exp. 1)2 
 Item Con Trp3 SEM P-value 
BW, kg     
Wk 0 5.9 5.9 0.02 0.548 
Wk 1 6.9 6.8 0.14 0.947 
Wk 2 9.3 9.4 0.23 0.837 
Wk 3 12.0 12.2 0.36 0.590 
Wk 4 15.6 15.9 0.50 0.657 
Wk 5 19.8 20.3 0.65 0.604 
ADFI, kg/d     
Wk 1 0.19 0.17 0.013 0.539 
Wk 2 0.45 0.43 0.027 0.512 
Wk 3 0.72 0.69 0.034 0.593 
Wk 4 0.87 0.84 0.039 0.581 
Wk 5 1.07 0.99 0.051 0.350 
Phase 1 0.31 0.29 0.018 0.518 
Phase 2 0.89 0.84 0.038 0.443 
Total 0.64 0.61 0.027 0.430 
ADG, kg/d     
Wk 1 0.14 0.14 0.014 0.748 
Wk 2 0.35 0.36 0.017 0.627 
Wk 3 0.38 0.41 0.023 0.362 
Wk 4 0.52 0.53 0.026 0.885 
Wk 5 0.60 0.62 0.029 0.576 
Phase 1 0.23 0.24 0.013 0.627 
Phase 2 0.50 0.52 0.022 0.538 
Total 0.39 0.40 0.017 0.531 
1BW = body weight; ADFI = average daily feed intake; ADG = average daily 
gain. 
2Phase 1 diet was fed for wk 1 and 2; Phase 2 diet was fed for wk 3 to 5. 
3Tryptophan added at 0.025 and 0.02% for phase 1 and 2, respectively. 
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Table 4.3. Growth performance of pigs supplemented with or without 
tryptophan (Trp) for 5 wk (Exp. 2)1 
 Item Con Trp Trp+ SEM P-value 
BW, kg      
Wk 0 6.5 6.4 6.6 0.05 0.029 
Wk 1 6.7 6.7 6.7 0.14 0.980 
Wk 2 8.2 8.6 8.3 0.26 0.453 
Wk 3 10.6 10.9 10.7 0.33 0.754 
Wk 4 14.6 15.2 14.7 0.45 0.605 
Wk 5 19.5 20.3 20.1 0.61 0.534 
ADFI, kg/d      
Wk 1 0.10 0.11 0.10 0.012 0.806 
Wk 2 0.25 0.30 0.26 0.020 0.211 
Wk 3 0.53 0.52 0.53 0.031 0.988 
Wk 4 0.88 0.88 0.84 0.046 0.802 
Wk 5 1.12 1.19 1.20 0.033 0.174 
Phase 1 0.18 0.21 0.18 0.015 0.316 
Phase 2 0.84 0.86 0.86 0.033 0.880 
Total 0.59 0.60 0.59 0.026 0.996 
ADG, kg/d      
Wk 1 0.01 0.04 0.02 0.019 0.524 
Wk 2 0.21 0.27 0.23 0.022 0.095 
Wk 3 0.35 0.34 0.35 0.019 0.742 
Wk 4 0.56 0.60 0.57 0.028 0.499 
Wk 5 0.70 0.73 0.76 0.030 0.285 
Phase 1 0.10 0.16 0.12 0.022 0.118 
Phase 2 0.52 0.56 0.55 0.025 0.303 
Total 0.35 0.40 0.38 0.022 0.246 
1BW = body weight; ADFI = average daily feed intake; ADG = average daily 
gain. 
2Phase 1 diet was fed for wk 1 and 2; Phase 2 diet was fed for wk 3 to 5. 
3Tryptophan added at 0.025 and 0.05% for phase 1 and 0.02 and 0.04% for 
phase 2 for Trp and Trp+ diets, respectively. 
  
118 
 Ta
bl
e 
4.
4.
 P
ig
 fe
ed
 c
os
t p
er
 k
g 
ga
in
, a
nd
 sa
vi
ng
s b
y 
tre
at
m
en
t f
or
 E
xp
. 1
 a
nd
 2
. 
 
Ph
as
e 
1 
 
Ph
as
e 
2 
Ex
p.
 1
 
Co
nt
ro
l 
Tr
p 
  
SE
M
 
P-
va
lu
e 
  
Co
nt
ro
l 
Tr
p 
  
SE
M
 
P-
va
lu
e 
Fe
ed
 $
/ k
g 
ga
in
 
3.
33
 
3.
05
 
 
0.
07
0 
0.
01
9 
 
2.
46
 
2.
26
 
 
0.
03
7 
0.
00
4 
D
iff
er
en
ce
, $
 
 
0.
28
 
 
 
 
 
 
0.
2 
 
 
 
G
ai
n/
pi
g,
 k
g 
3.
5 
 
 
 
10
.7
 
 
 
Sa
vi
ng
s/p
ig
, 
$1
 
 
0.
97
 
 
 
 
 
 
2.
14
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ex
p.
 2
 
Co
nt
ro
l 
Tr
p 
Tr
p+
 
SE
M
 
P-
va
lu
e 
  
Co
nt
ro
l 
Tr
p 
Tr
p+
 
SE
M
 
P-
va
lu
e 
Fe
ed
 $
/ k
g 
ga
in
 
2.
93
 
2.
68
 
2.
76
 
0.
20
2 
0.
66
1 
 
1.
67
 
1.
75
 
1.
72
 
0.
05
 
0.
56
9 
D
iff
er
en
ce
, $
 
 
0.
25
 
0.
18
 
 
 
 
 
-0
.0
7 
-0
.0
5 
 
 
G
ai
n/
pi
g,
 k
g 
1.
8 
 
 
 
11
.6
 
 
 
Sa
vi
ng
s/p
ig
, 
$1
 
  
0.
46
 
0.
33
 
  
  
  
  
-0
.8
1 
-0
.5
8 
 
 
1 S
av
in
gs
 p
er
 p
ig
 is
 d
iff
er
en
ce
 b
et
w
ee
n 
Tr
p 
or
 T
rp
+ 
an
d 
Co
nt
ro
l t
re
at
m
en
ts 
  
119 
 
A)
 
B) 
 
Figure 4.1. Feed efficiency for Exp. 1 (A) and Exp. 2 (B) by week, phase, and overall. 
Bars represent least square means ± SEM.†, P < 0.10; *, P < 0.05 
  
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
1 2 3 4 5 Phase 1 Phase 2 Total 
G
ai
n:
Fe
ed
, k
g/
kg
 
Week 
Control Tryptophan 
 †              †       *             *    *              *         * 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
0.6 
0.7 
0.8 
0.9 
1 
1 2 3 4 5 Phase 1 Phase 2 Total 
G
ai
n:
Fe
ed
, k
g/
kg
 
Week  
Control Tryptophan Tryptophan+ 
  
120 
 
 
Figure 4.2. Apparent total tract digestibility (ATTD) coefficients of dry matter and gross 
energy for Exp. 2. Bars represent least square means ± SEM. *, P < 0.05 
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A) 
 
B) 
 
Figure 4.3. Cytokine concentrations from pigs supplemented with tryptophan in 
experiment 1. Interleukin-8 from d 7 and 35 serum samples (A). Interleukin-22 
concentrations from intestinal tissue homogenates (B). Bars represent least square means 
± SEM. 
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A) 
 
B) 
 
Figure 4.4. Relative abundance of Lactobacillus amplicon sequence variants in pigs 
supplemented with tryptophan in the diet. Experiment 1 (A) and 2 (B). Bars represent 
least square means ± SEM.  
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ABSTRACT: Rhamnolipids (RL) are glycolipids secreted by bacteria that aid in 
motility, biofilm formation, nutrient uptake, and have antimicrobial activity. The latter 
two may be of use to improve swine nutrition and health. Work conducted in vitro 
utilized IPEC-J2 cells to determine cellular response to treatment. In the first experiment, 
cells were treated with 0, 0.01, 0.05, 0.5, 1.0, 2.4, and 10% RL or 1 µg/mL 
lipopolysaccharide (LPS). In the second experiment, cells were treated with 0, 0.0005, 
0.001, 0.005, and 0.01% RL or 1 µg/mL LPS. For both experiments, treated cells were 
incubated for 1 h and rinsed with PBS. Cells were further incubated in fresh non-treated 
media for 0, 1, 3, 6, 12 or 24 h in Exp. 1, or 6 h in Exp. 2. Transepithelial resistance 
(TER) measurements were collected immediately after addition of fresh media and after 
incubations. Media from both the apical and basolateral sides were collected for IL-8 
analysis. Visual observation and TER analysis of Exp. 1 showed RL treatment decreased 
TER after initial incubation, with RL concentrations ≥ 0.05% exhibiting significant cell 
death and loss of cellular matrix adherence to the Trans-well membrane. Using lower 
dosages in Exp. 2, TER changed inversely with RL dosage, however, even 0.0005% RL 
reduced TER by at least 20% over the 6 h period (P > 0.10). Production of IL-8 was 
lower in RL treatments compared with either the control or LPS wells on the apical side 
(P > 0.10). Basolateral IL-8 was expressed in a dose dependent fashion, but only the 
0.01% RL had higher concentration than the control (P > 0.10). A third experiment was 
conducted by culturing jejunal explants in media with 0, 0.0005, 0.005, 0.05, and 0.5% 
RL or 1 ug/mL LPS for 1 h followed by 3 h incubation in fresh media. Similar to Exp. 2, 
explants showed dose dependent IL-8 production in tissue obtained from 5 and 7 wk old 
pigs with 0.5% RL having higher IL-8 concentration compared to control or LPS samples 
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(P < 0.01). The lower doses of RL had similar or lower IL-8 production to the control or 
LPS samples (P > 0.10). Together these data show that low doses of RL (≤ 0.005%) can 
significantly impact IPEC-J2 TER, but do not cause increases in IL-8 production. More 
data is needed to determine the effect of RL on nutrient absorption, gut health, and the 
microbiome in pigs.   
  
Keywords: pig, rhamnolipid 
 
 
INTRODUCTION 
 
 
 Rhamnolipids (RL) are well-known glycolipid microbial biosurfactants, 
which reduce surface tension, as anionic amphiphilic molecules, with (hydrophilic) 
mono- or di-rhamnose sugar heads and (lipophilic) beta-hydroxyalkanoic acid tails of 
varying lengths. As reviewed by Chong and Li (2017), rhamnolipids are predominately 
produced by bacteria in the genus Pseudomonas genus with P. aeruginosa being the most 
widely researched due to its consistent and high production of RL in fermentation. 
Secretion of RL provides numerous benefits to Pseudomonas by enhancing motility, 
biofilm formation, and nutrient uptake while also being able to inhibit growth of other 
bacteria (both Gram negative and positive) and fungi (Abdel-Mawgoud et al., 2010). 
Rhamnolipids also act as potential virulence factors by causing histamine release from 
mast cells, suppressing phagocytic action of macrophages, or increasing permeability by 
opening up tight junctions in epithelial cells (Abdel-Mawgoud et al., 2010). These factors 
certainly benefit P. aeruginosa, which is a known and common colonizer and pathogen in 
Cystic Fibrosis patients.  
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 However, RL is commonly produced and used for various industrial purposes 
(Chong and Li, 2017). The amphipathic nature of RL makes it an ideal emulsifier and has 
been used in bioremediation of petroleum sites, food applications, and pharmaceuticals. 
As an antimicrobial, RL have been used in food applications against foodborne pathogens 
(e.g., Listeria monocytogenes) and used as biopesticides on crops to reduce 
phytopathogens. Additionally, RL has been utilized as an excipient in the pharmaceutical 
industry to aid in absorption of drugs by opening the tight junctions of intestinal epithelial 
cells.  Outside of industrial applications, RL has been researched for its effects on lung 
epithelial cells. However, investigation of the effect of RL on intestinal tissue has been 
limited to drug studies or cell culture models. Usage of RL, especially at higher doses, 
has been shown to decrease TER, increase paracellular permeability, and decrease cell 
viability of normal and cancer cell lines (Jiang et al., 2013; Jiang et al., 2014; Wallace et 
al., 2014; Perinelli et al., 2017).  
 Considering the antimicrobial and emulsifying effects of RL, usage as an 
antibiotic alternative would be of interest to the U.S. swine industry. Anecdotally, RL has 
been used as a feed additive in other species with improvements in growth performance. 
However, the lack of published evidence requires the need for a study to evaluate the 
effects of RL for use in swine. Thus, the goal of this study was to test the viability of RL 
for use in the swine industry using a porcine epithelial cell model (IPEC-J2) and jejunal 
explants. 
 
MATERIALS AND METHODS 
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Cells. The following experiments used the IPEC-J2 cell line. These cells are a non-
transformed jejunal epithelial cells derived from neonatal pigs (Rhoads et al., 1994) and 
characterized by Schierack et al. (2006). Cells were cultured in Dulbecco’s modified 
eagle medium (DMEM)/Ham’s F12 (1:1) (Gibco) with 5% fetal bovine serum (Hyclone), 
1% Streptomycin/pencillin (Gibco), 1% insulin-transferrin-sodium selenite solution 
(Sigma), and 5 ng/mL human epidermal growth factor (Sigma). Cells were grown in 5% 
CO2 atmosphere at 37˚C. For experiments, cells were seeded into 12-well polyethylene 
terephthalate transwell inserts (Falcon). Cells were cultured for 7 d to reach confluency 
and were used when transepithelial resistance was greater than 4000-Ω cm2. 
Transepithelial resistance (TER) was measured using an EVOM2 voltohmmeter (World 
Precision Instruments, Sarasota, FL). 
 
Experiment 1. Two replications were conducted. Cells were treated with antibiotic free 
media 24 h prior to experiment. Cells were then treated for 1 h with the following 
treatments: 0, 0.01, 0.05, 0.5, 1.0, 2.4, and 10% rhamnolipid (Jeneil Biotech Inc, 
Saukville, WI), or 1 µg/mL lipopolysaccharide (LPS; Sigma). After incubation with RL, 
cells were washed with PBS and given fresh media and then incubated for 0, 1, 3, 6, 12, 
and 24 h.  Transepithelial resistance measurements were collected after the media change 
and at the end of respective incubation times. Media was collected from both apical and 
basolateral sides of transwells and frozen at -20˚C. Cells were fixed using formalin. 
 
Experiment 2. Cells were treated with 0, 0.0005, 0.001, 0.005, and 0.01% RL or 1 µg/mL 
LPS for 1 h. Cells were subsequently washed with PBS and were incubated for 6 h in 
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fresh media. Transepithelial resistance measurements were taken at 0, 2, 4, and 6 h after 
media change. After media harvest, inserts were bathed in formalin to fix cells for 
histological staining. To identify mucin content, inserts were stained using Alcian Blue-
Period Acid Schiff stain kit (Thermo Scientific) and counterstained with hematoxylin 
following manufacturer’s instructions. Images of stained inserts were obtained using a 
microscope camera (Olympus, Center Valley, PA). 
 
Experiment 3. Approximately 0.5 m of fresh jejunum tissue, taken 3 m from the terminal 
ileum was obtained from 5 and 7-week old pigs euthanized via overdose using sodium 
pentobarbitol. Tissue was rinsed with cold PBS and opened longitudinally. Tissue 
explants were taken using an 8 mm biopsy punch (Integra York PA, York, PA). Explants 
were stored in warm IPEC-J2 cell culture media until all explants were collected. Four 
explants were placed in each well of a 12-well plate and treated with 0, 0.0005, 0.005, 
0.05, 0.5% RL, or 1 µg/mL LPS for 1 h. Afterwards, explants were washed, and fresh 
media added. Explants were further incubated for 3 h. Media was collected and frozen 
back for later use. 
 
Cytokine analysis. Interleukin-8 was measured using porcine specific ELISA kit (R & D 
Systems, Minneapolis, MN) following manufacturer’s instructions with inter- and intra-
assay CV of 8.4 and 7.9%. 
 
Image analysis. Images were analyzed using Fiji and processed using a custom-made 
macro (Appendix C). In short, images were deconvoluted using the hematoxylin-PAS 
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option. Nucleated cells were counted and outlined by using the “Analyze Particles” 
function to identify nuclei with a size of 40-500 pixels and a circularity of 0.50-1.00. 
Partial nuclei were excluded. Outlined nuclei were compared against the original image 
to ensure only nuclei were being counted. Cell and nuclei area fractions were determined 
through additional processing and results outputted (Appendix C). Eight images were 
analyzed for each well with three wells per treatment. 
 
Statistics. Data were analyzed using the Proc MIXED procedure from SAS 9.2 (SAS Inst. 
Inc., Cary, NC) and all results were expressed as least square means ± SEM. Well insert 
served as the experimental unit with treatment as a fixed effect and plate as a random 
effect. Statistical significance of differences was determined by Tukey’s range test for 
pair wise comparisons. Differences were deemed significant at P ≤ 0.05 and tendencies at 
P ≤ 0.10.  
 
RESULTS 
 
Experiment 1. IPEC-J2 cells were treated with rhamnolipids and LPS. Regardless of 
concentration, low TER was observed for cells treated with RL both after initial 1 h 
incubation and over the 24 h afterwards (Figure 5.1A). Further observation under a 
microscope revealed that wells treated with RL were mostly devoid of IPEC-J2 cells, 
supporting the previous observation that cells were being aspirated off the wells during 
washing and media changing steps. Due to lack of cells after the initial incubation, media 
was collected from 0 h plate during the second repetition of plates right after the 1 h 
incubation. Production of IL-8 (Figure 5.1B) was inversely related to concentration of 
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RL. This was likely due to the cytotoxicity at higher concentrations of RL lysing cells 
sooner in the incubation period.  
 
Experiment 2. Due to the cytotoxicity issues in Exp. 1, RL concentrations were reduced 
for experiment 2. Lower concentrations appeared to reduce cell cytotoxicity to RL 
allowing for cell monolayers to be retained on the well membrane upon visual inspection 
via microscopy. Likewise, TER measurements were obtained over the 6 h incubation 
period (Figure 5.2). As was expected, RL treated cells had reduced TER in dose response 
relative to the control, with the exception of the 0.005% RL. Cells treated with 0.001 and 
0.01% RL had >60% reduction in TER compared with control and LPS treatments (P < 
0.001). Interleukin-8 was measured in the media as a marker for inflammation. After the 
initial hour of incubation with RL (Figure 5.3A), the 0.01% RL showed the highest level 
of IL-8, about two times compared with all other treatments (P < 0.001). At 6 hours post 
RL treatment, apical secretion (Figure 5.3B) of IL-8 from RL-treated cells was lower 
than either the control or LPS (P < 0.076). Oddly, the 0.01% and 0.0005% RL treatments 
had the lowest and highest IL-8 responses, respectively, which was not expected. On the 
basolateral side, IL-8 secretion appeared to numerically decrease as RL concentration 
decreased (P = 0.69) and only the 0.01% RL exceeded the control.  
 
Cell inserts were stained for mucin content (Figure 5.4). Overall, the lowest 
concentrations of RL have similar or slightly lower mucin content compared with the 
control and LPS samples. The 0.01% RL appears to have less mucin content, as more 
white space is apparent, likely due to cell death. Using Fiji, images were quantified to 
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determine nuclei count and nuclei and cell area, the latter including mucin secretions. As 
expected, nuclei count (Figure 5.5A) for all RL treatments were decreased compared to 
the control and LPS treatments (P < 0.003). The 0.01% RL concentration lowest counts 
numerically but was not statistically different than the other RL treatments. The nuclei 
and cell area fractions (both, P < 0.001) (Figure 5.5B) were reduced by 19-22% in the 
three lowest RL treatments, and by 45-50% for the 0.01% RL treatment.  
 
Experiment 3. To determine the effect of RL on the jejunum, fresh explants were taken at 
two different time points and incubated with RL. Secretion of IL-8 (Figure 5.6) occurred 
in a dose-dependent fashion and the 0.01% RL treatment had a 73% increase compared to 
the control and LPS (P < 0.001). 
 
DISCUSSION 
 
 The goal of this experiment was to assess the response of IPEC-J2 cells and 
jejunal explants when exposed to rhamnolipids. To our knowledge this is the first study 
performed using a small intestinal cell line or a porcine cell line in conjunction with RL. 
This study shows that rhamnolipids can reduce TER, stimulate IL-8 secretion, and can 
cause cytotoxic cell loss in IPEC-J2 cells when used at concentrations ≥ 0.01%. 
However, when used at lower concentrations, inflammation and TER are similar to the 
control and LPS, with some potential for cell loss.  
 In our study, exposure to RL decreased TER relative to dosage. This agrees with 
similar TER and paracellular permeability values found in Caco-2 cells (Jiang et al., 
2013; Wallace et al., 2014; Perinelli et al., 2017) and Calu-3 cells (Perinelli et al., 2017). 
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This decrease in barrier function appears to be mediated by tight junction regulation, not 
degradation (Halldorsson et al., 2010). While paracellular transport was increased with 
RL exposure, Jiang et al. (2013) reported an increase in transcellular transport using the 
marker, propranolol. Jiang also reported an increase in transport of rhodamine 123 from 
the basolateral to apical side with an increase in RL, likely due to increase paracellular 
permeability.  
Although permeability was not measured in our data, another potential reason for 
an increase in permeability would be to cell loss due to cytotoxicity of RL at high 
concentrations. We found a decrease in nuclei counts and nuclei and cell area indicating 
the both less loss and decrease in cell size. Lactate dehydrogenase assays showed a minor 
non-dose dependent increase in leakage with RL treatment (Wallace et al., 2014), 
however, a dose dependent response was seen in other studies (Jiang et al., 2014; 
Perinelli et al., 2017). Cell viability was also shown to decrease as dose increased (Jiang 
et al., 2014; Perinelli et al., 2017) although earlier work by Jiang et al. (2013) showed no 
difference regardless on dosage.  
Most studies have used rhamnolipid mixtures containing both mono- and di-
rhamnolipids. Jiang et al. (2014) conducted a study evaluating the effects of mono- and 
di-rhamnolipids alone with normal and cancer cells lines. Their work found that as 
rhamnolipid concentration increases, mono-rhamnolipids have greater impact on 
reducing cell viability and increasing lactate dehydrogenase leakage compared with the 
di-rhamnolipids. The ability of rhamnolipid to decrease surface tension is a hallmark of 
surfactants and as rhamnolipid concentration increases, surface tension decreases and 
enables increased formation of micelles (Jiang et al., 2014; Perinelli et al., 2017). In 
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addition, decreasing surface tension increases cell cytotoxicity rapidly from 41 to 30 
mN/m (Jiang et al., 2014). This is important as decreasing surface tension increases 
likelihood for cell death, but it also necessary for emulsification. Interestingly, addition of 
FBS in the media increases surface tension, although this effect is lost at higher 
rhamnolipid concentrations (Jiang et al., 2014). Future studies aim to use rhamnolipid in 
the diet to increase in nutrient uptake in pigs. The interplay between rhamnolipid 
concentrations, the feed matrix containing RL, and the interaction with the intestinal 
epithelium will be of interest for determining impact on gut barrier and nutrient transport 
responses. 
Due to the diverse environment in the gut, homeostasis of the immune system is 
important for regulating barrier function and whole host animal health. We determined 
that the initial incubation of IPEC-J2 cells with rhamnolipids promoted an increased IL-8 
response in the 0.01% RL treatment, but once the stimulus was removed IL-8 production 
was reduced below the control and LPS treatments. Jejunum explants similarly exposed 
to rhamnolipids resulted in an increase in IL-8 secretion above control and LPS at a level 
of 0.5%.  Gerstel et al. (2009) found rhamnolipids only stimulated IL-8 production in 
human keratinocytes by inducing flagellin removal from P. aeruginosa. Rhamnolipids 
derived from Burkholderia (Pseudomonas) plantarii were shown to have endotoxin 
activity by stimulating TNF-a production, however, this stimulation was far below LPS 
from E. coli (Andrä et al., 2006) and came at the additional cost of poor antimicrobial 
activity compared to other rhamnolipids (Benincasa et al., 2004). 
 Presence of rhamnolipids can alter intestinal permeability, inflammation, and cell 
death in IPEC-J2 cells. Our work demonstrates that lower concentrations of rhamnolipids 
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may be less detrimental to cells under direct exposure. At present, there are no published 
studies using rhamnolipids in live animal models. We speculate that addition of 
rhamnolipids into animal feed may have a positive effect on nutrient uptake without 
causing negative effects on intestinal health when used at less than 0.5%. Additionally, 
the antimicrobial activity of rhamnolipids may induce changes to the microbiome. 
However, these effects will remain unclear until future animal studies are conducted. 
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A) 
 
B) 
 
Figure 5.1. Transepithelial resistance of IPEC-J2 cells initially treated for 1 h and 
incubated in fresh media for 1 to 24 h. Data presented in logarithmic form (A). 
Interleukin-8 concentrations from cells incubated with treatments for 1 h (B). 
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Figure 5.2. Transepithelial resistance of IPEC-J2 cells initially treated for 1 h and 
incubated in fresh media for 6 h. Points represent least square means ± SEM. Letters 
indicate statisitcal difference, P < 0.001. 
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Figure 5.3. Interleukin-8 secretion from IPEC-J2 cells treated with rhamnolipids. 
Concentrations of IL-8 after 1 h rhamnolipid incubation (0 h) or 6 h incubation in fresh 
media. Bars represent least square means ± SEM. Statistical difference indicated by *, P 
< 0.0001. 
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Figure 5.4. Cell inserts of IPEC-J2 cells treated with rhamnolipids for 1 h and incubated 
in fresh media for 6 h. Cells stained with Alcian Blue, Periodic Acid Schiff, and 
counterstained with hematoxylin (4x magnification). Mucins appear magenta to violet in 
color depending on composition of substance. 
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A) 
 
B) 
 
Figure 5.5. Image analysis of IPEC-J2 cells treated with rhamnolipids for 1 h and 
incubated in fresh media for 6 h. Nuclei counts (A) and cell and nuclei area fractions (B) 
measured using Fiji. Bars represent least square means ± SEM. Statistical differences 
denoted by superscripts, P < 0.05.    
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Figure 5.6. Interleukin-8 secretion from jejunum explants incubated with rhamnolipids 
for 1 h and fresh media for 3 h. Bars represent least square means ± SEM. Statistical 
difference indicated by *, P < 0.001. 
 
  
0	1000	
2000	3000	
4000	5000	
6000	7000	
8000	9000	
Control		 LPS	 0.5%	RL	 0.05%	RL	 0.005%	RL	 0.0005%	RL	
IL
-8
,	p
g/
m
L	
*
  
143 
CHAPTER 6: GENERAL DISCUSSION 
 
  
The swine industry is always looking for new ways to innovate and improve herd 
health, nutrition, and reproduction while also decreasing costs. Since the early 20th 
century, this has been achieved through genetic selection, expanded knowledge of 
nutrition, changes in housing conditions, and disease mitigation strategies. These 
strategies will continue to be employed in the future as dietary ingredients change or new 
ones become available, new diseases may emerge, and we improve our understanding of 
animal housing and welfare. 
 The growing pig requires nutrients for tissue growth, so maximizing nutrient 
uptake is critical for pig growth and health. However, the nursery pig represents a 
challenge as it must overcome the numerous stresses it experiences during the weaning 
transition (Campbell et al., 2013) and adapt to solid feed. The weaning transition is 
especially impactful on the gut as it induces short and long-term changes to intestinal 
absorption, secretion, and barrier function (Boudry et al., 2004). Disruptions to barrier 
function such as increased permeability may further enable translocation of bacteria or 
toxins that lead to further illness or tissue damage (Moeser et al., 2017). The use of in 
feed antibiotics has been useful in suppressing pathogenic bacteria and improving growth 
performance (Cromwell, 2002), although implementation of the Veterinary Feed 
Directive has put a halt to using antibiotics for growth promotion purposes (FDA, 2017). 
However, with this change there will be a greater focus on other types of antimicrobials 
and antibiotic alternatives for use in the swine industry (Liu et al., 2018). Viruses like 
porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome 
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(PRRS), and Mycoplasma hyopneumoniae are prevalent challenges in the swine industry, 
especially for younger pigs (Chae, 2016). However, the use of vaccines, particularly for 
PCV2 and Mycoplasma, has been successful in reducing clinical signs of illness and 
improving ADG (Witvliet et al., 2015; Park et al., 2016). Nevertheless, a poor weaning 
transition and disease can reduce pig growth performance and increase chances of 
morbidity and mortality leading to an increase production costs. Thus the overall theme 
of this dissertation was to assess different strategies for improving pig health and growth 
performance.  
In chapter 2, we assessed changes to the microbiome in pigs either vaccinated 
(VAC) for or inoculated (PCV) with PCV2. Changes in the microbiome were primarily 
age driven similar to other published data (Pajarillo et al., 2014; Frese et al., 2015). 
Overall, changes in abundance of Prevotellaceae, Bacteroidales, and Ruminococcaceae 
occurred between d 14 and d 28 for PCV pigs, although these changes were inversed 
when compared to VAC pigs. Changes in the PCV pigs may have been driven by an 
active PCV2 infection compared to the VAC pigs that had already been vaccinated for 
PCV2. Using multivariate analysis by linear associations (MaAsLin), we found 
Oscillibacter valericigenes (-0.094) and Intestimonas butyriciproducens (-0.073) were 
negatively associated with blood IgM whereas Prevotella stercorea (0.214) and Solitalea 
koreensis (0.407) were positively associated with blood IgG. However, it is not clear how 
these bacteria are directly involved with immunoglobulin production.  
Utilization of MaAsLin represents an opportunity to look for relationships of 
bacterial populations against matching phenotypic metadata (Morgan et al., 2015). This 
method has been shown to be useful in selecting for probiotic bacteria during a prebiotic 
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nursery trial (Li, 2017). This may be useful during and after a disease challenge to how 
bacteria respond. In addition, use of MaAsLin is being explored for use in human studies 
(Lim et al., 2016; Kim et al., 2018). 
Using the same PCV2 infection model from chapter 2, we assessed genetic 
selection for resistance to PCV2 infection and how that impacted pig performance from 
nursery to finishing in chapter 3. No differences were seen in growth performance across 
experiments, regardless of treatment or genotype. In the nursery phase (Exp. 1), PCV2 
viremia and IgG titers decreased with increased presence of the favorable C allele in the 
SNP site in infected pigs. Additionally, genotype appeared to have a positive impact on 
nutrient digestibility through the first four weeks as pigs with favorable genotypes had 
increased digestibility coefficients. Likewise, genotype had a beneficial impact on 
digestibility during the grow-finish phase of Exp. 2; however, this effect was not seen in 
the VAC pigs. In terms of production costs, PCV2 infected pigs with the CC genotype 
had a decreased feed cost per BW gain compared with the TT genotype. This trend 
carried through the grow-finish phase as favorable genotypes had a reduced feed costs 
compared with the susceptible pigs, regardless of PCV2 status. Surprisingly, in the PCV 
pigs, the CT genotype had higher feed costs in both the nursery and grow-finish phases 
than either the CC or TT pigs. Overall, the phenotypic effects of the favorable genotypes 
appeared to play a more prominent role during an active infection than vaccination, 
however, it is important to note that this experiment lacked sufficient CC genotype pigs 
to facilitate having a vaccinated CC group. Furthermore, the study design did not account 
for viremia and antibody titers of the vaccinated animals as the vaccination protocol 
occurred prior to the study. 
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Considering the prominence of PCV2 across North America, genetic selection for 
PCV2 resistance should be considered. Previous work identified three SNPs, including 
the SNP of interest in our study, associated with PCV2 viral load (McKnite et al., 2014). 
McKnite’s findings demonstrate that possession of at least one favorable allele across the 
three SNP sites conferred a 5% reduction in viral load and a 30% increase in ADG; 
however, the majority of pigs in the study possessed two to three favorable alleles. 
Further work by Engle et al. (2014) would also suggest that presence of some of the 
favorable alleles is common across pig breeds. There are also a number of effective 
vaccines for PCV2 on the market (da Silva et al., 2014) and our data would suggest that a 
PCV2 resistant genotype may be beneficial in reducing feed cost by $5-10 per head over 
the life of a market pig even when vaccinated.  
One of the limitations of this experiment was the lack of vaccinated CC group. 
Based on our data, we would speculate that the CC genotype would have improved feed 
efficiency, although size of the difference is difficult to ascertain due to the differential 
response we had between CT and TT groups when vaccinated and infected with PCV2. 
In addition to replicating the study, we would also like to collect further viremia and 
immunoglobulin data during the vaccination phase and afterwards to potentially assess 
the phenotypic response to vaccine efficacy and subsequent infection with live PCV2. In 
our study we did not specifically infect the VAC pigs, only enabling them to potentially 
contract the virus through nose-to-nose contact. This might shed some light on the 
differential response between PCV and VAC status while also seeing the underlying 
immune response. Finally, utilizing this model in metabolism crates would be useful for 
determining how genotype not only affects nutrient digestibility but also nitrogen 
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retention. This is important as immune system stimulation can decrease nutrient 
digestibility (Rakhshandeh and de Lange, 2012; Rakhshandeh et al., 2012) and nitrogen 
retention (de Ridder et al., 2012), especially for immunologically relevant amino acids 
like tryptophan (Reeds et al., 1994).  
For chapter 4, we wanted to see how supplementing additional tryptophan (Trp) 
in the diet would alter growth performance, nutrient digestibility, and the microbiome of 
nursery pigs. In our first experiment we found that feed efficiency was improved for pigs 
receiving Trp. This difference was driven by reduced feed intake in our parity 1 pigs 
(replication 1) and increased ADG in our parity 2 pigs (replication 2). Although we 
figured that supplemental Trp may benefit gut health through increased secretion of IL-22 
through the AhR-IL-22 axis due to metabolism of Trp by Lactobacillus. We saw 
numerical increases in relative abundance of Lactobacillus but found no difference in 
either IL-22 or pro-inflammatory IL-8. This could be indicative of high health status and 
low stress conditions of which these animals were born and raised into. Our second 
experiment aimed to build on the prior by adding an additional Trp+, with twice the 
amount of Trp, and assessing nutrient digestibility to determine if that was the cause of 
the difference in feed efficiency. Overall, we saw numerically higher feed efficiency in 
the Trp and Trp+ groups, but the effect was subdued compared with Exp. 1. This may 
have been the result of subclinical illness that impacted the first week of data and may 
have been a confounding factor throughout the rest of the experiment. Indeed we saw an 
increase in nutrient digestibility of the Trp pigs compared to the control and Trp+ pigs in 
phase 2. This was not the case with phase 1 as the Trp group had the lowest digestibility 
coefficients, but it is unclear if this is a diet effect or a result of illness. Although it is 
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interesting that the relative abundance of Lactobacillus follows the same trend as the 
digestibility, but it is unclear if it means anything. 
Tryptophan is seen as important to the swine industry as it can be a limiting 
amino acid (NRC, 2012) and is important in the acute phase response of the immune 
system (Reeds et al., 1994). It has been noted that the Trp requirement may be low 
relative to current NRC guidelines (Goncalves et al., 2015), especially under immune 
challenge conditions (de Ridder et al., 2012). Studies have demonstrated the benefit of 
supplemental Trp for low sanitation conditions or during health challenges in pigs 
(Capozzalo et al., 2012; Messori et al., 2013; Capozzalo et al., 2015) and mice (Zelante et 
al., 2013). Our study did not seek to directly challenge pigs, but to look at pig response 
post weaning. Additionally, our conditions were quite hygienic which is atypical for 
commercial nurseries; however, we did see an improvement in performance for Exp. 1, 
but not Exp. 2. Furthermore, Trp supplementation has been shown to decrease pro-
inflammatory cytokines and increase tight junctions proteins (Liang et al., 2018). 
Although, we did not measure barrier function, it should be considered for future trials as 
the concentration utilized by Liang, exceeded the values reported by (Goncalves et al., 
2015) for optimal growth. In fact, while diets are typically formulated to ensure adequate 
concentrations and ratios of essential amino acids, there has been a growing body of work 
looking at supplementing methionine, threonine, and tryptophan in the diet, particularly 
in conditions where health challenges may be more prevalent (Xu et al., 2014; van der 
Meer et al., 2016; van der Meer et al., 2017). While feeding extra amino acids would 
increase diet costs and reduce profits, the ability for disease to manifest and propagate 
through densely stocked finishers may result in a reduction of mortality, morbidity, and 
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overall production losses through supplementation. Although not the specific focus of 
this body of work, research and usage of antibiotic alternatives continues to important for 
understanding their impact on animal health and performance. 
Finally, chapter 5 focused on using IPEC-J2 cells and tissue explants treated with 
rhamnolipids to determine how treatment altered barrier function and pro-inflammatory 
cytokine production. Similar to work done in Caco-2 cells (Jiang et al., 2013; Wallace et 
al., 2014), we found that rhamnolipids do reduce TEER with increasing concentrations. 
We have shown that concentrations greater than 0.01% can have cytotoxic effects on the 
IPEC-J2s, although lower concentrations of rhamnolipids may still facilitate some cell 
loss as we saw through histology analysis. The apical IL-8 response after an hour of 
incubation appeared to be dose dependent with the highest concentrations exceeding both 
our control and LPS treatments although no differences were observed on the basolateral 
side. A similar result was seen on the basolateral side after six hours without continued 
exposure to rhamnolipid, but we did not see any difference on the apical side. The jejunal 
explants were more robust (0.50%) in their tolerance to rhamnolipids. Contrary to our 
initial experiments with rhamnolipids, the higher doses induced an increasing IL-8 
response, but did not appear to be blunted by cell death as we had seen in the IPEC-J2s. 
Overall, we determined that rhamnolipids have cytotoxic effects and induce IL-8 
production, especially at higher concentrations. 
Rhamnolipids have been considered for use as excipients due to ability to relax 
tight junctions, facilitating paracellular uptake of drugs (Jiang et al., 2013; Wallace et al., 
2014). In the case of the swine industry, the emulsifying and antimicrobial properties 
may be of interest. Pigs, like other animals, produce bile to facilitate absorption of dietary 
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lipid, but the addition of an exogenous emulsifier like rhamnolipid may increase nutrient 
uptake, allowing for improved nutrient digestibility. However, Gerstel et al. (2009) 
reported rhamnolipids stimulating IL-8 production by inducing flagellin removal from P. 
aeruginosa. This implies rhamnolipids may facilitate the removal and transport of 
bacterial surface markers to or across the epithelium that would stimulate the immune 
system. Although to our best knowledge, there are no published articles with regards to 
rhamnolipids utilizing whole gut epithelium or animal models. 
The antimicrobial properties could be beneficial in animal feed to determine if 
rhamnolipids are capable of interfering with any microbial contamination that may occur. 
Mold and mycotoxins are often a possible contaminate in feed. In the years following the 
2013-2014 porcine epidemic diarrhea virus (PEDV) outbreaks, there was concern 
regarding transmission of the virus in feed ingredients (Bowman et al., 2015). Work by 
the Jones group at Kansas State University has looked at using feed additives such as 
medium chain fatty acids to mitigate viral survivability and infectivity in feed (Cochrane 
et al., 2016; Cochrane et al., 2017). Rhamnolipids have been shown to have a wide array 
of antimicrobial activity including antiviral properties (Remichkova et al., 2008; Abdel-
Mawgoud et al., 2010). Additionally, the antibacterial properties have been shown to be 
effective against both Gram positive and negative bacteria including a number of 
pathogenic and opportunistic pathogens (Abdel-Mawgoud et al., 2010). Thus these 
properties may beneficial for suppressing pathogenic bacteria in the pig gut and 
improving growth performance in lieu of in feed antibiotics no longer allowed by the 
VFD. To our knowledge, no published experiments have been conducted in feed or 
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animal models to determine the effect of rhamnolipids; however, we are planning to 
conduct a nursery study in the near future to determine some of these effects. 
 In summary, these strategies represent opportunities to continue improving upon 
pig performance. With that said, there is a continued need to further research areas that 
improve swine health and performance not only in the nursery and grow-finish barns but 
even with gilts and sows. Continued emphasis on researching intestinal physiology, 
especially in conjunction with growing interest in the microbiome and the interplay with 
nutrition, will be necessary to help reduce intestinal perturbations that can impact feed 
intake, tissue deposition, and health. 
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APPENDIX A: Bioinformatics Chapter 2  
 
Bioinformatics Protocol 
 
Adapted from protocol provided by Chris Anderson, Samodha Lab Group Fall 2014 
 
Mothur to QIIME OTU table 
 
./mothur_to_qiime_otu_map.pl -file=exp13404.16S.binseq.fasta 
 
Number of input sequences: 65547  
Number of OTUs: 2107 
 
 
./mothur_to_qiime_rep_set.pl -file=exp13404.16S.repset.fasta  
 
Total sequences (equal to OTUs): 2107 
 
 
Make the OTU table, create a phylogenetic tree and remove samples with low 
sequencing numbers 
 
Assign Taxonomy to your new qiime repset created above (the location of files for the –t 
and –r parameters may be different than my computer): 
 
assign_taxonomy.py  -i exp13404.qiime_repset.txt –t 
/macqiime/greengenes/gg_12_10_otus/taxonomy/97_otu_taxonomy.txt -r 
/macqiime/greengenes/gg_12_10_otus/rep_set/97_otus.fasta -o exp13404.assign_gg_taxa 
 
Construct the OTU table in QIIME using the otu mapping file and assigned taxonomy: 
 
make_otu_table.py -i exp13404.mapping.txt -o exp13404.biom -t 
exp13404.assign_gg_taxa/exp13404.qiime_repset_tax_assignments.txt  
 
Convert the biom formatted OTU table to a txt file and ensure the taxonomy was added to 
the OTU table: 
convert_biom.py -i exp13404.biom -o exp13404.txt -b --header_key taxonomy --
output_metadata_id "Consensus Lineage" 
 
#biom convert replaced convert_biom.py 
biom convert –i exp13404.txt –o exp13404test.biom --table-type=”OTU table”  
--to-json –process-obs-metadata taxonomy 
 
biom summarize-table –i exp13404.biom –o exp13404.summary.txt 
 
You may want to remove any chloroplast sequences from your dataset: 
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filter_taxa_from_otu_table.py -i exp13404.biom -o exp13404.taxa_filter.biom -n 
p_Cyanobacteria 
 
You can sort your OTU table by a certain treatment or category in your mapping file so 
that your results appear in that order: 
sort_otu_table.py -i exp13404.taxa_filter.biom -m exp13404.mapping.txt -s Diet -o 
exp13404.sort.biom 
 
-s could be trt, phase, or trtxphase 
 
Get a sample distribution of your OTU table: 
biom summarize-table –i exp13404.sort.biom –o exp13404.sort.summary.txt  
 
Num samples: 35 
Num observations: 893 
Total count: 320235 
Table density (fraction of non-zero values): 0.449 
Table md5 (unzipped): 5529513b58e377bbc5c133a3d4e7e20a 
 
Counts/sample summary: 
 Min: 2137.0 
 Max: 20051.0 
 Median: 8479.000 
 Mean: 9149.571 
 Std. dev.: 4989.870 
 Sample Metadata Categories: None provided 
 Observation Metadata Categories: Taxonomy 
 
Counts/sample detail: 
 G24: 2137.0 
 G31: 2714.0 
 G10: 2787.0 
 G16: 3217.0 
 G29: 3240.0 
 G33: 3682.0 
 G34: 4529.0 
 G32: 4816.0 
 G12: 4865.0 
 G1: 5212.0 
 G28: 5435.0 
 G36: 5728.0 
 G27: 5774.0 
 G22: 6003.0 
 G14: 6202.0 
 G9: 7268.0 
 G15: 7672.0 
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 G35: 8479.0 
 G7: 8755.0 
 G3: 9188.0 
 G25: 10464.0 
 G30: 11504.0 
 G8: 11544.0 
 G2: 11635.0 
 G13: 11964.0 
 G23: 12348.0 
 G4: 12689.0 
 G21: 13291.0 
 G26: 13492.0 
 G20: 14406.0 
 G6: 15074.0 
 G5: 17366.0 
 G19: 18004.0 
 G18: 18700.0 
 G17: 20051.0 
 
Need to filter out the control samples and any samples that are due to low sequencing 
numbers: 
filter_samples_from_otu_table.py -i exp13404.sort.biom -m exp13404.mapping.txt --
sample_id_fp keep_samples.txt -o exp13404.sort.keep.biom 
 
Align your qiime repset file in RDP and replace dots with dashes in the resulting file 
Add AAAAAAAAAA 
Remove the last line from RDP aligned (weird info on it) 
 
Create a distance matrix in mothur using your aligned repset file 
mothur > dist.seqs(fasta=repset.qiime.aligned.fasta, output =phylip, processors=5) 
mothur > clearcut (phylip=phylip.dist) 
For QIIME, we do three levels of analysis generally: Total, No Singletons (singletons 
are generally biologically insignificant to us and may actually be sequencing errors), 
and Core defined by a treatment of interest.  For this analysis, I have created a 
mapping file already when I demulitplexed and quality controlled your data.   
 
Note: remove AAAAAAAAAA from .tre file. Check alignment text file for OTUs that 
had incorrect alignment start and stops. Save a list of chimeras in chimera.txt 
 
filter_otus_from_otu_table.py –i exp13404.sort.keep.biom –o 
exp13404.no_chimera.keep.biom –e chimera.txt 
 
Total Analysis  
Create a rarefraction curve for looking at alpha diversity (this will take a while but you 
can open another terminal window and proceed to the next commands while it runs) 
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alpha_rarefaction.py -i exp13404.sort.keep.biom -m exp13404.mapping.txt -p 
qiime_parameters_working.txt -n 10 -o analysis_singletons/total.alpha_rarefaction 
 
#qiime_working_parameters.txt not actively kept up anymore, may need to transfer old 
copy 
 
Look at the some alpha diversity measures: 
alpha_diversity.py -i exp13404.sort.keep.biom -m 
chao1,shannon,observed_species,ace,simpson -o 
analysis_singletons/total.alpha_diversity.txt 
 
Make an OTU network – can create cytoscape images from the resulting files later if you 
wish 
 
make_otu_network.py -i exp13404.sort.keep.biom -m exp13404.mapping.txt -o 
analysis_singletons/total.network 
 
Create a summary of the taxonomy information that be used to plot in the next command: 
 
summarize_taxa.py -i exp13404.sort.keep.biom -L 2,3,4,5,6,7 -o 
analysis_singletons/total.summarize_taxa 
 
Plot the taxonomy: 
plot_taxa_summary.py -i 
analysis_singletons/total.summarize_taxa/rumen.sort.keep_L2.txt,analysis_singletons/tot
al.summarize_taxa/rumen.sort.keep_L3.txt,analysis_singletons/total.summarize_taxa/rum
en.sort.keep_L4.txt,analysis_singletons/total.summarize_taxa/rumen.sort.keep_L5.txt,ana
lysis_singletons/total.summarize_taxa/rumen.sort.keep_L6.txt,analysis_singletons/total.s
ummarize_taxa/rumen.sort.keep_L7.txt -l Phylum,Class,Order,Family,Genus,Species -c 
bar,area,pie -o analysis_singletons/total.taxa_plots 
 
 
File names for the next two commands may be different but provides a contxt for the 
commands: 
 
The –t parameter is the phylogenetic tre that you created in mothur 
The –e parameter is the sample with the lowest number of reads (subsample the 
remaining samples to this amount) 
 
Note: Need to run code further down to generate “no_singletons.biom” 
 
beta_diversity_through_plots.py -i exp13404.no_singletons.biom -e 2511 -m 
exp13404.mapping.txt -p qiime_parameters_working.txt -t exp13404.align_pynast.tre -c 
Diet -o analysis_no_singletons/total.no_singletons.beta_diversity 
 
“-e 8147” for Kelly, no –c option in this version of script 
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jackknifed_beta_diversity.py -i exp13404.no_singletons.biom -e 2511 -m 
exp13404.mapping.txt -p qiime_parameters_working.txt -t exp13404.align_pynast.tre -o 
analysis_no_singletons/total.no_singletons.jk.beta_diversity 
 
Remove Singletons 
 
Remove any OTUs with just 1 sequence: 
 
filter_otus_from_otu_table.py -i exp13404.sort.keep.biom -n 2 -o 
exp13404.no_singletons.biom 
 
Look at the OTU table breakdown now: 
biom summarize-table –i exp13404.sort.biom –o exp13404.sort.summary.txt  
 
Num samples: 35 
Num observations: 893 
Total count: 320235 
Table density (fraction of non-zero values): 0.449 
Table md5 (unzipped): 16b2b32e3480c505ab9cddaab0fe1997 
 
Counts/sample summary: 
 Min: 2137.0 
 Max: 20051.0 
 Median: 8479.000 
 Mean: 9149.571 
 Std. dev.: 4989.870 
 Sample Metadata Categories: None provided 
 Observation Metadata Categories: taxonomy 
 
Counts/sample detail: 
 G24: 2137.0 
 G31: 2714.0 
 G10: 2787.0 
 G16: 3217.0 
 G29: 3240.0 
 G33: 3682.0 
 G34: 4529.0 
 G32: 4816.0 
 G12: 4865.0 
 G1: 5212.0 
 G28: 5435.0 
 G36: 5728.0 
 G27: 5774.0 
 G22: 6003.0 
 G14: 6202.0 
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 G9: 7268.0 
 G15: 7672.0 
 G35: 8479.0 
 G7: 8755.0 
 G3: 9188.0 
 G25: 10464.0 
 G30: 11504.0 
 G8: 11544.0 
 G2: 11635.0 
 G13: 11964.0 
 G23: 12348.0 
 G4: 12689.0 
 G21: 13291.0 
 G26: 13492.0 
 G20: 14406.0 
 G6: 15074.0 
 G5: 17366.0 
 G19: 18004.0 
 G18: 18700.0 
 G17: 20051.0 
 
make_otu_heatmap.py -i exp13404.no_singletons.biom -o 
analysis_no_singletons/total.no_singletons.otu_heatmap 
 
make_otu_network.py -i exp13404.no_singletons.biom -o 
analysis_no_singletons/total.no_singletons.network -m exp13404.mapping.txt  
 
summarize_taxa.py -i exp13404.no_singletons.biom -L 2,3,4,5,6,7 -o 
analysis_no_singletons/total.no_singletons.summarize_taxa 
 
plot_taxa_summary.py -i 
analysis_no_singletons/total.no_singletons.summarize_taxa/exp13404.no_singletons_L2.
txt,analysis_no_singletons/total.no_singletons.summarize_taxa/exp13404.no_singletons_
L3.txt,analysis_no_singletons/total.no_singletons.summarize_taxa/exp13404.no_singleto
ns_L4.txt,analysis_no_singletons/total.no_singletons.summarize_taxa/exp13404.no_singl
etons_L5.txt,analysis_no_singletons/total.no_singletons.summarize_taxa/exp13404.no_si
ngletons_L6.txt,analysis_no_singletons/total.no_singletons.summarize_taxa/exp13404.no
_singletons_L7.txt -l Phylum,Class,Order,Family,Genus,Species -c bar,area,pie -o 
analysis_no_singletons/total.no_singletons.plot_taxa 
 
alpha_diversity.py -i exp13404.no_singletons.biom -m 
chao1,shannon,observed_species,ace,simpson -o 
analysis_no_singletons/total.no_singletons.alpha_diversity.txt 
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alpha_rarefaction.py -i exp13404.no_singletons.biom -m exp13404.mapping.txt -p 
qiime_parameters_working.txt -n 10 -o 
analysis_no_singletons/total.no_singletons.alpha_rarefaction 
 
Use the same –t file as you have been but the –e value changes (lowest number of 
sequences in a sample – see above OTU breakdown to understand where 2511 used 
below come from) 
 
beta_diversity_through_plots.py -i exp13404.no_singletons.biom -e 2511 -m 
exp13404.mapping.txt -p qiime_parameters_working.txt -t exp13404.align_pynast.tre -c 
Diet -o analysis_no_singletons/total.no_singletons.beta_diversity 
“-e8147” no –c command 
 
jackknifed_beta_diversity.py -i exp13404.no_singletons.biom -e 2511 -m 
exp13404.mapping.txt -p qiime_parameters_working.txt -t exp13404.align_pynast.tre -o 
analysis_no_singletons/total.no_singletons.jk.beta_diversity 
 
Core 
 
Split the OTU table (with singletons removed) based on the category in the mapping file 
by which you wish to define the core: 
split_otu_table.py -i exp13404.no_singletons.biom -m exp13404.keep.mapping.txt -f 
trtxphase -o exp13404.no_singletons.split 
 
Filter the split OTU tables based on how many samples should have a given OTU to be 
considered a part of the core.  For the example below I was doing 2 out of 2 samples, 2/3 
(s=2), or 3/4 (s=3) 
 
For exp13404 it was 5/6 (s=5)  
 
filter_otus_from_otu_table.py -i 
exp13404.no_singletons.split/exp13404.no_singletons_d0_I.biom -s 5 -o 
exp13404.core.split/d0_I.core.biom 
 
filter_otus_from_otu_table.py -i 
exp13404.no_singletons.split/exp13404.no_singletons_d0_V.biom -s 5 -o 
exp13404.core.split/d0_Vcore.biom 
 
filter_otus_from_otu_table.py -i 
exp13404.no_singletons.split/exp13404.no_singletons_d14_I.biom -s 5 -o 
exp13404.core.split/d14_I.core.biom 
 
filter_otus_from_otu_table.py -i 
exp13404.no_singletons.split/exp13404.no_singletons_d14_V.biom -s 5 -o 
exp13404.core.split/d14_Vcore.biom 
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filter_otus_from_otu_table.py -i 
exp13404.no_singletons.split/exp13404.no_singletons_d28_I.biom -s 5 -o 
exp13404.core.split/d28_I.core.biom 
 
filter_otus_from_otu_table.py -i 
exp13404.no_singletons.split/exp13404.no_singletons_d28_V.biom -s 5 -o 
exp13404.core.split/d28_Vcore.biom 
 
 
Merge the resulting OTU tables together: 
merge_otu_tables.py -i 
exp13404.core.split/d0_I.core.biom,exp13404.core.split/d0_V.core.biom,exp13404.core.s
plit/d14_I.core.biom,exp13404.core.split/d14_V.core.biom,exp13404.core.split/d28_I.cor
e.biom,exp13404.core.split/d28_V.core.biom -o exp13404.core.biom 
 
Now you have all the OTU identifiers that would be a part of the core.  However, the 
abundances for those OTUs are just for the samples we defined.  We need the abundances 
for all samples.  So you need to take the OTU identifiers for the core and filter the OTU 
table that has singletons removed: 
 
Convert the .biom formatted OTU table to a .txt OTU file.  Now you copy the first 
column of the table (open in excel) into a word document and save the identifiers as a 
separate file 
 
biom convert -i merged.core.biom -o merged.core.txt -b 
 
Copy the OTU ids from the OTU .txt file into a separate file and save it (next command 
that file is core_keep.txt) 
Filter the OTU table that has singletons removed: 
 
filter_otus_from_otu_table.py -i exp13404.no_singletons.biom --negate_ids_to_exclude -
e core_keep.txt -o exp13404.core.biom 
 
Take a look at the OTU table breakdown now.  Take note of the number of sequences 
that are in the core compared to the total and table with singletons removed.  The core 
generally has 80-90% of the sequences of the total with singletons removed 
 
biom summarize-table -i exp13404.core.biom  
Num samples: 35 
Num observations: 383 
Total count: 249888 
Table density (fraction of non-zero values): 0.519 
Table md5 (unzipped): 0594eed876b94a648c5f476cf82c16f8 
 
Counts/sample summary: 
 Min: 1657.0 
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 Max: 17497.0 
 Median: 6298.000 
 Mean: 7139.657 
 Std. dev.: 4059.211 
 Sample Metadata Categories: None provided 
 Observation Metadata Categories: taxonomy 
 
Counts/sample detail: 
 G24: 1657.0 
 G31: 1925.0 
 G33: 2414.0 
 G10: 2463.0 
 G16: 2646.0 
 G29: 2741.0 
 G32: 3238.0 
 G12: 3853.0 
 G34: 3864.0 
 G28: 4392.0 
 G35: 4436.0 
 G14: 4484.0 
 G1: 4593.0 
 G27: 4736.0 
 G22: 4908.0 
 G36: 5404.0 
 G3: 6045.0 
 G7: 6298.0 
 G9: 6532.0 
 G15: 6659.0 
 G21: 7756.0 
 G30: 8272.0 
 G8: 8650.0 
 G25: 8653.0 
 G23: 9009.0 
 G13: 10027.0 
 G2: 10030.0 
 G26: 10250.0 
 G6: 10766.0 
 G19: 10865.0 
 G4: 11680.0 
 G20: 12884.0 
 G5: 13999.0 
 G17: 16262.0 
 G18: 17497.0 
 
Run the same commands for the core OTU table as you did for the total and no singletons 
analysis 
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make_otu_heatmap_html.py -i exp13404.core.biom -o analysis_core/core.heatmap 
 
make_otu_network.py -i exp13404.core.biom -m exp13404.keep.mapping.txt -o 
analysis_core/core.network 
 
summarize_taxa.py -i exp13404.core.biom -L 2,3,4,5,6,7 -o 
analysis_core/core.summarize_taxa 
 
plot_taxa_summary.py -i 
analysis_core/core.summarize_taxa/exp13404.core_L2.txt,analysis_core/core.summarize
_taxa/exp13404.core_L3.txt,analysis_core/core.summarize_taxa/exp13404.core_L4.txt,a
nalysis_core/core.summarize_taxa/exp13404.core_L5.txt,analysis_core/core.summarize_
taxa/exp13404.core_L6.txt,analysis_core/core.summarize_taxa/exp13404.core_L7.txt -l 
Phylum,Class,Order,Family,Genus,Species -c bar,area,pie -o analysis_core/core.plot_taxa 
 
alpha_rarefaction.py -i exp13404.core.biom -m exp13404.keep.mapping.txt -p 
qiime_parameters_working.txt -n 10 -o analysis_core/core.alpha_rarefaction 
 
Use the same –t file as you have been but the –e value changes (lowest number of 
sequences in a sample) 
 
beta_diversity_through_plots.py -e 2369 -i exp13404.core.biom -m 
exp13404.keep.mapping.txt -c Diet -p qiime_parameters_working.txt -t 
exp13404.align_pynast.tre -o analysis_core/core.beta_diversity 
 
jackknifed_beta_diversity.py -e 2369 -i exp13404.core.biom -m 
exp13404.keep.mapping.txt -p qiime_parameters_working.txt -t 
exp13404.align_pynast.tre -o analysis_core/core.jk.beta_diversity 
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APPENDIX B: Bioinformatics Chapter 4 
 
Protocol adapted from dada2 pipeline and phyloseq tutorials by Wesley Tom, Samodha 
Lab group 
 
R and RStudio will need to be installed on the computer. This was done on a Mac with 
OS X 10.11.6 
 
Refer to the installation guides for the dada2 pipeline 
(https://benjjneb.github.io/dada2/tutorial.html) and phyloseq 
(https://joey711.github.io/phyloseq/index.html) 
 
The Silva reference database (v132) used to generate amplicon sequence variants (ASV) 
was retrieved from https://mothur.org/wiki/Silva_reference_files 
 
 
#Make sure that all required packages are installed via the following: 
source("https://bioconductor.org/biocLite.R") 
biocLite("BiocStyle") 
#Updated all packages that are needed updated 
 
#Once BiocStyle is installed you can run the following commands to install relevant 
packages ggplot, gridExtra, dada2, DECIPHER, and phangorn, as well as activate all of 
the relevant packages: 
 
library("knitr") 
library("BiocStyle") 
.cran_packages <- c("ggplot2", "gridExtra") 
.bioc_packages <- c("dada2", "phyloseq", "DECIPHER", "phangorn") 
.inst <- .cran_packages %in% installed.packages() 
if(any(!.inst)) { 
 install.packages(.cran_packages[!.inst]) 
} 
.inst <- .bioc_packages %in% installed.packages() 
if(any(!.inst)) { 
 source("http://bioconductor.org/biocLite.R") 
biocLite(.bioc_packages[!.inst], ask = F) 
} 
 
#Load packages into session, and print package version 
sapply(c(.cran_packages, .bioc_packages), require, character.only = TRUE) 
 
#Set up the directory your fastq files are in to the main directory where output files will 
be stored and set the working directory to where fastq files are stored 
path <- 
("/Users/danavansambeek/Desktop/PhD/Tryptophan_Study/dada2_analysis/fastq_files") 
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list.files(path) 
setwd("/Users/danavansambeek/Desktop/PhD/Tryptophan_Study/dada2_analysis/fastq_f
iles /") 
 
#Sort ensures forward/reverse reads are in the same order: 
fnFs <- sort(list.files(path, pattern="_R1_001.fastq", full.names = TRUE)) 
fnRs <- sort(list.files(path, pattern="_R2_001.fastq", full.names = TRUE)) 
 
# Extract sample names, assuming filenames have format: SAMPLENAME_XXX.fastq 
sample.names <- sapply(strsplit(basename(fnFs), "_"), `[`, 1) 
 
#Visualizes the quality profiles of the forward and reverse reads 
#fnFs[1:2] 2 profiles will be shown, 10 as shown below   
plotQualityProfile(fnFs[1:10]) 
plotQualityProfile(fnRs[1:10]) 
#Will give you an idea where the quality score begins to drop. Keep this in mind for the 
filterAndTrim step 
#My data fell below a QS threshold of 30 around read 250 for both forward and reverse. 
So Nirosh suggested truncating around 240 for both 
 
#Before filtering we have to define the file name for the filtered reads. 
filt_path <- file.path(path, "filtered")#places filtered files in filtered subdirectory 
if(!file_test("-d", filt_path)) dir.create(filt_path) 
filtFs <- file.path(filt_path, paste0(sample.names, "_F_filt.fastq")) 
filtRs <- file.path(filt_path, paste0(sample.names, "_R_filt.fastq")) 
 
#Now we filter and use a max of 2 expected errors per read (Edgar and Flyvberg 2015): 
#Modify your truncation length for your reads here, forward and reverse respectively. 
out <- filterAndTrim(fnFs, filtFs, fnRs, filtRs, truncLen = c(240,240), maxN = 0, maxEE 
= c(2,2),truncQ = 2, rm.phix = TRUE, multithread = TRUE ) 
head(out) 
 
#Uses an algorithm to learn error rates 
errF <- learnErrors(filtFs, multithread=TRUE) 
errR <- learnErrors(filtRs, multithread=TRUE) 
 
#Plots estimates of error rates 
#Ideally your black trend line should fit the data well 
plotErrors(errF, nominalQ=TRUE) 
plotErrors(errR, nominalQ=TRUE) 
 
#Next we want to dereplicate all redundant reads into unique sequences, all with a 
corresponding abundance. 
derepFs <- derepFastq(filtFs, verbose = T) 
derepRs <- derepFastq(filtRs, verbose = T) 
#Name derep class objects by sample names 
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names(derepFs) <- sample.names 
names(derepRs) <- sample.names 
 
#Runs the dada2 algorithm for the forward and reverse reads 
dadaFs <- dada(derepFs, err = errF, multithread = T) 
dadaRs <- dada(derepRs, err = errR, multithread = T) 
 
#Inspects the following object about sequence variants in your reads 
dadaFs[[1]] 
dadaRs[[1]] 
 
#Merge froward and reverse reads processed by the dada2 algorithm 
mergers <- mergePairs(dadaFs, derepFs, dadaRs, derepRs) 
 
#Inspect the merger data.frame from the first sample 
head(mergers[[1]]) 
 
#Constructs sequence table 
seqtabAll <- makeSequenceTable(mergers[!grepl("1502_bact", names(mergers))]) 
dim(seqtabAll) 
 
#Inspect distribution of sequence lengths 
table(nchar(getSequences(seqtabAll))) 
 
#Remove chimeras 
seqtabNoC <- removeBimeraDenovo(seqtabAll) 
#Shows how many chimeras make up merged sequence variants 
dim(seqtabNoC) 
 
#Shows non-chimeric sequence variants while also accounting for abundance. Mine was 
about 0.99 
sum(seqtabNoC)/sum(seqtabAll) 
 
#Now we assign taxonomy, needs to know where your reference file location is 
fastaRef <- 
"/Users/danavansambeek/Desktop/PhD/Tryptophan_Study/dada2_analysis/fastq_files/sil
va_nr_v132_train_set.fa.gz" 
taxTab <- assignTaxonomy(seqtabNoC, refFasta = fastaRef, multithread = T) 
unname(head(taxTab)) 
 
#Try and summarize the filtration steps as follows 
getN <- function(x) sum(getUniques(x)) 
track <- cbind(out, sapply(dadaFs, getN), sapply(mergers, getN), rowSums(seqtabAll), 
rowSums(seqtabNoC)) 
colnames(track) <- c("input", "filtered", "denoised", "merged", "tabled", "nonchim") 
rownames(track) <- sample.names 
  
169 
head(track) 
 
#Now we want to attempt to construct a phylogenetic tree, showing the relationship 
between all ASVs 
#which is used to calculate distances between samples. 
#Use DECIPHER R package for alignment 
seqs <- getSequences(seqtabNoC) 
names(seqs) <- seqs #this spreads the sample name to the tips of the tree 
alignment <- AlignSeqs(DNAStringSet(seqs), anchor = NA, verbose = F) 
 
phangAlign <- phyDat(as(alignment, "matrix"), type = "DNA") 
write.phyDat(phangAlign, file = "trp_alignment.fasta", format = "fasta") 
 
 
#Now that we have our table made and we are happy with the quality control, we need to 
align our sequences. So to begin we want to create a directory and write tables of the 
results from the dada algorithm (dada_outputs_for_mothurQIIME/) 
write.table(seqtabNoC, file = "trp_table.txt", col.names = TRUE, row.names = TRUE, 
sep = "\t") 
write.table(track, file = "trp_track.txt", col.names = TRUE, row.names = TRUE, sep = 
"\t") 
write.table(taxTab, file = "trp_taxa.txt", col.names = TRUE, row.names = TRUE, sep = 
"\t") 
 
#Generate a table that will work with QIIME 
transpose_seqtab <- t(seqtabNoC) 
write.table(transpose_seqtab, file = "trp_table_for_qiime.txt", col.names = TRUE, 
row.names = TRUE, sep = "\t") 
 
#Create a tab delimited text file to be used for creating a fasta file eventually to use for a 
phylogenetic tree. 
asv_vector <- as.data.frame(row.names(transpose_seqtab), stringsAsFactors = 
default.stringsAsFactors()) 
rownames(asv_vector) <- row.names(transpose_seqtab) 
colnames(asv_vector) <- NULL 
write.table(asv_vector, file = "tab_sep_asvs_for_fasta.txt",sep = "\t") 
 
#Note from Wes 
#I haven't figured a nice way in code to do this, but the next thing we want to do is 
convert the tab delimited asv file into fasta format.  
#I used 
http://sequenceconversion.bugaco.com/converter/biology/sequences/tab_to_fasta.php to 
do this. It is fast and works well... 
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#Next we are going to use Mothur to align our ASVs, and use Phylip and Clearcut to 
generate distances and a phylogenetic tree within the mothur environment using the 
following steps 
 
#Activate mothur using a terminal (note, you should be in the directory in which you just 
generated all of the ASV ouputs, specifically the fasta file of all ASV species) 
#Alternatively, you could upload the fasta file onto Crane and use Mothur out there if it is 
set up. 
#danavansambeeek$ ./mothur 
#Mothur will load up 
#The Silva reference can be retrieved from the Mothur website  
 
######### 
Wes' Example 
'mothur > align.seqs(fasta=1502_bactASV.fasta, 
reference=/Volumes/SBPD/Silva.seed_v132/silva.seed_v132.align, processors=8)' 
 
Using 8 processors. 
 
Reading in the /Volumes/SBPD/Silva.seed_v132/silva.seed_v132.align template 
sequences... DONE. 
It took 15 to read  11180 sequences. 
Aligning sequences from 1502_bactASV.fasta ... 
 
It took 16 secs to align 4795 sequences. 
 
Output File Names:  
  1502_bactASV.align 
1502_bactASV.align.report 
 
 
'mothur > dist.seqs(fasta=1502_bactASV.align, output=lt)"" 
 
Output File Names:  
1502_bactASV.phylip.dist 
 
It took 150 seconds to calculate the distances for 4795 sequences. 
 
 
mothur > clearcut(phylip=1502_bactASV.phylip.dist) 
 
Output File Names:  
1502_bactASV.phylip.tre 
########## 
 
#Switch to phyloseq.R analysis 
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setwd("/Users/danavansambeek/Desktop/PhD/Tryptophan_Study/dada2_analysis/bacteri
a/") 
 
bacteria_all_samples<- import_biom("trptaxa_noplates.otutable.biom", treefilename = 
"trp.phylip.tre", parseFunction = parse_taxonomy_default) 
bacteria_all_samples_mapping<- read.delim2("mapping_noplates.txt", header = T, sep = 
"\t") 
row.names(bacteria_all_samples_mapping)<- bacteria_all_samples_mapping[,1] 
bacteria_all_samples_mapping<- sample_data(bacteria_all_samples_mapping, 
errorIfNULL = T) 
bacteria_all_samples_ps<- merge_phyloseq(bacteria_all_samples, 
bacteria_all_samples_mapping) 
 
#Rarefy phyloseqs to even depth: 
bact_even_depth_ps<- rarefy_even_depth(bacteria_all_samples_ps, sample.size = 
min(sample_sums(bacteria_all_samples_ps)), rngseed = T, replace = TRUE, trimOTUs = 
F, verbose = TRUE) 
#Notification 
#`set.seed(TRUE)` was used to initialize repeatable random subsampling. 
#Please record this for your records so others can reproduce. 
#Try `set.seed(TRUE); .Random.seed` for the full vector 
 
#create merged distance matrices based on even depth data: 
bacteria_even_bray_dm <- phyloseq::distance(bact_even_depth_ps, method = "bray") 
bacteria_even_bray_dm <- as.matrix(bacteria_even_bray_dm) 
 
bacteria_even_unifrac_dm <- phyloseq::distance(bact_even_depth_ps, method = 
"unifrac") 
bacteria_even_unifrac_dm <- as.matrix(bacteria_even_unifrac_dm) 
 
bacteria_even_wunifrac_dm <- phyloseq::distance(bact_even_depth_ps, method = 
"wunifrac") 
bacteria_even_wunifrac_dm <- as.matrix(bacteria_even_wunifrac_dm) 
 
#convert mapping files to adonis compatible data.frames: 
bacteria_all_metadata <- as(sample_data(bacteria_all_samples_ps), "data.frame") 
 
#perform adonis PERMANOVA analysis on each of the datasets for each breed (6 
permanovas in total): 
#Now I want to run the PERMANOVA analysis for the bacteria for all samples and 
treatment samples: 
adonis(bacteria_even_bray_dm ~ Experiment + Sex + Treatment + Week + Trtxweek + 
ExpxTrt + ExpxTrtxWk, data = bacteria_all_metadata, permutations = 999) 
adonis(bacteria_even_unifrac_dm ~ Experiment + Sex + Treatment + Week + Trtxweek 
+ ExpxTrt + ExpxTrtxWk, data = bacteria_all_metadata, permutations = 999) 
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adonis(bacteria_even_wunifrac_dm ~ Experiment + Sex + Treatment + Week + 
Trtxweek + ExpxTrt + ExpxTrtxWk, data = bacteria_all_metadata, permutations = 999) 
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APPENDIX C: Fiji Code Chapter 5 
 
Program: Fiji (Fiji Is Just ImageJ) 
 
“Read and Write Excel” plugin required. 
This plugin creates an Excel file on the desktop called “Rename me.....” 
Running a large number of images may result in system lag with Excel as this plugin will 
open the file, append the new data, and close the file. Eventually the file size will get 
quite large causing the potential lag. Consider running in batches. 
 
Macro should be run with a few test images to ensure parameters are properly capturing 
nuclei and area. Adjustments can be made prior to running full batches. 
 
Be careful when running as files in the output directory can be overwritten. This includes 
images although the summary table and Excel file are more likely to be overwritten. 
Consider using different directories for each run or change the name of the summary 
table and Excel files prior to running. 
 
Macro file for Fiji: Cell_count.ijm 
Procedure by: Elizabeth Cody, Department of Food Science, University of Nebraska 
Marco by: Dana Van Sambeek, Department of Animal Science, University of Nebraska  
 
/* 
 * Macro template to process multiple images in a folder 
 */ 
 
#@ File (label = "Input directory", style = "directory") input 
#@ File (label = "Output directory", style = "directory") output 
#@ String (label = "File suffix", value = ".tif") suffix 
 
// See also Process_Folder.py for a version of this code 
// in the Python scripting language. 
 
processFolder(input); 
 
// function to scan folders/subfolders/files to find files with correct suffix “.tif”  
function processFolder(input) { 
 list = getFileList(input); 
 list = Array.sort(list); 
 for (i = 0; i < list.length; i++) { 
  if(File.isDirectory(input + File.separator + list[i])) 
   processFolder(input + File.separator + list[i]); 
  if(endsWith(list[i], suffix)) 
   processFile(input, output, list[i]); 
 } 
} 
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function processFile(input, output, file) { 
 // Do the processing here by adding your own code. 
 // Leave the print statements until things work, then remove them. 
 // This code will process the images one by one. 
 print("Processing: " + input + File.separator + file); 
 open(input + File.separator + file); 
  
//Subtracts background noise from image 
run("Subtract Background...", "rolling=50 light"); 
 
//Splits the image using the filter type. This create one image with 
hematoxylin stain (Colour_1), one with PAS stain (Colour_2), and the third 
will be the remainder (Colour_3). 
 run("Colour Deconvolution", "vectors=[H PAS]"); 
  
//Selects the hematoxylin window 
selectWindow(file + "-(Colour_1)"); 
 
//Threshold will look at pixel darkness (0-255, higher is darker). Anything 
lower than 140 will be considered background and left white. Anything 
above 140 will be black and left for analysis, this should be the outline of 
your nuclei. Additional processing and cleanup occurs with “Convert to 
Mask”, “Despeckle”, and “Watershed”.  
setAutoThreshold("Default"); 
 run("Threshold..."); 
 setThreshold(0, 140); 
 setOption("BlackBackground", false); 
 run("Convert to Mask"); 
 run("Despeckle"); 
 run("Watershed"); 
  
//Nuclei and nuclei area will be counted here. If the pixel quantity is too low, 
you will pick up noise that might not be nuclei. Likewise nuclei are somewhat 
round so circularity should be higher (0.00 would be a straight line, 1.00 is a 
perfect circle). Data will be summarized in a table.  
//A total count, average size, total area, and %area will be generated. 
run("Analyze Particles...", "size=40-500 circularity=0.50-1.00 show=Outlines 
display exclude clear include summarize"); 
 
//The a new particle analysis image “Drawing of “filename” (Colour_1)” will 
have outlines for all nuclei counted. The next steps will modify the outlines to 
be red and then overlay this with Colour_1 and save so the user can 
determine if the parameters are correct for capturing the nuclei. 
 run("Invert LUT"); 
 run("Red"); 
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 run("Invert LUT"); 
 run("RGB Color"); 
 selectWindow(file); 
 run("RGB Color"); 
 imageCalculator("Add create", file,"Drawing of " + file+  "-(Colour_1)"); 
 selectWindow("Result of " + file); 
 saveAs("tiff", output +File.separator + "Overlay" + file); 
 
//This will add the nuclei back into the “Colour_2” for calculating total cell 
coverage area which includes mucin coverage of the PAS stain. 
imageCalculator("Subtract create", file + "-(Colour_2)", file +  "-(Colour_1)"); 
 setAutoThreshold("Otsu"); 
 run("Threshold..."); 
 setThreshold(0, 150); 
 setOption("BlackBackground", false); 
 run("Convert to Mask"); 
 run("Measure"); 
  
//File will contain analysis of each picture include individual nuclei sizes, and 
the total area measurement. 
run("Read and Write Excel", file); 
  
//save Summarytable, and results table, this will save the summary data from 
each picture, count, total area, average size, and %area. 
 print("Saving to: " + output); 
 run("Close All"); 
 call("java.lang.System.gc"); 
} 
selectWindow("Summary"); 
saveAs("text", output + File.separator + "SummaryTable"); 
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APPENDIX D: Abstracts Authored 
 
147 Effects of energy restriction during gilt development on characterization and 
quantification of milk oligo saccharides. 
 
S. M. Barrett, M. D. Trenhaile-Grannemann, D. M. van Sambeek, P. S. Miller, J. 
Salcedo, D. Barile, T. E. Burkey 
 
Journal of Animal Science, Volume 96, Issue suppl_2, 10 April 2018, Pages 78-79, 
https://doi.org/10.1093/jas/sky073.145 
 
Current research at the University of Nebraska-Lincoln (including 14 batches of gilts) has 
shown that energy restriction during gilt development will increase sow longevity and 
may also have beneficial impacts with respect to litter performance. Milk 
oligosaccharides (OS) are structurally diverse carbohydrates comprised of monomers of 
glucose, galactose, N-Acetylglucosamine, N-Acetyl galactosamine, fucose, and sialic 
acid, which may support gut health and development in suckling neonates via prebiotic 
mechanisms (e.g., modulation of gut microbes and mucosal immunity). The objective of 
this work was to evaluate the effects of energy restriction during gilt development on 
oligosaccharides production in milk. During the development period (d 123 to 240 of 
age), gilts (n = 128, 8 gilts/pen) were fed dietary treatments including: 1) Control diet 
formulated to NRC (2012) specifications (CTL); 2) Restricted (20% energy restriction 
via addition of 40% soy hulls; RESTR). Diets were fed ad libitum and applied in a 3 
phase feeding regimen. At 240 d of age gilts were bred and fed a common diet. For this 
analysis, milk samples were collected (n = 7/treatment) on d 0 and 14 post-farrowing 
(i.e., early and mid-lactation). Milk OS were characterized by Nano LC Chip QTOF MS 
and quantified by High Performance Anion Exchange Chromatography–Pulsed 
Amperometric Detection. Across the two diets (RESTR and CTL), 63 OS were identified 
(58.7, 25.4 and 15.9%, neutral, acidic OS and fucosyl, respectively). On d 0, CTL had 
greater neutral and less acidic OS (P < 0.05) compared to RESTR. Of the neutral OS 
quantified, RESTR had greater LNnT (a neutral OS) than CTL (P < 0.05). Also, both 
RESTR and CTL had an increase in fucosyl OS and decrease in acidic OS from d 0 to d 
14 (P<0.05). Of the fucosyl OS quantified, samples from CTL had greater LNDFH-I (a 
fucosyl OS) than RESTR (P < 0.05) at d 0. Lastly, only the RESTR showed an increase 
in neutral OS over time. Total OS quantification was lower in the RESTR when 
compared to CTL (P < 0.05). Quantification of OS also decreased in both dietary 
treatments over time (P < 0.0001). In conclusion, nutritional management of the 
developing gilt may impact OS profile during lactation; however, more research is 
warranted to further OS understanding and to evaluate the effects of OS on gut health and 
litter performance. 
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399 Response of IPEC-J2 cells and jejunal explants to treatment with rhamnolipids. 
 
D. M. van Sambeek, T. E. Burkey, L. Smalley 
 
Journal of Animal Science, Volume 96, Issue suppl_2, 10 April 2018, Pages 214–
215,https://doi.org/10.1093/jas/sky073.396 
 
Rhamnolipids (RL) are glycolipids secreted by bacteria that aid in motility, biofilm 
formation, nutrient uptake, and have antimicrobial activity. The latter two may be of use 
to improve swine nutrition and health. Work conducted in vitro utilized IPEC-J2 cells to 
determine cellular response to treatment. In the first experiment, cells were treated with 0, 
0.01, 0.05, 0.5, 1.0, 2.4, and 10% RL or 1 ug/mL lipopolysaccharide (LPS). In the second 
experiment, cells were treated with 0, 0.0005, 0.001, 0.005, and 0.01% RL or 1 ug/mL 
LPS. For both experiments, treated cells were incubated for 1 h and rinsed with PBS. 
Cells were further incubated in fresh non-treated media for 0, 1, 3, 6, 12 or 24 h in Exp. 
1, or 6 h in Exp. 2. Transepithelial resistance (TER) measurements were collected 
immediately after addition of fresh media and final incubation. Media was collected from 
both sides of Trans-well inserts for IL-8 analysis. Visual observation and TER analysis of 
Exp. 1 showed RL treatment decreased TER after initial incubation, with RL 
concentrations ≥ 0.05% exhibiting significant cell death and loss of cellular matrix 
adherence to the Trans-well membrane. Using lower dosages in Exp. 2, TER changed 
inversely with RL dosage, however, even 0.0005% RL reduced TER by at least 20% over 
the 6 h period (P > 0.10). Production of IL-8 was lower in RL treatments compared with 
either the control or LPS wells on the apical side (P > 0.10). Basolateral IL-8 was 
expressed in a dose dependent fashion, but only the 0.01% RL had higher expression than 
the control (P > 0.10). A third experiment was conducted by culturing jejunal explants in 
media with 0, 0.0005, 0.005, 0.05, and 0.5% RL or 1 ug/mL LPS for 1 h followed by 3 h 
incubation in fresh media. Similarly to Exp. 2, explants showed dose dependent IL-8 
production in 5 and 7 wk old tissue with 0.5% RL having higher IL-8 concentration 
compared to control or LPS samples (P < 0.01). The lower doses of RL had similar or 
lower IL-8 production to the control or LPS samples (P > 0.10). Together these data 
show that low doses of RL (≤ 0.005%) can significantly impact IPEC-J2 TER, but do not 
cause increases in IL-8 production. More data is needed to determine the effect of RL on 
nutrient absorption, gut health, and the microbiome in pigs. 
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166 Effects of energy restriction during gilt development on milk nutrient profile and 
progeny biomarkers 
 
S. M. Barrett, M. D. Trenhaile-Grannemann, P. S. Miller, T. E. Burkey, D. M. van 
Sambeek 
 
Journal of Animal Science, Volume 95, Issue suppl_2, 1 March 2017, Pages 78–
79,https://doi.org/10.2527/asasmw.2017.12.166 
 
Research at the University of Nebraska investigating the effects of energy restriction on 
gilt development (including 14 batches with data collected over 4 parities per batch) has 
lead to the observation that this approach increases sow longevity but may also provide 
beneficial effects to first parity progeny with respect to health and growth. Specifically, 
parity 1 progeny may have increased weaning weight compared to progeny derived from 
gilts fed an ad libitum control diet. Thus, our objective was to evaluate the effects of 
energy restriction during gilt development on milk nutrient profile and post-natal progeny 
biomarkers. During the development period, gilts (n = 128, 8 gilts/pen) were fed three 
dietary treatments including: 1) Control diet formulated to NRC (2012) specifications 
(CTL); 2) Restricted (20% energy restriction via addition of 40% soy hulls; RES); and 3) 
Control diet plus addition of crystalline amino acids equivalent to the SID Lys:Met of the 
RES diet (CTL+). All diets were fed ad libitum and applied in a 3 phase feeding regimen 
during gilt development (d 120 to 240). Average daily feed intake was used to estimate 
daily ME intake (Mcal/d) during each phase (Phase 1: 10.13, 6.97, 9.95; Phase 2: 11.25, 
8.05, 10.94; and Phase 3: 9.47, 7.95,11.07) for CTL, RES, and CTL+, respectively. At 
240 d of age gilts were bred and fed a common diet. For this preliminary analysis, milk 
samples were collected from batch 14 gilts (n = 7/treatment) on d 0 and 14 post-
farrowing for analysis of N, CP, DM, GE and milk insulin, and piglet blood samples (n = 
6 piglets/sow) were obtained on d 1 and 15 for quantification of glucagon-like peptide-2 
(GLP-2) and insulin. No effects of diet were observed for milk N, CP, or insulin; 
however, N, CP, and insulin were increased (P < 0.05) on d 1 compared to d 14. When 
evaluating DM and GE, no diet or time effects were observed. For piglet GLP-2, a 
treatment by time interaction was observed (P < 0.009); specifically, GLP concentrations 
were greater (P < 0.001) in CTL+ compared to RES (6.73 vs. 1.21 ng/mL). For serum 
insulin, a treatment by time interaction was observed (P < 0.01); specifically, insulin in 
RES was greater (P < 0.03) than CTL on d 1. In conclusion, nutritional management of 
the developing gilt may impact piglet serum biomarkers during lactation. 
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212 Effects of mannan oligosaccharides and Lactobacillus mucosae on the intestinal 
morphology of weanling pigs challenged with Escherichia coli lipopolysaccharides 
 
Y. S. Li, M. D. Trenhaile, D. M. van Sambeek, K. C. Moore, S. M. Barrett, S. C. 
Fernando, P. S. Miller, T. E. Burkey 
 
Journal of Animal Science, Volume 95, Issue suppl_2, 1 March 2017, Pages 101–
102,https://doi.org/10.2527/asasmw.2017.12.212 
 
To determine the effects of feeding mannan oligosaccharides (MOS) and Lactobacillus 
mucosae (LM) on intestinal morphology of weanling pigs under immune challenge, 96 
pigs (BW = 5.88 kg; d 23 post-farrowing) were randomly allotted to 16 experimental 
pens with a 2 × 2 factorial arrangement of treatments (4 pens per treatment; mixed 
gender). Diets with or without 0.1% MOS were randomly assigned to pens and 
109 cfu/pig LM broth or an equal volume of control broth were top-dressed daily. Pigs 
were given 1 of the 4 dietary treatments (control, MOS, LM, and MOS+LM) during 
phase-1 and phase-2 (d 0 to 7 and d 7 to 21 post-weaning, respectively). On d 14, all pigs 
were challenged with 100 µg/kg BW of Escherichia coli lipopolysaccharides (LPS). On d 
15 and 21, 1 pig per pen was euthanized for collection of intestinal tissue samples. Villus 
height (VH), crypt depth (CD), and villus surface area of duodenal and ileal samples were 
measured. Data were analyzed using PROC GLIMMIX of SAS. On d 15, feeding LM 
tended (P < 0.10) to decrease ileal CD; pigs fed LM had decreased (P < 0.05) ileal CD 
compared to pigs fed the control diet, but were not different (P> 0.10) from the pigs fed 
MOS or MOS+LM diets. However, all other ileal and duodenal measurements on d 15 
and 21 were not different (P > 0.10) among treatments. In conclusion, feeding LM may 
have beneficial effects on gut health of weanling pigs under LPS-challenge. 
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289 Effects of mannan oligosaccharides and Lactobacillus mucosae on the growth 
performance and immune response of weanling pigs challenged with Escherichia coli 
lipopolysaccharides 
 
Y. S. Li, M. D. Trenhaile, D. M. van Sambeek, K. C. Moore, S. M. Barrett, S. C. 
Fernando, T. E. Burkey, P. S. Miller 
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Previously, dietary mannan oligosaccharides (MOS) increased fecal abundances 
of Lactobacillus mucosae, which was positively correlated with circulating IgA 
concentration. To determine the effects of feeding MOS and L. mucosae as prebiotic and 
probiotic sources in weanling pigs under immune challenge, 96 pigs (5.88 kg BW; d 23 
after farrowing) were randomly allotted to 16 experimental pens with a 2 × 2 factorial 
arrangement of treatments (4 pens per treatment; mixed gender). Corn–soybean meal–
based diets (without plasma or antibiotics) with or without 0.1% yeast-derived MOS 
(Saccharomyes cerevisiae) were randomly assigned to pens, and 109 cfu/pig L. 
mucosae broth or a control broth were top dressed daily. Pigs were given 1 of the 4 
dietary treatments (control, MOS, L. mucosae, and MOS + L. mucosae) in phase 1 and 
phase 2 (d 0 to 7 and d 7 to 21 after weaning, respectively) and a common diet during 
phase 3 (d 21 to 35 after weaning). On d 14, all pigs were challenged with 100 µg/kg BW 
of Escherichia coli lipopolysaccharides (LPS) via intraperitoneal injection. Feed 
disappearances and pig BW were measured weekly. Blood samples were collected 
weekly and on d 1 and 3 after LPS challenge. Data were analyzed using PROC 
GLIMMIX of SAS (SAS Inst. Inc., Cary, NC). From d 0 to 14, feeding L. 
mucosaedecreased (P < 0.05) G:F. From d 14 to 21, G:F (g/kg) in pigs fed L. 
mucosae (715) was greater compared with pigs fed MOS + L. mucosae (P < 0.05; 600) 
and the control (P < 0.10; 615) but was not different (P > 0.10) from pigs fed MOS (674). 
After removal of treatments (d 28 to 35), G:F was decreased (P < 0.05) in the L. 
mucosae treatment group. Feeding MOS- vs. non-MOS-treated diets increased IgG 
(mg/mL) on d 1 and 3 after LPS challenge (P < 0.05; 3.15 and 4.39 vs. 2.58 and 3.34, 
respectively) and on d 14 and 21 after weaning (P < 0.10; 3.68 and 4.56 vs. 2.94 and 
3.72, respectively). On d 21, serum IgA concentrations (mg/mL) were greater (P < 0.05) 
in pigs fed L. mucosae (0.416) compared with pigs fed MOS (0.341) and MOS + L. 
mucosae (0.342) and tended to be greater (P < 0.10) in pigs fed L. mucosae vs. pigs fed 
control (0.347). Using d 0 (P < 0.05) IL-1β concentration as a covariate, circulating IL-1β 
in control and MOS + L. mucosae pigs increased (P < 0.05) on d 1 after LPS challenge 
but did not change (P > 0.10) in MOS and L. mucosae groups. In conclusion, feeding L. 
mucosae alone improved feed efficiency during the first week of LPS challenge; 
additionally, feeding L. mucosae and MOS may have beneficial effects relative to 
immune biomarkers. 
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A previous experiment evaluated pigs selected for a porcine circovirus type 2b (PCV2)-
susceptibility marker QTL (C, resistant, and T, susceptible) and were inoculated (PCV) 
with or vaccinated (VAC) against PCV2 in the nursery phase. Pigs genotyped for the C 
allele had reduced viremia and IgG production compared with the T allele when infected 
with PCV. Two experiments were conducted to evaluate growth performance through the 
finishing phase. A model was used to assess the residual between final and predicted BW 
on pigs from the previous trial. Pigs with a low or high net residual were used for Exp. 1 
or Exp. 2, respectively. In Exp. 1, a total of 40 pigs (38.5 kg; 8 pigs/treatment) were 
selected from (genotype-PCV status) CC-PCV, CT-PCV, TT-PCV, CT-VAC, and TT-
VAC. Pigs were housed by treatment, with 2 pigs per pen and 4 pens per treatment. In 
Exp. 2, 4 pigs from each residual, high (41.9 kg BW) and low (30.2 kg BW), were 
selected from the following (genotype-PCV status): CT-PCV, TT-PCV, CT-VAC, and 
TT-VAC, for a total of 32 pigs, individually housed. All pigs had ad libitum access to a 
4-phase grow–finish corn–soybean meal diet that met or exceeded the NRC (2012) 
requirements, with titanium dioxide as an indigestible marker. Growth performance was 
measured every 14 d, whereas blood and fecal samples were collected at the end of each 
phase. Loin eye area and backfat were determined via ultrasound at the end of phase 4, 
and HCW was determined at harvest. For Exp. 2, data was analyzed using initial BW as a 
covariate. In Exp. 1, ADFI in phase 1 was reduced in the CC-PCV group compared with 
the TT-PCV group (P < 0.05). In phase 3, ADFI was reduced in the VAC group 
compared with the PCV group (P < 0.05). In phase 1 thru 3, digestibility of GE and DM 
were greater in the CC-PCV group compared with the TT-PCV group (P < 0.05). In Exp. 
2, low residual pigs had greater G:F during the phases 2 and 3 (P < 0.05). No differences 
were found for GE and DM digestibility between groups (P > 0.10). Pigs with the CT 
genotype were found to have less backfat (P < 0.10) and greater lean (P < 0.05) and 
percent lean (P < 0.05) than those with TT genotype with no difference in BW. Together, 
these data suggest that the PCV2-susceptibility marker genotype may affect ADFI, 
nutrient digestibility, and carcass traits during the growing–finishing period. 
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To determine the effects of dietary prebiotics on growth performance and immune status 
of weanling pigs, 64 crossbred pigs (initial BW = 6.6 kg; d 20 to 22 post-farrowing) were 
selected and randomly allotted to 16 experimental pens with 4 dietary treatments (2 
barrows and 2 gilts per pen, 4 pens per treatment). The treatments were maintained 
during Phase I (d 0 to 14 postweaning) and Phase II (d 14 to 28 postweaning). The 
control diet was a conventional nursery diet formulated with corn, soybean meal, dried 
whey, fish meal, bovine plasma, and supplements to meet or exceed the 2012 NRC 
requirements. The additional 3 diets were formulated to contain 0.1% chicory, 0.1% 
mannan oligosaccharides (MOS), and 0.02% chitosan, respectively. Pigs were given ad 
libitum access to feed and water in an environmentally-controlled room. From d 0 to 28 
postweaning, feed disappearance and individual BW were measured weekly for 
determination of ADG, ADFI, and G:F. Blood samples were collected weekly for 
measurements of serum IgA concentrations. Data were analyzed as a completely 
randomized design using the MIXED procedure of SAS. Overall, dietary prebiotics did 
not affect (P > 0.10) BW (average 16.7 kg; d 28), ADG (361 g), or ADFI (513 g). 
However, from d 7 to 14, pigs fed MOS had lower (671 g/kg; P < 0.05) G:F compared to 
pigs fed control (830 g/kg), chicory (851 g/kg), and chitosan (871 g/kg) diets. For Phase 
I, G:F of pigs fed MOS tended to be lower (656 g/kg; P < 0.10) than pigs fed control (791 
g/kg) and chitosan (783 g/kg), but was not different from chicory (755 g/kg; P > 0.10). 
For Phase II, G:F of pigs fed control (673 g/kg), chicory (686 g/kg), MOS (695 g/kg), and 
chitosan (695 g/kg) were not different (P > 0.10). There were no time × treatment 
interactions (P > 0.10) affecting circulating IgA concentrations. Serum IgA increased 
(P < 0.05) over time from 0.148 to 0.438 mg/mL (d 0 to 28 postweaning), but was not 
affected by dietary prebiotic. In conclusion, with the exception of subtle decreases in feed 
efficiency, prebiotic supplementation had no effect on growth performance or serum IgA 
concentrations in weanling pigs. 
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Many factors affect control of feed intake and regulation of energy balance including 
external (e.g., environment) and internal (e.g., hormones) factors. The objective was to 
evaluate effects of nutrient restriction on feed efficiency, apparent total tract digestibility 
(ATTD), and an immune biomarker in growing-finishing pigs. Crossbred barrows (n = 
36; initial BW = 52.3 kg) were randomly allotted to 36 individual pens with 2 dietary 
treatments in an 8 wk experiment. Treatments included a control (ADLIB; n = 16 pigs) 
diet formulated to meet or exceed 2012 NRC requirements and an energy restricted 
(RESTR; n = 16) diet. Pigs maintained on RESTR were provided feed representing a 
50% (wk 1) or 25% (wk 2 to 8) reduction in amount of feed relative to amount of feed 
provided to ADLIB pigs. All diets were corn-soybean meal-based, fed in 2 phases (phase 
1, wk 1 to 4; phase 2, wk 5 to 8) and contained 0.5% TiO2 (digestibility marker). Feed 
disappearance and individual BW were measured weekly for determination of ADG, 
ADFI, G:F. At the end of each phase, fecal samples were collected from each pig twice 
daily for 3 consecutive days and pooled by phase. Feces were analyzed for DM, TiO2, 
and GE. Blood samples were collected from each pig (wk 0, 1, 2, 4, 6, and 8) and serum 
analyzed for C-reactive protein (CRP). No differences in BW (P = 0.79) were observed 
on d 0 and RESTR pigs had lower (P < 0.001) BW compared to ADLIB at subsequent 
time points. Final mean BW was 100.5 and 112.0 kg, respectively for RESTR and 
ADLIB pigs. Overall, ADG (0.86 vs. 1.05 kg) and ADFI (2.65 vs. 3.44 kg) decreased 
(P < 0.001) and G:F (0.37 vs. 0.34 kg/kg) increased in RESTR compared to ADLIB pigs, 
respectively. With respect to ATTD, no differences were detected in phase 1; however, in 
phase 2, DM (83.45 vs. 81.62%) and GE digestibility (82.88 vs. 80.87%) was increased 
(P < 0.008) in RESTR compared to ADLIB pigs, respectively. For CRP, no overall 
differences were observed; however, CRP tended to decrease (P = 0.06) in RESTR 
compared to ADLIB pigs in wk 1. Pigs may compensate for nutrient restriction by 
becoming more efficient with respect to nutrient assimilation. 
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Data from a previous PCV2b experimental challenge revealed the presence of a QTL 
associated with viral load, a measure of susceptibility. A study was conducted to evaluate 
the effects of this QTL on growth in PCV2b-experimentally infected and vaccinated pigs. 
Before challenge the pigs were genotyped for the QTL (CC, resistant; TT, susceptible; 
and CT) and profiled for PCV2-specific maternal antibodies. Experimental pigs were 
either vaccinated (VAC) at 3 wk of age, or inoculated (NOV) with PCV2b at 5 wk of age. 
Pigs (n = 111) were allocated to 5 groups; VAC included pigs with CT and TT genotypes 
while NOV included pigs with all genotypes. Pigs were allocated to pens by genotype-
PCV2b treatment, and were ad libitum fed an antibiotic free, corn-soybean meal based 
nursery diet that met or exceeded NRC (2012) requirements. Titanium dioxide was added 
to the diet as an indigestible marker. Feed disappearance and individual BW were 
obtained weekly for determination of ADG and feed disappearance. Blood (for viremia 
analysis) and fecal samples (for microbiome analysis; data not shown) were collected 
weekly. Pen fecal samples were collected at wk 2, 4, and 6 for digestibility analyses (data 
not available). Overall, ADG, feed disappearance, and BW were not different between 
treatment, genotype, or treatment × genotype (P > 0.10). In the NOV group, 
the CC genotype had numerically greater BW than CT and TT genotypes throughout the 6 
wk trial (33.9, 30.9, and 29.5 kg at wk 6, respectively). This trend, with the C allele being 
considered favorable, was consistent in the VAC pigs (CT = 32.8 kg; TT = 30.4 kg). 
Although d 7–28 viremia data showed an increased viral titer in NOV pigs as expected, 
the CC genotype had a reduced titer compared with the CT and TT genotypes (P < 0.05). 
These preliminary data suggest that selection for the CC genotype may reduce the need 
for PCV2 vaccination by providing greater resistance to PCV2 challenge compared to the 
other genotypes. However, additional research is needed to delineate the long term and 
cellular effects of this QTL. 
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